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Abstract 
 
The high affinity iron scavenging glycoprotein transferrin sequesters trace 
amounts of serum Fe3+ to concentrations below what is required to sustain 
microbial life.  Iron may be liberated from this important innate immune factor 
after interaction with molecules that chelate or reduce Fe3+.  Organisms with 
cognate transport systems for these iron coordinating molecules can survive in 
the bloodstream using transferrin iron. 
Staphylococcus aureus is an opportunistic bacterial pathogen.  S. aureus 
executes numerous strategies for overcoming the innate immune barrier of iron 
deprivation in the bloodstream.  In addition to specialized mechanisms for 
hemoglobin iron extraction, S. aureus can proliferate on serum iron, but factors 
enabling this growth are not described.  Production of at least two siderophores 
(microbial iron chelators) has been documented on numerous occasions, and 
their contribution to growth on transferrin is documented here.  Genomic 
inactivation of genes involved in production of molecules subsequently termed 
staphyloferrin A (SA; the sfa locus) and staphyloferrin B (SB; the sbn operon) 
resulted in a mutant severely incapacitated for growth in serum as well as on 
rarefied human transferrin as sole iron sources.  Transport of staphyloferrins 
was correlated to adjacently encoded cognate ABC type transporter operons, 
hts (SA) and sir (SB), using previously constructed transport mutant strains.  
Mass spectrometry confirmed the molecular structure of SB as being the same 
as the previously described S. aureus metabolite, staphylobactin. 
Alternate siderophores were not detectable for the double biosynthetic 
iv 
  
mutant.  Growth in the presence of transferrin could be rescued by addition of 
saturating concentrations of iron, and restored by molecules that bind Fe3+ 
through catechol-iron coordination, including mammalian catecholamine stress 
hormones.  In silico analysis and mutational inactivation confirmed this transport 
function to be encoded by the sst operon.  Biochemical assays revealed that the 
Sst transporter lipoprotein has a high affinity for ferrated catecholate iron 
ligands. 
Siderophore biosynthesis and transport mutants displayed reduced 
virulence during systemic mouse infection.  Decreased bacterial loads were 
documented in mouse hearts, an important finding as S. aureus is a leading 
cause of endocarditis.  The data collected in this study show that acquisition of 
serum iron is an important part of staphylococcal pathogenesis, and suggest 
that therapeutics targeting the numerous facets of this process may be effective 
in combating invasive infection. 
 
Keywords:  Staphylococcus aureus, siderophores, staphyloferrin A, 
staphyloferrin B, serum, transferrin, ABC transporters, catecholamine hormones, 
catechol siderophores, mouse infection model 
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1.1   Iron 
1.1.1   Iron chemistry 
With the exception of some lactobacilli and spirochaetes (8, 204), iron is an 
essential nutrient for bacteria.  Iron is most commonly found in Fe(II) (ferrous) 
and Fe(III) (ferric) valence states; however, it is able to achieve valence ranging 
from Fe(-II) to Fe(IV), and is amenable to ligand-mediated transition through a 
redox range of -750 to +1150 mV at neutral pH (198), making it an exceptionally 
versatile catalyst.  The heme centre of cytochromes is crucial to respiratory and 
photosynthetic ATP biosynthesis; Fe–S clusters are central to redox reactions 
mediated by proteins such as nitrogenase and hydrogenase; and iron is a 
cofactor for numerous other metalloproteins.  In aerobic, oxidizing environments, 
iron predominates in the ferric form (Fe3+), forming poorly soluble hydroxides.  A 
widely cited calculation describes the primary Fe3+ species in pH neutral solution 
to be Fe(OH)3, restricting solubility to 10
-18 M (93, 225).  A revised solubility 
calculation posits Fe(OH)2
+ to be the primary species, improving solubility to 
almost 10-9 M (41); nevertheless, this is below the threshold required to sustain 
microbial life in the absence of specialized acquisition mechanisms. 
 
1.1.2   Iron toxicity 
In spite of low solubility, residually soluble iron is a hazardous catalyst.  
Fe2+ readily reacts with hydrogen peroxide, generating hydroxyl radical, as 
shown in equation 1 (105).  Soluble Fe3+ is renewed to Fe2+ by reaction with 
superoxide, shown in equation 2 (13). 
  
3 
 
Fe2+ + H2O2    Fe
3+ + OH• + OH-  (equation 1) 
Fe3+ + O2
-    Fe2+ + O2   (equation 2) 
 
Hydroxyl radical generated through equation 1 is extremely cytotoxic, 
being reactive with cell membranes (19), and inducing single and double strand 
breaks in DNA (30, 252).  To mitigate toxicity of catalytic iron, most biological 
systems control iron levels tightly using high affinity storage and transport 
proteins, described below. 
 
1.2   Iron absorption and storage in mammalian systems 
1.2.1  Iron absorption 
The average human body contains three to four grams of iron (26).  The 
process of absorption from dietary sources, reviewed here (5, 75), occurs 
principally in the duodenum.  Briefly, Fe3+ is reduced to readily soluble Fe2+ by 
the low pH of the intestinal lumen, and by the duodenal cytochrome B (DCytB), 
found on the apical membrane of the duodenal enterocyte.  Fe2+ is transported 
into enterocytes through a proton-coupled solute transporter, DMT1.  Release of 
Fe3+ from erythrocytes into plasma occurs through a solute carrier, ferroportin.  
In plasma, Fe3+ is bound by the carrier protein transferrin, which is described in 
detail below.   
A surplus of bodily iron stimulates release of the peptide hormone hepcidin 
from the liver.  Hepcidin binds to ferroportin on enterocytes, triggering its 
degradation and internalization.  Rather than being passaged into plasma, 
subsequently absorbed dietary iron is instead compartmentalized within the 
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protein ferritin (described next), and excess iron can be shed through sloughing 
of enterocytes into the feces. 
 
1.2.2   Bodily iron reservoirs:  ferritin 
Ferritin is a stable, hollow, 450 kDa proteinaceous sphere composed of 24 
“heavy” and “light” subunits, capable of harbouring up to 4500 Fe3+ atoms (35).  
Ferritin is an important component of iron homeostasis in the body, specifically 
in regards to storage of surplus iron in a soluble and nontoxic form, and is found 
with high conservation in eukaryotes and prokaryotes alike (7).  In animals, 
ferritin is most abundant in liver hepatocytes, which act as the body’s primary 
iron reserve (25).  Release of ferritin into serum may aid in iron delivery from the 
liver to other tissues (73, 86).  More importantly, elevated serum ferritin serves 
to reduce iron overload caused by hemochromatosis or some cancers (262). 
 
1.2.3   Bodily iron reservoirs:  heme and heme carrier proteins 
The majority of iron in humans is found within heme prosthetic groups of 
metalloproteins, including peroxidases, cytochromes, and most abundantly, in 
the hemoglobin of erythrocytes, which contain around two-thirds of the total 
bodily reservoir (69).  Variations on heme structures exist.  The primary 
mammalian form is heme-b, a planar molecule composed of a large heterocyclic 
ring (protoporphyrin IX) with four central nitrogen atoms coordinating one atom 
of ferrous iron.  The two remaining uncoordinated positions of heme iron permit 
interactions with axial ligands, including histidine/cysteine/methionine/tyrosine 
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residues of heme carrier proteins, water, or small molecule aqueous solutes, the 
most noteworthy being oxygen.  
The largest reservoir of bodily heme is the circulatory hemoglobin pool.  
Hemoglobin is a globular heterotetramer found within erythrocytes whose 
primary function is to bind O2 to heme prosthetic groups and deliver it from the 
lungs to all other tissues.  Human blood contains approximately 1.3 x 1018 
hemoglobin tetramers per mL (adapted from reference range provided by the 
Department of Pathology at the University of Texas Southwestern Medical 
Centre).  Erythrocyte lysis and oxidative hemoglobin degradation leads to heme 
liberation into serum.  Owing to its hydrophobicity, heme can intercalate into lipid 
bilayers, and is reactive with H2O2, producing hydroxyl radicals that lead to 
tissue damage (219).  Capture of extracellular heme is a vital maintenance 
function for bodily well being and mechanisms exist for its removal. 
Serum hemoglobin is scavenged by the glycoprotein haptoglobin (88).  
Haptoglobin irreversibly forms a soluble complex with hemoglobin.  The complex 
is recognized by a specific receptor expressed on the surface of macrophages, 
internalized, then degraded (138).  Iron captured in this fashion is released back 
to the serum in hemosiderin, a molecular aggregate comprised mostly of ferritin 
and denatured ferritin (71, 119, 270).  Serum heme is readily bound by low and 
high density lipoprotein (175).  This binding is transient, as the heme is then 
gradually removed by the glycoprotein hemopexin (120).  Hemopexin delivers 
heme back to the liver, where it is internalized by receptor-mediated 
endocytosis; hemopexin is a true iron carrier protein, as it is released back into 
circulation undegraded (121).   
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1.2.4   Bodily iron reservoirs:  transferrin and lactoferrin 
Less than 5 mg of bodily iron (<0.1%) is found in the labile pool circulating 
within serum and lymph (adapted from (256)); this fraction, however, undergoes 
the highest turnover.  After ferroportin-mediated export of dietary Fe3+ occurs 
from intestinal enterocytes, the binding and redistribution of iron in serum is 
performed chiefly by transferrin, an 80 kDa glycoprotein synthesized by the liver.  
The transferrin reference range for healthy adult serum is roughly 25 to 30 µM 
(adapted from (12)).  Transferrin has two high affinity Fe3+ binding sites, with 
equilibrium constants of 4.7 x 1020 M-1 and 2.4 x 1019 M-1 at physiological pH; 
both have negligible affinity for Fe2+ (3).  Binding of Fe3+ at either site is random 
and noncooperative (1).  Serum transferrin is about 30% iron saturated in 
healthy individuals; saturation below 20% is a clinical indicator of iron deficiency 
(269).  Transferrin is the primary agent of circulatory iron distribution, and its 
mode of action is summarized here (122).  Briefly, upon contacting recipient 
tissue cells, ferrated (holo) transferrin binds a ubiquitously expressed cell 
membrane receptor.  The amount of receptor found on a cell membrane is 
directly proportional to the cell’s iron demand.  Binding triggers endocytosis and 
internalization within a vesicular compartment, which is acidified to promote 
dissociation of iron.  Fusion of the vesicle with the cell membrane returns 
deferrated (apo) transferrin, to the cell surface, where it is released back into 
circulation.  Percent saturation of serum transferrin is sensed through the 
transferrin receptor and an interacting protein, human hemochromatosis factor 
(HFE protein), with increased saturation being a key stimulus for upregulation of 
hepcidin production, decreasing absorption of dietary iron (83). 
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The glycoprotein lactoferrin is highly related to transferrin in sequence 
(61.4% identical) and structure (260).  This iron scavenging protein is found 
primarily in secretions such as mucus, milk, and tears, and releases iron at a 
much lower pH than transferrin (pH 3.0 vs 5.5) (11).  It is also released by 
polymorphonuclear leukocytes as an antimicrobial agent during degranulation 
(47).  Lactoferrin has no demonstrated role in iron transport, but is an important 
contributor to bacteriostasis in tissues and bodily fluids, by reducing the amount 
of iron available to pathogens (206, 210); this aspect of bodily iron homeostasis 
is discussed next. 
 
1.2.5   Iron sequestration and innate immunity 
Restricting iron availability is crucial for limiting the spread of infection in 
blood.  Conversely, iron overload associated with diseases such as 
hemochromatosis increases susceptibility to bacteremic infection (130).  The 
inflammatory response involves suppressing uptake of dietary iron.  This 
renders serum anemic, a phenomenon known as hyposideremia.  In this 
fashion, uptake of dietary iron can be further reduced even if transferrin 
saturation is already low.  Hepcidin production by the liver and spleen is 
increased during inflammation (187, 199), and this is mediated at least in part by 
cytokines interleukin-6 (185) and interleukin-1α and 1β (142).  Hepcidin binding 
to ferroportin on intestinal enterocytes triggers degradation of this transport 
protein and reduces absorption of dietary Fe3+ (186).   
Hyposideremia also involves increasing levels of circulating iron binding 
proteins.  Serum ferritin levels increase due to upregulated secretion by hepatic 
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cells in response to interleukin-1 (217, 254).  Serum lactoferrin increases during 
septicemia and viral infection, as degranulating neutrophils deliver lactoferrin to 
sites of infection, leading to localized sequestration of iron (103, 163, 208).  
Hepatocyte secretion of the hemoglobin/heme removal proteins haptoglobin and 
hemopexin is also upregulated during the acute phase response (158, 263).  
Only one serum iron transport protein is maintained at a stable concentration 
during inflammation:  transferrin (191).  Its contribution to innate immunity should 
not be understated, however.  The iron binding capacity of the transferrin pool is 
routinely high, as average saturation rarely exceeds 50% (214).  When dietary 
absorption is repressed by acute phase increases in circulating hepcidin, the 
labile transferrin-bound iron supply is more rapidly depleted by erythropoiesis 
(205), effectively increasing the iron binding capacity of serum. 
 
1.3   Bacterial strategies for acquisition of host iron 
1.3.1   Active transport of iron ligands:  an overview 
As outlined above, animal serum maintains a consistently low level of 
freely dissolved iron through complexation to an abundant pool of transferrin.  
The labile iron pool may be further depleted through enhanced production of 
other serum iron scavenging proteins during the acute phase inflammatory 
response to disease.  This effectively limits the amount of free iron below the 
threshold required to support microbial growth, meaning invasive pathogens 
must respond by expressing specialized, high affinity iron transport systems. 
Bacteria import iron from the host milieu primarily as a liganded substrate.  
This can include heme extracted from host carrier proteins, or Fe3+ coordinated 
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by bacterial or host-synthesized molecules in a stable and kinetically labile 
arrangement.  At the bacterial cytoplasmic membrane, most examples of iron 
transport are active processes involving ATP-binding cassette (ABC) 
transporters (Figure 1-1).  These systems comprise three functional domains.  
The first is a high affinity receptor for recognition of the transported substrate; in 
Gram-positive bacteria this is covalently linked to the cytoplasmic membrane at 
a N-terminal lipidation motif, while in Gram-negative bacteria it is usually freely 
soluble in the periplasmic space.  The second domain comprises the permease, 
a homodimeric or heterodimeric transmembrane domain which associates with 
the receptor and permits solute transport through the lipid bilayer.  The final 
domain is an ATPase, a cytosolically-located, permease-associating, dimeric, 
ATP-hydrolyzing unit.  The different components of the ABC transporter are 
usually distinctly translated proteins, but examples of translational domain 
fusions exist.  (For a more comprehensive review on bacterial ABC transporters, 
see (52).) 
In Gram-negative bacteria, the presence of an outer membrane and a 
periplasm necessitates additional components for substrate capture 
(Figure 1-1).  An outer membrane receptor protein is involved in substrate 
recognition.  A cytoplasmic membrane complex, comprising proteins TonB, 
ExbB, and ExbD, captures energy generated by proton motive force across the 
cytoplasmic membrane to drive substrate transport through the outer membrane 
receptor into the periplasm.  The outer membrane receptor is a pore-forming 
β-barrel protein occluded by a N-terminal β-sheet “plug” domain.  
Conformational changes induced by ligand binding and interaction with TonB  
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Figure 1-1:  Model of active ligand transport in Gram-negative and Gram-
positive bacteria.  (A)  Model of transport in Gram-negative bacteria.  Substrate 
(yellow star with red centre) is recognized at the outer membrane by the outer 
membrane receptor (OMR) and transported into the periplasm with energy 
provided by the Ton complex (TonB/ExbD/ExbB).  A periplasmic binding protein 
(PBP) captures the substrate and delivers it to an ABC transporter comprising a 
homo- or heterodimeric permease (P) and dimeric ATPase (A), the latter 
hydrolyzing ATP to drive translocation of the substrate into the cytoplasm.  
(B)  Model of transport in Gram-positive bacteria.  Substrate at the outer face of 
the cytosolic membrane binds to a receptor lipoprotein (LP) and is translocated 
through a permease (P) with energy coming from ATPase-mediated (A) ATP 
hydrolysis.   
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move the plug to relieve occlusion, permitting translocation of the substrate to 
the periplasm, where it is recognized by the periplasmic binding protein.  (For 
excellent, comprehensive reviews of Gram-negative transport across the outer 
membrane and periplasm, consult (66, 137).) 
 
1.3.2   Heme uptake:  capture from heme carrier proteins  
The majority (~65%) of bodily iron is found in heme groups of hemoglobin, 
sequestered in red blood cells (48).  The overwhelming abundance of 
hemoglobin in the mammalian host has selected for pathogens capable of 
exploiting this iron pool using specialized uptake mechanisms.  In 
Gram-negative bacteria, heme uptake is initiated by binding of heme or 
hemoproteins to a bacterial outer membrane protein.  In the case of Neisseria 
spp., two independent outer membrane receptors are involved.  HmbR is a 
β-barrel/plug protein which recognizes heme and hemoglobin (242).  HpuAB is a 
bipartite receptor, involving a β-barrel outer membrane protein (HpuB) working 
in concert with an outward facing lipoprotein (HpuA); this complex binds 
hemoglobin as well as hemoglobin-haptoglobin (148).  Some bacterial outer 
membrane receptors recognize a variety of host hemoproteins; PhuR from 
Pseudomonas aeruginosa can bind heme, hemoglobin, haptoglobin-
hemoglobin, and hemopexin (192).  The mechanism(s) by which receptor 
proteins disengage heme from the host protein are not well described.  
Following extraction, passage of heme through the periplasm may require a 
periplasmic binding protein, as exemplified by PhuT of P. aeruginosa; this also 
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serves as the receptor component of the ABC-type transporter at the 
cytoplasmic membrane (248). 
Heme capture by Gram-positive bacteria has received less scrutiny.  
Recognition of hemoproteins by pathogens including Staphylococcus aureus, 
Bacillus, and Group A Streptococcus occurs at the outer face of the cell wall and 
requires a complement of cell wall-anchored proteins that bind hemoproteins, 
extract heme, and serially passage it through the peptidoglycan to cytoplasmic 
membrane ABC transporters (84, 152, 168, 277).  The iron-regulated surface 
determinant (Isd) system of S. aureus is fairly well understood and will be 
described in more detail in a later section. 
 
1.3.3   Heme uptake:  hemophores 
Hemophores are secreted proteins that extract heme from solution or from 
heme carrier proteins and deliver it to the bacterial cell.  The HasA hemophores 
form a unique, highly conserved family of proteins produced by pathogenic 
bacteria including Serratia marcescens (144), P. aeruginosa (146), and Yersinia 
pestis (218).  HasA binds a large number of heme carrier proteins, including 
hemoglobin and hemopexin (261).  Due to its binding affinity for heme 
exceeding that of host carrier proteins, transfer of heme is passive (145).  An 
active, TonB-dependent transfer occurs at the bacterial surface, where outer 
membrane receptor protein HasR initiates passage of the heme molecule into 
the periplasm and toward the cytoplasmic membrane (143).  Hemophore 
production by Gram-positive bacteria has been documented only for Bacillus 
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anthracis, which secretes soluble proteins with heme-binding motifs homologous 
to those found in its Isd system (157). 
 
1.3.4   Direct uptake of Fe3+ from transferrin 
Some bacteria secure transferrin and lactoferrin iron through direct binding 
and manipulation of these serum proteins using cell surface receptors.  The best 
documented transferrin receptor system is found in Neisseria spp.  This involves 
a bipartite outer membrane receptor complex, TbpAB, that binds transferrin and 
conformationally manipulates it to force release of Fe3+ (44, 150).  TbpB, the 
outer membrane β-barrel protein, delivers Fe3+ to periplasmic chaperone FbpA; 
surprisingly, this transfer is not energetically dependent on TonB (194).  
FbpABC form an ABC-type transporter for active uptake of Fe3+ into the 
bacterial cytoplasm (131).  Sporadic reports of transferrin binding by cell wall 
proteins of Gram-positive bacteria exist (111, 177, 247), but mechanistic data 
are lacking; this phenomenon may merely reflect the promiscuity cell wall 
adhesion factors demonstrate in interacting with a range of host molecules. 
 
1.3.5   Indirect uptake of Fe3+ from transferrin:  siderophores 
Siderophores are small, high affinity Fe3+ chelators secreted by numerous 
bacteria, fungi, and plants in response to the stress of iron limitation.  They 
scrounge soluble ferric iron or compete for it with other high affinity iron 
chelators.  As will be discussed in greater detail in ensuing sections, 
siderophores come in a wide variety of molecular structures (also reviewed here 
(113)).  Cellular uptake is preceded by ligand recognition through cell surface 
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receptors that are highly specific for particular molecular features of the 
substrate, rendering siderophore iron a privilege of organisms equipped with 
cognate transporters.  Many siderophores are competitive with transferrin and 
lactoferrin for iron binding, and siderophore production has been shown to 
contribute to growth of numerous bacteria in serum (Table 1-1). 
 
1.3.6   Indirect uptake of Fe3+ from transferrin:  catecholamine stress 
hormones 
The low affinity of transferrin and lactoferrin for Fe2+ means their function 
may be compromised by interaction with agents that reduce Fe3+.  Recent 
studies have demonstrated that the catecholamine stress hormones, including 
adrenaline (epinephrine), noradrenaline (norepinephrine), dopamine, and 
L-3,4-dihydroxyphenylalanine (L-DOPA), are capable of forming direct 
complexes with holotransferrin and hololactoferrin, and reductively liberating iron 
as Fe2+ (80, 220).  Although Fe2+ is readily reoxidized in biological fluids, 
catecholamines have been proposed to provide the hexadentate coordination 
required to stabilize Fe3+ in solution via their catechol moieties, in a 3:1 molar 
ratio (220); thus these hormones may also act as biological chelators that 
compete with transferrin. 
Elevated levels of catecholamines have been correlated to higher rates of 
postoperative sepsis (99) and experimental elevation of systemic norepinephrine 
has been shown to promote translocation of enteric bacteria in mice (156).  
Addition of catecholamines stimulates growth on transferrin or serum for 
pathogenic bacteria including Bordetella bronchiseptica (6), Escherichia coli 
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Table 1-1:  Siderophores contributing to growth of bacteria in the presence 
of transferrin or in serum 
Species Siderophore Ref. 
Aeromonas spp. Amonabactin (161) 
Bordetella bronchiseptica Alcaligin (78) 
Burkholderia cepacia Salicylic acid (233) 
Escherichia coli Aerobactin, enterobactin (135) 
Mycobacterium spp. Exochelins (59, 90) 
Pseudomonas aeruginosa Pyoverdin, pyochelin (238) 
Pseudomonas pseudomallei Malleobactin (276) 
Salmonella enterica Salmochelin, enterobactin (265) 
Staphylococcus aureus Staphyloferrins A and B This study 
Vibrio parahaemolyticus Vibrioferrin (274) 
Vibrio vulnificus Vulnibactin (151) 
Yersinia pestis Yersiniabactin (67) 
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(220), and Staphylococcus epidermidis (184). 
 
1.3.7   Uptake of Fe2+ 
Under aerobic (oxidizing) conditions, iron predominates in solution as Fe3+; 
under anaerobic or microaerophilic conditions, however, transport of Fe2+ is a 
relevant iron uptake strategy for many bacteria, involving the Feo (ferrous iron) 
transport system.  First characterized in Escherichia coli (107, 127), this 
comprises two or three proteins:  1) FeoB, a large protein with an integral 
membrane domain, acting as the permease component (127), and a N-terminal 
G-protein domain, acting as a GTPase driving active transport of Fe2+ (159); 
2) FeoA, a small, cytosolic protein that activates the GTP-hydrolyzing activity of 
FeoB; 3) FeoC, a small hydrophilic protein associated only with γ-proteobacterial 
Feo systems, that may be a transcriptional repressor (32).  FeoB-mediated iron 
uptake from the gastrointestinal tract contributes to colonization by and 
pathogenesis of Campylobacter jejuni (183) and Helicobacter pylori (258); FeoB 
also contributes to intracellular growth of Legionella pneumophila (215). 
FeoB-mediated uptake of Fe2+ could theoretically work in concert with 
mechanisms that reductively convert Fe3+ on or around the bacterial surface.  
Extracellular ferric reductase activity has been reported for several bacteria 
(224, 257), but few reports empirically demonstrate a role for this phenomenon 
in microbial iron acquisition.  Insofar as extracellular reduction contributes to the 
iron uptake strategy of pathogenic bacteria, this has only been shown for 
capture of transferrin and lactoferrin iron by Listeria monocytogenes under 
anaerobic conditions (14). 
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1.4   Siderophores 
1.4.1   Siderophore chemistry and iron coordinating groups 
Numerous plants, fungi, saprotrophic bacteria, and bacterial pathogens 
secrete small molecules called siderophores to serve as high affinity Fe3+ 
scavengers.  Siderophores are assembled from amino acids, organic acids, and 
other small organic metabolites.  Huge diversity has been documented in terms 
of the structure and iron-binding affinity of these compounds, although some 
broadly shared themes describe their physicochemical properties (for more 
comprehensive reviews, see (49, 171, 261)).  Siderophores are small, being 
typically less than 1 kDa in mass.  They are highly electronegative and surround 
Fe3+ to form a hexacoordinated complex involving three bidentate coordinating 
sites, although the stoichiometry of iron atoms to siderophore coordinating 
groups may vary if surrogate oxygen, nitrogen, or sulfur donors from solution 
compensate for vacancies.  The stoichiometry of siderophore molecules to iron 
atoms may also deviate from 1:1 if the siderophore has more or less than three 
coordination moieties; rhodotorulic acid, for instance, has four, and coordinates 
iron in a 2:3 (Fe3+:siderophore) molecular ratio.   
In general, three types of functional groups can act as siderophore iron 
coordination motifs (Figure 1-2A).  First are the adjacent hydroxyl groups of 
catechol moieties (ortho-dihydroxybenzene), exemplified in the enterobactin 
structure (Figure 1-2B) (123).  This siderophore group forms extremely stable 
ligand-Fe3+ complexes and includes some of the strongest known iron chelators.  
Most functional groups of catecholate siderophores are derived from a common 
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Figure 1-2:  Siderophore Fe3+ coordination group types.  (A)  Siderophores 
coordinate Fe3+ in solution using catecholate, hydroxamate, or carboxylate 
moieties (Fe3+-coordinating atoms in red).  (B)  Examples of siderophores 
include enterobactin (catecholate coordination), coprogen B (hydroxamate 
coordination), rhizoferrin (carboxylate coordination), and petrobactin (mixed 
catecholate and carboxylate coordination) (Fe3+-coordinating atoms in red).  
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precursor, 2,3-dihydroxybenzoic acid (Figure 1-3) (49).  This molecule is itself 
capable of coordinating Fe3+ in a 3:1 molecular ratio, and is secreted as a 
siderophore by bacteria including Brucella abortus (154), Azospirillum lipoferum 
(222), and Rhizobium leguminosarum (195).  Structurally similar biological 
molecules, including mammalian catecholamine stress hormones (Figure 1-3), 
have also been proposed to coordinate iron in solution; invasive bacteria with 
cognate transport systems could theoretically capitalize on these to meet 
nutritional iron demands (220). 
The second type of siderophore iron coordination involves hydroxamate 
motifs (Figure 1-2A), where adjacent carbonyl and aminohydroxyl groups 
provide an iron coordination site, as in coprogen B (Figure 1-2B) (271).  This 
chemistry is frequent among fungal siderophores.  The third type of coordination 
involves carboxylate motifs (Figure 1-2A).  These may involve two sites provided 
by α-hydroxycarboxylates derived from citrate, or from carboxylic acid moieties, 
as in rhizoferrin (Figure 1-2B).  Numerous siderophore molecules, such as 
petrobactin (Figure 1-2B) and aerobactin use combinations of the three iron 
coordinating groups (110, 141).  
 
1.4.2   Nonribosomal peptide synthetase assembly 
Siderophore assembly pathways fall into two broad classes:  nonribosomal 
peptide synthesis (NRPS) and NRPS-independent siderophore (NIS) synthesis 
(34).  NRPS siderophores involve polypeptidic scaffolds, often incorporating 
nonproteinogenic amino acids and their derivatives, assembled without the 
benefit of a ribosomal template (49).  Numerous NRPS siderophores have been 
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Figure 1-3:  3:1 coordination of Fe3+ in solution by small catecholate 
molecules.  (A)  Coordination of Fe3+ by three molecules of 2,3-
dihydroxybenzoic acid (DHBA).  (B)  Catecholamine stress hormones, which 
have been proposed to coordinate Fe3+ in an arrangement mimicking DHBA.  
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described, including enterobactin (207), yersiniabactin (173), and vibriobactin 
(129).  Important antibiotics such as penicillin (223) and vancomycin (244) are 
also NRPS metabolites.  Independently of a ribosome, NRPS siderophores are 
condensed and modified stepwise on a multimodular enzyme, the NRP 
synthetase, for which the roles of functional domains can be summarized as 
follows (243):  1) Activation of an amino acid or growing intermediate 
aminoacyl-AMP by adenylation domains; 2) Transfer to peptidyl carrier protein 
(PCP) domains; 3) Condensation of PCP-bound amino acids by condensation 
domains; 4) Amino acid modifications, for example by epimerization domains;  
5) Transesterification (TE) of the peptide chain from the terminal PCP onto the 
TE domain, with subsequent liberation of the mature metabolite through 
hydrolysis or macrocyclization.  The modular arrangement of the NRPS 
synthetase essentially creates a protein assembly line, allowing metabolite 
assembly and modification to occur in a progressive, stepwise fashion. 
 
1.4.3   Nonribosomal peptide synthetase independent assembly 
Less well characterized are the mechanisms for assembly of NIS 
siderophores.  These are created from the condensation of alternating subunits 
of dicarboxylic acids (usually succinate, citrate, and α-ketoglutarate) with 
diamines, amino alcohols, and alcohols (34).  NIS synthetases are not 
homologous to their modular counterparts in NRPS pathways.  They primarily 
serve to catalyze formation of amide and ester bonds between an organic acid 
and a substrate bearing an amino or a hydroxyl group (34).  Individual NIS 
reactions are performed by individual synthetases.  The proposed assembly of 
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aerobactin represents the archetypal pathway of NIS biosynthesis (54, 55), even 
though the biochemical roles of synthetases IucA and IucC have not been 
empirically characterized.  Elucidation of the molecular structure of other 
siderophores and annotation of the genetic loci encoding their biosynthesis 
suggest rhizobactin (155), achromobactin (79), vibrioferrin (246), and alcaligin 
(128) are also assembled in an NRPS-independent fashion.  Recent efforts have 
described the pathway involved in production of petrobactin (141, 197), which is 
a rare example of a siderophore assembled via a hybrid NRPS/NIS strategy. 
A model has been proposed to classify NIS synthetases based on 
specificity for a carboxylic acid (34, 126).  Type A enzymes, represented by 
IucA, catalyze condensation of a prochiral carboxyl group of citrate to an amine 
or alcohol functional group of a second substrate, resulting in an amide or ester 
bond, respectively.  Type B enzymes catalyze a similar reaction substituting the 
C5 carboxyl of α-ketoglutarate for the citrate carboxyl.  Type C enzymes, 
represented by IucC, catalyze condensation of monoamide/monoester 
derivatives of citrate or succinate to carboxyl groups on molecules with an amine 
or an alcohol.  For the most part, predictions of NIS synthetase type based on 
phylogenetic analysis have accurately described their role in functional enzyme 
assays, but this is based on limited data, and at least one exception is known 
and will be discussed in a later section.  Additional modifications to precursors, 
such as decarboxylation, isomerization, or oxidation, are performed by separate 
enzymes typically encoded by genes clustering near to those encoding the 
synthetases. 
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1.4.4   Siderophore uptake and iron liberation 
In Gram-negative bacteria, siderophore import to the periplasm is mediated 
by outer membrane receptors and the Ton system, as previously described.  
Siderophore transport across the bacterial cytoplasmic membrane is typically 
performed by ABC-type transporters.  Genetic loci for ABC transporters often 
reside in close genomic proximity to loci involved in biosynthesis of the cognate 
siderophore.  Siderophore binding proteins sometimes exhibit plasticity in their 
substrate affinity, recognizing multiple siderophores within the same iron 
coordination chemistry.  Examples include E. coli FhuA and FhuD, the outer 
membrane receptor and periplasmic binding proteins, respectively, for 
aerobactin and a broad host of exogenously derived hydroxamate type 
siderophores (65, 136).  Homologous FhuD lipoproteins in S. aureus also 
recognize a variety of actively transported hydroxamate molecules (226). 
Upon cellular internalization, two mechanisms may be used for liberation of 
siderophore-bound iron.  Extraction from exceptionally high affinity siderophores 
often requires destruction of the molecule, while those with lower affinity may be 
deferrated through a reductive mechanism.  Both scenarios occur in E. coli.  
Enterobactin, the strongest known siderophore (Kd = 10
52 M-1), is cleaved by 
esterase FesA at ester groups in the trilactone backbone, yielding subunits of 
2,3-dihydroxybenzoyl-L-serine (43); concomitant reduction of Fe3+ occurs 
through an unknown mechanism (29).  On the other hand, the hydroxamate 
siderophore aerobactin, with a more modest affinity for Fe3+, is acted upon by 
cytoplasmic ferrisiderophore reductase FhuF, yielding Fe2+ for cellular 
processes, and reusable aposiderophore (166). 
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1.4.5   Contributions to virulence 
Numerous studies have demonstrated the impact of siderophore-mediated 
iron uptake on virulence, even among organisms capable of extracting host 
heme iron; key reports are summarized in Table 1-2.  Pathogenic bacteria may 
also produce siderophores for survival outside of a host niche, and rely on other 
iron uptake strategies in vivo; for instance, production of a catecholate 
siderophore is important for survival of the veterinary pathogen Rhodococcus 
equi as an environmental saprotroph, while having no significant impact on 
virulence in a murine infection model (176). 
 
1.4.6   Siderocalin and stealth siderophores 
The lipocalins are a family of roughly 20 small, soluble proteins, produced 
by prokaryotes and eukaryotes.  Their three dimensional structure comprises an 
eight-stranded anti-parallel β-barrel that forms a cavity capable of enclosing low 
molecular weight solutes (77).  The mammalian protein lipocalin-2, alternately 
named neutrophil gelatinase-associated lipocalin or, pertinently to this study, 
siderocalin, is secreted by macrophages and neutrophils during the 
inflammatory response to bacterial antigens such as lipopolysaccharide, leading 
to rapid rises in serum titres (76).  Expression of recombinant siderocalin in 
E. coli serendipitously revealed it binds the catecholate siderophore enterobactin 
(91), and it is now known to sequester a variety of bacterial siderophores, 
primarily those with catecholic or phenolic moieties (91, 116).  
Siderocalin-deficient mice are more susceptible to sepsis and pneumonia 
caused by E. coli strains that rely on enterobactin for siderophore-mediated iron   
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Table 1-2:  Siderophores contributing to the virulence of bacteria in animal 
models of colonization or infection. 
Species Siderophore Animal model Ref. 
Bacillus 
anthracis 
Petrobactin Mouse inhalation anthrax (31) 
Bordetella 
bronchiseptica 
Alcaligin Neonatal pig intranasal 
colonization 
(209) 
Bordetella 
pertussis 
Alcaligin Mixed competition mouse 
respiratory infection 
(28) 
Burkholderia 
cenocepacia 
Ornibactin Rat agar bead lung infection (234) 
Escherichia coli Aerobactin Mouse intraperitoneal lethal 
challenge 
(266) 
Escherichia coli Salmochelin Mouse intraperitoneal lethal 
challenge 
(72) 
Mycobacterium 
tuberculosis 
Carboxymycobactin Mouse aerosol inhalation 
infection 
(216) 
Neisseria 
gonorrhoeae 
Gonobactin Chicken embryo bacteremia (70) 
Pseudomonas 
aeruginosa 
Pyoverdin Burned mouse subcutaneous 
infection 
(170) 
Salmonella 
enterica 
Salmochelin, 
enterobactin 
Mouse cecal colonization (265) 
Salmonella 
typhimurium 
Enterobactin Mouse intraperitoneal infection (275) 
Staphylococcus 
aureus 
Staphyloferrins A 
and B 
Mouse sepsis This 
study 
Vibrio cholerae Vibriobactin Mouse suckling intragastric 
infection 
(112) 
Vibrio vulnificus Vulnibactin Mouse suckling intragastric 
infection 
(151) 
Yersinia pestis Yersiniabactin Mouse pneumonic plague, 
bubonic plague 
(67) 
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uptake (76, 272).  Siderocalin is also capable of binding catecholamine stress 
hormones (172), further enhancing bacteriostasis through iron sequestration. 
The binding of iron chelators by siderocalin is not indiscriminate, and many 
bacteria can subvert this immune factor by producing alternate, unrecognizable 
siderophores, or by incorporating structural modifications or substitutions within 
preexisting siderophore molecular templates.  Siderocalin-evading siderophores 
are frequently described using the adjective “stealth”.  The salmochelin family, 
for instance, includes enterobactin glucosylated at the C5 position of one or 
more of the molecule’s catecholic arms (22), and 2,3-dihydroxybenzoylserine 
subunits bridged by glucose residues (109).  These enzymatic modifications to 
siderocalin-cognate siderophores are mediated by genes encoded in the iroA 
cluster, a virulence locus typically situated within pathogenicity islands or 
plasmids of exceptionally virulent strains of E. coli and species of Salmonella 
(17, 60, 236).  Salmochelins are not bound by siderocalin, and iroA-expressing 
E. coli strains are insensitive to its growth inhibitory effects (72).   
The anthrax pathogen also employs a similar strategy for bypassing 
siderocalin.  B. anthracis produces two siderophores:  petrobactin, which 
coordinates iron using an unusual combination of one carboxylate and two 
3,4-catecholate moieties (Figure 1-2B) (20), and the more conventional 
bacillibactin, with three 2,3-catecholate-type coordination sites (167).  
Petrobactin is the only siderophore known incorporating 3,4-catechols.  Owing to 
this unusual chemistry, petrobactin is not recognized by siderocalin, unlike 
bacillibactin, for which siderocalin has exquisite affinity (2).  Petrobactin but not 
bacillibactin was found to contribute to the intracellular survival of B. anthracis in 
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macrophages and in a murine subcutaneous anthrax model of infection (33).  
This has been subsequently interpreted as proving a correlation between 
siderocalin evasion and pathogenesis, although other observations reveal 
bacillibactin to be dispensible in a range of host-independent conditions despite 
a high affinity for Fe3+, convoluting the narrative that acquisition of petrobactin 
biosynthesis is necessarily an evolutionary countermeasure to siderocalin.  
Petrobactin but not bacillibactin is sufficient to sustain vegetative growth of 
B. anthracis in chelated culture medium, and furthermore to induce vegetative 
growth from dormant spores (33); the chronology of siderophore production at 
the onset of vegetative growth proceeds as petrobactin first, bacillibactin second 
(267).  While petrobactin clearly contributes to the enhanced virulence of 
B. anthracis, it may be inadequate to describe its evolutionary significance 
based solely on its contribution toward virulence. 
 
1.5   Bacterial regulation of iron transport mechanisms 
1.5.1   The ferric uptake regulator is a conserved mechanism governing 
bacterial transcriptional responses to iron limitation 
A decrease in intracellular iron stores is a key sensory trigger for the 
genetic expression of iron uptake mechanisms and virulence factors that play 
roles in liberating host iron stores or circumventing host immune strategies.  The 
Fur protein (ferric uptake regulation) was first proposed for Salmonella 
typhimurium (63) and first described for E. coli (108); it is now recognized as the 
canonical global iron responsive regulator in bacteria.  Fur is a homodimeric 
transcriptional repressor whose mode of action has been reviewed extensively 
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(64, 106).  In brief, when cellular iron exceeds the level required for proper 
function of essential iron-containing metalloenzymes, association of one Fe2+ ion 
to each Fur monomer causes protein to bind a roughly 19-bp DNA motif, called 
the Fur box, within the operator region of target genes.  The E. coli-deduced 
consensus Fur box reads as GATAATGATAATCATTATC (56), and similar 
sequences are found in the operator regions of iron responsive genes in other 
organisms.  Typically, the Fur/DNA association blocks RNA polymerase, 
repressing gene transcription.  As intracellular iron levels become depleted, 
Fur/Fe2+ dissociation occurs, alleviating DNA binding and derepressing iron 
responsive genes.  Fur is known to indirectly activate some genes, via 
repression of small RNA silencing molecules (162), and direct upregulation of a 
target gene has also been reported (57). 
 
1.5.2   Alternate examples of regulatory mechanisms contributing to iron 
homeostasis 
Many bacteria use additional regulatory systems to respond to specific iron 
ligands.  In Gram-negative bacteria, the most common mechanism involves the 
use of extracytoplasmic function σ factors (ECF factors), with the archetypal 
example being FecI in E. coli (for a review, see (27)).  This factor enables E. coli 
to express genes specific for uptake of citrate-coordinated iron, genes that are 
Fur repressible but require additional positive regulation for expression that 
occurs only in the presence of extracellular ferric citrate.  Briefly, under 
nonactivating conditions (in the absence of ferric citrate), ECF factor FecI is 
sequestered at the inner leaflet of the cytoplasmic membrane by 
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membrane-spanning anti-σ factor FecR.  When ferric citrate is imported to the 
periplasm through TonB-dependent outer membrane protein FecA, with 
simultaneous interaction between FecA and FecR, FecI is released into the 
cytosol.  FecI associates with RNA polymerase and recruits it to the operator 
region of the fec operon, which encodes the proteins required for reduction of 
iron in periplasmic ferric citrate and transport of Fe2+ through the cytoplasmic 
membrane. 
While Fur functions to repress genes required for acquisition of iron when 
iron is abundant, additional regulatory measures may be necessary to help 
bacteria respond to toxic intracellular accumulation of iron or iron ligands.  
Recently, a heme responsive efflux system has been described for S. aureus, 
and bioinformatic analysis suggests this mechanism is conserved across a 
range of Gram-positive bacterial pathogens (240, 251).  This involves a two 
component regulatory system, HssSR, which senses intracellular heme 
accumulation (HssS) and activates a transcriptional regulator (HssR) for the 
expression of an ABC-type heme efflux transporter (encoded by hrtAB).  In this 
fashion, S. aureus can mitigate toxicity of dangerously rapid heme accumulation 
following derepression of Fur regulated heme uptake genes. 
 
1.6   Staphylococcus aureus 
1.6.1   The genus Staphylococcus 
The Gram-positive bacterial genus Staphylococcus comprises 49 member 
species.  Most are mammalian commensalists or opportunistic pathogens, 
occupying niches including skin, nares, and mucosal membranes.  Four species 
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are of particular medical and veterinary relevance.  S. saprophyticus is the 
second leading cause of uncomplicated urinary tract infection (117).  
S. intermedius is a leading cause of pyoderma in dogs and has become a 
significant reservoir of antimicrobial resistance factors for the genus (101, 102).  
S. epidermidis is a normal component of the epidermal flora of most mammals.  
Its ubiquity and ability to produce a viscous, hydrophobic, extracellular 
polysaccharide slime make it a leading cause of biofilm contamination of 
prostheses and indwelling medical devices (68). 
The most nefarious staphylococcal species is S. aureus, the causal agent 
of a staggering variety of disease symptoms, ranging from cosmetic to lethal.  
Following traditional diagnostics, S. aureus is distinguished from the rest of its 
genus by its abundant production of secreted coagulase, an enzyme which 
converts serum fibrinogen to fibrin and promotes clotting.  However, some 
strains of S. lugdunensis produce coagulase, as a bound form (165); and a 
recent emergence of veterinary strains of coagulase-secreting non-aureus 
species (213, 221) is further reducing the usefulness of this marker as a 
taxonomic tool.  Accuracy notwithstanding, Staphylococcus species are for the 
time being classified as coagulase positive staphylococci (CPS, i.e. S. aureus) 
or coagulase negative (CNS, i.e. all other staphylococci).   
 
1.6.2   Pathogenesis 
S. aureus is a frequent commensal; 30% of the American population is 
asymptomatically colonized in the nostrils (92).  Progression to disease is often 
opportunistic on immunocompromise, injury, or other medical complications of 
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the host; however, environmental strains exist that can severely infect healthy 
individuals.  S. aureus causes suppurative skin and subcutaneous infections, 
including furunculosis, impetigo, cellulitis, mastitis, and flesh eating disease (10, 
15, 42, 160, 174); respiratory infections, including nonsevere and necrotizing 
forms of pneumonia (89, 212); and sepsis, which can lead to osteomyelitis, 
septic arthritis, and endocarditis (62, 147, 181).  Staphylococcal infection can 
also result in toxic shock if the invading strain produces superantigens (169).  
Severe, necrotizing disease manifestations are frequently caused by 
community-acquired strains, which are often capable of infecting individuals with 
no predisposing medical conditions; for recent reviews, consult (16, 53). 
Systemically disseminated S. aureus can become persistent as the result 
of abscession (36).  Colonies seeded in organ tissues induce inflammatory 
responses and attract macrophages, neutrophils, and other phagocytes.  
Recruited immune cells mediate liquefaction necrosis as the host seeks to 
prevent bacterial spread.  Lesions containing necrotic tissue and leukocytes form 
around S. aureus communities enclosed by pseudocapsules, protecting them 
from the action of phagocytic immune cells.  Abscesses that grow and rupture 
contribute to secondary waves of sepsis. 
Invasion and persistence of S. aureus in a host is dependent on a battery 
of virulence factors.  These include, but are not limited to, proteins and 
molecules involved in:  attachment (fibrinogen/fibronectin/collagen binding 
proteins, polysaccharide capsule), resistance to immune cells (protein A, 
complement inhibitory protein, staphylokinases, proteases), destruction of 
immune cells (Panton Valentine leukocidins, phenol soluble modulins), 
35 
 
subversion of immune cells (superantigens, chemotaxis inhibitory protein), 
intracellular survival (catalase, carotenoid pigments), and lysis of erythrocytes 
(hemolysins); for recent reviews, consult (188, 189, 255). 
S. aureus coordinates expression of virulence genes such that 
surface-associated factors are preferentially produced during exponential growth 
phase, promoting adherence, while secreted factors are preferentially produced 
in postexponential phase.  This coordination is largely mediated by two 
regulatory mechanisms, whose genes are encoded within the agr locus 
(accessory gene regulator) and gene sarA (staphylococcal accessory regulator) 
(37-39, 253).  Additional mechanisms also fine tune expression of virulence 
factors.  The two component regulator SaeRS, for instance, is responsive to 
stimuli associated with phagocytic immune cells, such as hydrogen peroxide 
(85), leading to expression of secreted toxins and capsule (190, 259).  As will be 
discussed further below, iron limitation is also a key sensory trigger for the 
expression of staphylococcal virulence factors. 
 
1.6.3   Antibiotic resistance 
Antibiotics are crucial to treatment of S. aureus disease.  Alexander 
Fleming originally documented staphylococcal sensitivity to what is now known 
as penicillin in his hallmark 1929 report on the antibacterial properties of the 
fungus Penicillium notatum (74).  By the 1940’s, penicillin was being hailed as 
the miracle cure to a wide range of infections.  The β-lactam ring of the penicillin 
molecule irreversibly binds cell wall transpeptidases (264), also known as 
penicillin binding proteins (PBPs).  Staphylococcal PBPs link pentapeptide side 
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chains of neighbouring glycan strands, via a displacement reaction where the 
L-lysine (third position) of one side chain is bonded to the a D-alanine (fourth 
position) of the other side chain via a pentaglycine bridge (87, 268).  Impairing 
this function disrupts the cell wall and is bactericidal.  As early as 1944, penicillin 
inactivation by what is now known as β-lactamase was being reported for 
resistant strains of S. aureus (133).  Semisynthetic penicillin derivatives 
including methicillin (1959) and oxacillin (1961), unrecognizable to β-lactamase, 
offered renewed hope in the battle against S. aureus.  This hope proved 
short-lived as resistance to these drugs readily emerged (125).  This mechanism 
of resistance appeared to be nondestructive toward the antibiotic (245), and was 
eventually shown to be due to expression of an alternate PBP, i.e. PBP2a, with 
vastly reduced affinity for β-lactams (82).  The gene encoding staphylococcal 
PBP2a, mecA, is localized in a mobile segment of DNA referred to as a 
staphylococcal chromosome cassette (SCCmec), integrated into the S. aureus 
chromosome at a site-specific location near the origin of replication (140).  
Seven different SCCmec elements have been described; compositional 
differences include regulatory genes for mecA, and the presence of additional 
antibiotic resistance determinants (58).  Methicillin resistant S. aureus (MRSA) 
strains have become widely disseminated across the globe (100), and SCCmec 
is increasingly documented in especially aggressive community-acquired 
S. aureus infections (58). 
The glycopeptide antibiotic vancomycin is the effective alternative for 
treating MRSA.  Glycopeptides inhibit cell wall synthesis by binding the two 
terminal D-alanine residues of the pentapeptide side chains of peptidoglycan, 
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blocking transglycosylation and transpeptidation reactions (211).  Vancomycin 
intermediate (VISA) and resistant (VRSA) strains are emerging from MRSA 
lineages.  Intermediacy (i.e., decreased sensitivity) results from a reworking of 
the regulatory circuitry in the S. aureus cell, with increased resources going 
toward cell wall thickening; this has the effect of saturating vancomycin.  VISA is 
also frequently associated with altered metabolism, production of protein A, and 
autolysis, although the mechanisms by which these changes contributes to 
vancomycin tolerance are not understood; for a more comprehensive review, 
consult (118).  Outright resistance to vancomycin in S. aureus is mediated by 
the vanA operon, encoding for enzymes that replace terminal D-alanine residue 
of peptidoglycan side chains with D-lactate (9).  First reported in Japan in 1997 
(115) VISA were soon documented in North America (232).  The first report of 
VRSA in North America occurred in Michigan in 2002, and has since reemerged 
nine times in the USA (196).  This threat to our last line of defense highlights the 
need for research into new antistaphylococcal drugs. 
 
1.6.4   Response to iron starvation 
Iron is a cofactor of numerous proteins involved in central metabolism and 
respiration.  Metabolically, S. aureus responds to iron limitation by upregulating 
glycolysis and downregulating the tricarboxylic acid (TCA) cycle; extreme iron 
limitation results in inactivation of the electron transfer chain, leading to 
fermentative growth (81).  The TCA cycle involves numerous enzymes that 
require iron as a cofactor (235).  Glycolysis generates ATP independently of 
respiration, with accumulation of pyruvate and lactate.  Lactate was shown to be 
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secreted by iron-starved S. aureus, resulting in acidification of the surrounding 
medium; this might contribute to liberation of iron from host sequestration 
proteins transferrin and lactoferrin (81). 
S. aureus pathogenesis is also influenced by iron availability.  Fur-Fe2+ 
indirectly contributes to coordinated repression of secreted hemolysins and 
cytotoxins, and under sustained conditions of iron limitation upregulation of 
these factors occurs.  On the other hand, Fur-Fe2+ contributes to positive 
regulation of immunomodulatory proteins, including superantigens, protein A, 
complement inhibitory protein, and chemotaxis inhibitor (249).  A fur inactivated 
mutant was shown to be less virulent in a murine pneumonia model of infection 
(249), suggesting that in the absence of this key regulatory protein, i.e. in a 
strain that consitutively expresses an iron starvation response, virulence is 
compromised due to improved clearance by immune cells despite the enhanced 
cytotoxicity of the mutant.   
The iron restriction response of S. aureus also involves secretion of 
siderophores.  A review of the scientific literature uncovers at least four named 
molecules:  staphyloferrin A (SA, 479 Da) (134), staphyloferrin B (SB, 449 Da) 
(104), aureochelin (577 Da) (46), and staphylobactin (822 Da) (50).  It should be 
noted that the first three studies involved many collection-specific isolates, 
whose taxonomic identification has not been corroborated using molecular 
techniques.  Contemporary bioinformatic interrogation has uncovered only two 
potential NIS pathways (loci sfa and sbn) and one NRPS pathway (gene aus) 
encoded within all sequenced S. aureus genomes.  One of the NIS pathways is 
also conserved broadly among CNS genomes; the NRPS pathway appears less 
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frequently (principally, within Staphylococcus epidermidis).  The NRPS 
synthetase has been recently characterized (273, 278), and does not produce 
an iron-binding metabolite (N. Magarvey, personal communication).  As will be 
discussed below, only the staphyloferrins appear to be bona fide S. aureus 
siderophores, and SB appears thus far to be exclusive to S. aureus within the 
genus. 
 
1.6.5   S. aureus siderophores:  staphyloferrin A (SA) 
SA has been identified from supernatants of both S. aureus and CNS (134, 
149).  All sequenced staphylococcal genomes contain a highly conserved locus 
comprising genes sfaABC sfaD, which encodes two NIS synthetases 
(Figure 1-4A).  The biosynthetic pathway for synthesis of SA was recently 
characterized using recombinant, S. aureus-derived, Escherichia coli-expressed 
proteins SfaD and SfaB (Figure 1-4B) (45).  SfaD condenses a molecule of 
citrate to the δ-amine group of D-ornithine, followed by condensation of a second 
citrate to the α-amine group by SfaB to yield SA.  Fe3+ coordination by SA 
involves two sites provided by α-hydroxy-carboxylates derived from citrate (95), 
making SA a carboxylate type siderophore.  The putative function of SfaC is an 
amino acid racemase, presumably for isomerization of ornithine from L- to D- 
forms.  SfaA is predicted to be a member of the major facilitator family of efflux 
pumps. 
Based on sequence alignments, SfaB and SfaD cluster among B type NIS 
synthetases (34).  Their chemistry, however, aligns them with the A-type 
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Figure 1-4:  The S. aureus hts/sfa locus encodes for transport and 
biosynthesis of staphyloferrin A.  (A)  Schematic of the hts operon, encoding 
the receptor lipoprotein and permease components of an ABC transporter, and 
the sfa locus, encoding enzymes involved in biosynthesis of staphyloferrin A.  
Numbers refer to locus tags within the S. aureus strain Newman genome (e.g. 
NWMN_2076).  (B)  NIS synthetases SfaD and SfaB assemble SA from two 
molecules of citric acid and one molecule of D-ornithine.  Proposed Fe3+-
coordinating atoms of SA are in red.   
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enzymes (i.e. specificity for citrate); they have been recently been reassigned to 
a subgroup within the A-type enzymes (193). 
 
1.6.6   S. aureus siderophores:  staphyloferrin B (SB) 
SB was first purified from supernatant extracts of Stapylococcus hyicus 
(CNS) (104).  The biochemical pathway for SB synthesis was recently 
characterized using recombinant, S. aureus-derived, Escherichia coli-expressed 
proteins (40).  The requisite NIS synthetases include SbnC, SbnE, and SbnF, 
encoded within operon sbnABCDEFGHI (siderophore biosynthesis) 
(Figure 1-5A), which was previously implicated in staphylobactin production 
using molecular genetics techniques (50); thus, SB and staphylobactin are one 
and the same.  The sbn operon has not been annotated in any sequenced CNS 
genome, and a host of CNS isolates tested negative for sbn genes (50), calling 
into question early reports of SB production by CNS species (104, 149); it 
should be noted, however, that the S. hyicus genome is still unsequenced.  
Curiously, sbn genes and SB production have also been described for two 
proteobacteria:  the plant pathogen Ralstonia solanacearum (21), and the heavy 
metal tolerant saprotroph Cupriavidus metallidurans (124, 180). 
Biosynthesis of SB can be summarized as follows (Figure 1-5B):  
molecules of citrate and L-diaminopropionic acid (L-Dap) are condensed by 
SbnE, forming citryl-Dap; SbnH decarboxylates the carboxyl group from the 
L-Dap moiety, creating citryl-diaminoethane (C-Dae); SbnF condenses a second 
molecule of L-Dap to the remaining free prochiral carbon of the citrate moiety; 
finally, SbnC condenses α-ketoglutarate to the free amine of the diaminoethane  
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Figure 1-5:  The S. aureus sir/sbn locus encodes for transport and 
biosynthesis of staphyloferrin B.  (A)  Schematic of the sir operon, encoding 
the receptor lipoprotein and permease components of an ABC transporter, and 
the sbn operon, encoding enzymes involved in biosynthesis of staphyloferrin B.  
Numbers refer to locus tags within the S. aureus strain Newman genome (e.g. 
NWMN_0057).  (B)  NIS synthetases SbnE, SbnF, and SbnC, and 
decarboxylase SbnH, assemble SB from one molecule of citric acid, one 
molecule of α-ketoglutaric acid, and two molecules of L-diaminopropionic acid.  
Proposed Fe3+-coordinating atoms of SB are in red.  
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moiety (40).  In contrast to the Sfa synthetases, phylogenetic alignments of the 
Sbn synthetases agree well with their NIS activity class (34):  SbnE has A-type 
activity, SbnC has B-type activity, and SbnF has C-type activity.  The 
hexadentate coordination of Fe3+ by SB is unusual for a carboxylate-type 
siderophore; in addition to typical coordination using five oxygen atoms, the sixth 
coordinating atom is nitrogen from the primary amine group of the terminal 
L-Dap residue (94). 
The roles of remaining Sbn proteins have not been published.  Based on 
bioinformatic analyses, their putative functions include a serine sulfhydrylase 
(SbnA) and an ornithine cyclodeaminase (SbnB), which could work in concert to 
generate L-Dap; a major facilitator family protein (SbnD), possibly for efflux of 
aposiderophore; an aldolase (SbnG); and a protein of unknown function (SbnI). 
 
1.6.7   Siderophore transport:  the staphyloferrins 
The ABC transporter for SA consists of lipoprotein receptor SirA and 
heterodimeric permease SirBC (18, 51).  The sirABC (staphylococcal iron 
regulated) operon resides adjacent to the sbn operon on the S. aureus 
chromosome, is preceded by a consensus Fur box, and is upregulated under 
conditions of iron limitation (51).  SirA has a dissociation constant for ferrated SB 
in the low nanomolar range (94), and is required by S. aureus for uptake of SB 
produced biologically (51) and synthetically (40).  Among the CNS, only the 
S. lugdunensis genome appears to encode an ABC transporter with reasonable 
sequence homology to sirABC, albeit lacking the sbn operon. 
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An operon encoding a putative ABC transporter preceded by a Fur box is 
situated adjacent to the sfa locus in S. aureus and CNS chromosomes, making it 
an attractive candidate for the genetic component involved in SA uptake.  The 
operon in question has been annotated htsABC (heme transport system) based 
on observations that mutations in either permease gene result in an iron source 
preference shift toward transferrin (231).  This conclusion was derived from 
limited experimental analysis and no subsequent publications have contributed 
to the paradigm of HtsABC-mediated heme uptake.  Furthermore, the crystal 
structure of HtsA bound to SA has recently been published (95).  The HtsA 
binding pocket is lined with positively charged arginine residues that are quite 
conducive to interacting with anionic siderophores; accommodation of 
hydrophobic, planar heme molecules seems less likely, but has not been 
empirically discounted. 
Notably absent from sir and hts operons is a candidate ATPase gene.  
Transport of both staphyloferrins is dependent on gene fhuC, which encodes the 
ATPase required for transport of exogenously produced hydroxamate 
siderophores via the FhuBG permease, and is transcribed from unlinked operon 
fhuCBG (further described below) (237). 
 
1.6.8   Siderophore transport:  exogenous siderophores 
S. aureus uses a number of hydroxamate type siderophores, including 
aerobactin, ferrichrome, and desferrioxamine-B.  S. aureus culture supernatants 
test negative for production of this siderophore class; thus they are considered 
exogenous.  Transport is dependent on a permease/ATPase complex encoded 
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from operon fhuCBG (227).  As mentioned previously, the FhuC ATPase is 
coopted by SirABC and the SA transporter (237).  Two homologous receptor 
lipoproteins, both genetically unlinked to fhuCBG, are involved in substrate 
recognition:  FhuD1 and FhuD2.  The latter demonstrates higher substrate 
affinity and a broader proficiency for recognition of different 
hydroxamate-containing molecules (229).  Hydroxamate-mediated iron 
acquisition is especially relevant to medical practices, specifically with regards to 
chelation therapy for treatment of iron overload disorders such as thalassemia.  
A frequently administered plasma chelator is desferrioxamine-B, which is 
distributed under various commercial names including DesferalTM (Novartis); 
without precaution, chelation therapy may actually predispose patients to 
bacterial sepsis. 
S. aureus is also known to transport enterobactin as an iron ligand despite 
being deficient in production of catecholate siderophores (226).  Prior to the 
body of work presented here, the transporter for this siderophore class had not 
been identified.  An attractive candidate is encoded within the sstABCD operon, 
which includes genes for a dimeric permease (SstAB), an ATPase (SstC), and a 
lipoprotein sharing sequence identity with bacterial receptors for iron ligands 
(SstD).  This operon was shown to be iron regulated in vitro and in vivo (178), 
but no transported substrates were identified. 
 
1.6.9   Heme uptake 
Heme uptake by S. aureus is mediated by the Isd system of cell wall and 
membrane proteins (168).  Recognition of hemoproteins occurs at the outer face 
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of the cell wall.  In Gram-positive bacteria this is a robust yet dynamic structure 
that acts as a scaffold for covalently linked surface proteins; for pathogens, 
many of these are involved in recognition of and adherence to host factors.  
S. aureus binds hemoglobin and hemoglobin-haptoglobin using wall-anchored 
proteins IsdB (250) and IsdH (61).  These extract heme through an 
uncharacterized mechanism and passage it to the cytoplasmic membrane via 
transfers along wall-embedded proteins IsdC and IsdA, toward membrane 
protein IsdE (153, 182, 277).  IsdA/B/C/H all contain NEAT (Near-iron transport) 
domains:  ~120 residue motifs forming eight-stranded immunoglobulin 
β-sandwich folds, creating hydrophobic heme binding pockets (200).   At the 
cytoplasmic membrane, IsdE and IsdF form the receptor and permease 
components, respectively, of the heme ABC transporter (98); within the cytosol, 
iron liberation through heme degradation is mediated by monooxygenases IsdG 
and IsdI (230).  A model explaining the directionality of the heme relay from the 
surface of the cell wall to the IsdE/F transporter has been proposed, and is 
dependent on two factors:  i) the localization of the heme binding proteins, which 
are situated progressively closer to the cytoplasmic membrane; ii) the dynamic 
rate of transfer, which is slowest at the surface of the cell wall (IsdB/H to IsdA) 
but becomes progressively faster approaching the membrane (IsdC to IsdE) 
(96).  The contribution of Isd to virulence in animal models of infection is 
significant, suggesting this system makes a major contribution to fulfilling the 
nutritional iron needs of this important pathogen (201, 250).  Additionally, IsdB is 
one of the most abundantly expressed factors on the surface of iron-starved S. 
aureus, making it an attractive candidate for antistaphylococcal vaccines (132, 
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139).  The importance of Isd to heme uptake should not be overstated, however; 
even in its absence, S. aureus readily grows on heme as a sole iron source, and 
at least one alternate uptake system has recently been uncovered 
(D. E. Heinrichs and C. Chung, unpublished data). 
 
1.6.10   Summary of S. aureus iron homeostasis genes 
A review of the scientific literature pertaining to characterized S. aureus 
iron homeostasis factors, combined with a swath of annotated but 
uncharacterized genes from genome sequencing projects, reveals S. aureus is 
exquisitely proficient at adapting to fluctuations in iron availability.  Known and 
putative iron homeostasis genes are summarized in Table 1-3.  The redundancy 
and complexity of iron acquisition mechanisms suggests that therapeutics 
targeting the overall process may be of limited efficacy unless they are equally 
comprehensive. 
 
1.7   Objective and hypotheses 
Septic S. aureus infection can lead to numerous debilitative and lethal 
disease symptoms.  Prior to the start of this study, it was known that S. aureus 
uses serum transferrin as an iron source, but the mechanism or mechanisms for 
this phenomenon were not described.  It was also known that S. aureus 
produces at least two siderophores, but their contributions to infection were 
poorly characterized.  During the course of this study, noteworthy publications 
describing the role of catecholamine stress hormones in liberating iron from 
transferrin also prompted the question of whether this interaction could   
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Table 1-3:  S. aureus genes with known or putative roles in iron 
homeostasis 
 
Genetic locus       
(S. aureus Newman) 
Gene 
nomenclature 
Role Ref. 
NWMN_0059-0057 sirABC Staphyloferrin B aka 
staphylobactin transporter 
(receptor lipoprotein and 
heterodimeric permease 
components) 
(18, 
51, 
94) 
NWMN_0060-0068 sbnABCDE 
FGHI 
Staphyloferrin B aka 
staphylobactin biosynthesis 
(18, 
40, 
50) 
NWMN_0111 isdI Heme monooxygenase (230) 
NWMN_0336-0338 fepABC Ferrous iron ABC transporter 
(receptor lipoprotein, putative 
ferrous iron peroxidase, 
homodimeric permease 
components) 
(23) 
NWMN_0581, 0582 fepA, fepG Putative iron compound ABC 
transporter (receptor 
lipoprotein and homodimeric 
permease components) 
(24) 
NWMN_0603-0601 sitABC Iron-regulated putative ABC 
transporter (heterodimeric 
permease components, 
ATPase, and lipoprotein 
receptor) 
(114, 
164) 
NWMN_0604 feoA/sirR Putative iron/divalent 
cation-dependent repressor 
(114, 
164) 
NWMN_0616-618 fhuCBG ATPase for hydroxamate/ 
staphyloferrin A/ staphyloferrin 
B ABC transporters; 
hydroxamate siderophore 
transporter (heterodimeric 
permease components) 
(227, 
237) 
NWMN_0702-0705 sstABCD Putative siderophore ABC 
transporter (heterodimeric 
permease components, 
ATPase, and lipoprotein 
receptor) 
(178)  
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Table 1-3 continued 
NWMN_0908 N/A Iron-regulated putative 
receptor lipoprotein 
(4) 
NWMN_1040 isdB Hemoglobin/haptoglobin 
binding; heme extraction 
(250) 
NWMN_1041, 1042 isdA, isdC Heme transfer (97, 
182, 
203, 
277) 
NWMN_1043-1045 isdDEF Heme transporter (lipoprotein 
and heterodimeric permease 
components) 
(97, 
202) 
NWMN_1047 isdG Heme monooxygenase (230) 
NWMN_1320 brnQ3 Putative branched chain amino 
acid transport protein; heme 
transport protein 
N/A 
NWMN_1406 fur Ferric uptake regulatory 
protein 
(249) 
NWMN_1931 fhuD1 Hydroxamate siderophore 
transporter (receptor 
lipoprotein) 
(229) 
NWMN_2043 ftnA Putative bacterioferritin (179) 
NWMN_2078-2076 htsABC Heme transporter?  
Staphyloferrin A transporter 
(receptor lipoprotein and 
heterodimeric permease 
components) 
(18, 
95, 
231) 
NWMN_2082,   
2081-2079 
sfaD, sfaABC Staphyloferrin A biosynthesis (18, 
45) 
NWMN_2185 fhuD2 Hydroxamate siderophore 
transporter (receptor 
lipoprotein) 
(228) 
NWMN_2262-2261 hrtBA Heme transporter (efflux) (239) 
NWMN_2263-2264 hssRS Heme-sensing two-component 
regulator 
(241) 
NWMN_2450 feoB Putative ferrous iron ion 
transport protein 
N/A 
NWMN_2614 isdH Hemoglobin/haptoglobin 
binding; heme extraction 
(61) 
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contribute to the growth of S. aureus in serum.  The primary objective of this 
study was thus to describe the ways in which S. aureus acquires transferrin iron.  
Experiments were designed to test the following hypotheses: 
 
1) Secreted siderophores and their cognate transport systems contribute to 
growth of S. aureus on transferrin and to virulence. 
 
2) Liberation of iron from transferrin following interaction with catecholamine 
stress hormones provides S. aureus with iron for growth on transferrin and 
contributes to virulence, and acquisition of this iron is dependent on a transport 
system encoded by the sst operon. 
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Chapter 2 
Siderophore-mediated iron uptake in 
Staphylococcus aureus 
 
 
Significant portions of this chapter have been published in the following article: 
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Murphy, and D. E. Heinrichs (2009).  Characterization of staphyloferrin A 
biosynthetic and transport mutants in Staphylococcus aureus.  Molecular 
Microbiology, 72:947-963.  This work was carried out with Dr. G. A. Lajoie’s 
research group, Department of Biochemistry, University of Western Ontario, and 
with Dr. M. E. Murphy’s research group, Department of Microbiology and 
Immunology, University of British Columbia. 
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2.1   Introduction 
The extracellular fluid of the mammalian host is low in iron due to this 
element’s poor solubility at neutral pH, and through its stringent sequestration by 
host scavenging proteins.  This is an important facet of innate resistance to 
disease, and is described as nutritional immunity (66).  The primary 
sequestration factor in the serum component of plasma is the globular 
glycoprotein transferrin, which has the ability to bind two atoms of ferric iron with 
high affinity.  In the healthy host, transferrin is perpetually undersaturated 
(approximately 30% iron loaded) (16), providing a constitutive capacity for 
sequestration of trace Fe3+ ions.  Invasive pathogenic bacteria frequently target 
host ferroproteins, including transferrin, through secretion of siderophores:  
small, soluble molecules with affinities for iron approaching or exceeding the 
target molecule.  Siderophores are often peptidic molecules assembled by 
cytosolic enzymes without the benefit of a ribosomal template. 
The pathogenic bacterium Staphylococcus aureus is a leading cause of 
bacteremia, as it is well adapted to overcoming iron deprivation in blood.  Its 
abilities to lyse erythrocytes (7, 8, 13, 21, 26, 28, 37) and capture hemoglobin 
iron through the Isd system of cell wall-anchored and transmembrane proteins 
(32, 45, 48, 52, 65) are well described, and are prominently touted as the 
strategy through which S. aureus acquires iron during sepsis (62).  The ability to 
grow on transferrin as an iron source has also been noted (44, 51, 55), but 
studies have contributed little toward a mechanistic explanation of this process, 
and have not evaluated any contribution to virulence.   
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At the commencement of this study, S. aureus had previously been shown, 
using molecular genetic techniques, to produce at least one structurally 
uncharacterized siderophore, termed staphylobactin.  This metabolite’s 
production was a function of the sbnABCDEFGHI operon (staphylobactin or 
siderophore biosynthesis) (Figure 1-5A), which is induced under conditions of 
iron limitation (17).  Uptake of Fe-staphylobactin was shown to be a function of 
the SirABC (staphylococal iron regulated) transporter, whose operon is situated 
adjacent to sbn on the S. aureus chromosome (18, 35).   
The sbn operon encodes three NIS synthetases:  SbnC, SbnE, and SbnF 
(12).  Chromosomal inactivation of a synthetase was reported to curtail growth 
of S. aureus under conditions of severe iron chelation (17).  S. aureus genome 
sequencing projects subsequently uncovered two alternate loci from sbn which, 
according to annotation, could be involved in production of nonribosomal 
peptides.  One encodes a recently characterized multidomain NRPS (69), which 
does not produce metabolites with iron coordination capacities (N. Magarvey, 
personal communication).  Annotation of the third locus (Figure 1-4A) described 
it to encode two NIS synthetases.  Curiously, this locus is chromosomally 
adjacent to an operon encoding an ABC transporter implicated in heme 
acquisition based on limited evidence (62).  Concurrently to this study, the NIS 
locus was annotated by another research group as sfna (staphyloferrin A 
biosynthesis) (14).  It is hereby rebranded sfa for compliance with proper 
protocols in bacterial genetic nomenclature. 
In this study, mutagenesis was performed to eliminate loci sbn, sfa, sir, and 
hts from the staphylococcal chromosome in an attempt to categorize the entire 
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complement of S. aureus siderophore biosynthesis/transport systems, as well as 
to dissect their individual and combined contributions toward growth of S. aureus 
in iron-restricted media such as serum, and to assess their roles in virulence in 
murine infection models.   
 
2.2   Materials and methods 
2.2.1   Bacterial growth conditions 
All bacteria were cultured at 37 °C unless otherwise indicated.  Bacterial 
strains used are summarized in Table 2-1.  Escherichia coli was grown in Difco 
Luria-Bertani broth (BD Diagnostics).  Staphylococcus epidermidis was grown in 
Gibco RPMI Medium 1640 [+] L-glutamine [+] 25 mM Hepes (Invitrogen) 
enriched with 1% w/v Difco casamino acids (CAA-RPMI) (Becton, Dickinson and 
Co.).  For genetic manipulations, S. aureus was grown in Difco tryptic soy broth 
(TSB) (Becton, Dickinson and Co.).  For subsequent experiments, S. aureus 
strains were grown, as specified below, in:  Tris-minimal succinate broth (TMS) 
(61); TMS chelated with 2,2’-dipyridyl (Sigma-Aldrich) or 
ethylenediaminedi-N,N’-bis(2-hydroxyphenylacetic acid) (EDDHA) (LGC 
Standards GmbH); a 40:60 mixture of TMS and horse serum (Sigma-Aldrich) 
that was previously incubated at 55 °C for 2 h to inactivate complement 
(HoS-TMS); TMS treated for 24 h at 4 °C with 10% w/v Chelex-100 resin 
(Bio-Rad) prior to addition of post-autoclaving nutrients (C-TMS); or C-TMS 
amended with 10 to 20 µM human apotransferrin or holotransferrin 
(approximately 60% iron saturated) (Sigma-Aldrich).  For iron repletion of 
restricted growth media, FeCl3 was added to a final concentration of 50 to 
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100 µM.  Solid media were prepared by incorporating 1.5% w/v low iron Difco 
Bacto agar (Becton, Dickinson and Co.) to specified media.  
 For selection of plasmids and recombinant alleles, antibiotics (BioShop, 
Burlington, Ontario) were added to media at the following concentrations:  
ampicillin (100 μg/mL), tetracycline (4 µg/mL), kanamycin (50 µg/mL), neomycin 
(50 µg/mL), chloramphenicol (30 µg/mL for E. coli and 5 μg/mL for 
Staphylococcus sp.), erythromycin (300 µg/mL for E. coli and 3 μg/mL for 
S. aureus), and lincomycin (20 μg/mL).  All media were made with water purified 
through a Milli-Q water purification system (Millipore).  All glassware was treated 
overnight in 0.1 M HCl and rinsed thoroughly in Millipore water to remove 
residual contaminating iron. 
 
2.2.2   General molecular genetic methodologies 
Purification of plasmid DNA was performed using a QIAPrep Mini-spin kit 
(QIAgen) according to the manufacturer’s instructions.  For preparations from 
Staphylococcus, 10 µg lysostaphin (Sigma-Aldrich) and a 37 °C incubation were 
incorporated into the P1 buffer treatment until cell lysis occurred.  Plasmids used 
are summarized in table 2-1.  Purification of S. aureus chromosomal DNA was 
performed as previously described (60).   
Polymerase chain reaction (PCR) was performed using Taq polymerase 
(New England Biolabs) or Pwo polymerase (Roche Diagnostics) according to 
manufacturers’ instructions.  Primers were designed using Primer3 software 
(Whitehead Institute and Howard Hughes Medical Institute).  Primers are 
summarized in table 2-1.  Restriction digests were performed using enzymes   
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Table 2-1:  Bacterial strains, plasmids, and oligonucleotides used in this 
study 
 
 Description Ref. 
E. coli strains   
DH5α F- ϕ80lacZΔM15 Δ(lacZYA-argF)U169 
recA1 endA1 hsdR17(rk
- mk
+) phoA supE44 
thi-1 gyrA96 relA1 ʎ- 
Invitrogen 
S. aureus 
strains 
  
RN4220 rk
- mk
+; accepts foreign DNA (41) 
RN6390 Prophage-cured laboratory strain (56) 
Newman Wild-type clinical isolate (22) 
H306 RN6390 sirA::Km (18) 
H672 RN6390 sbnF::Km (originally described as 
sbnE::Km) 
(17) 
H1448 RN6390 ΔhtsABC::Tc This study; (6) 
H1480 RN6390 sirA::Km ΔhtsABC::Tc This study; (6) 
H803 Newman sirA::Km (18) 
H1262 Newman ΔhtsABC::Tc This study; (6) 
H1497 Newman sirA::Km ΔhtsABC::Tc This study; (6) 
H1321 RN6390 ΔsbnABCDEFGHI::Tc This study; (6) 
H1661 RN6390 ΔsfaABCsfaD::Km This study; (6) 
H1649 RN6390 ΔsbnABCDEFGHI::Tc 
ΔsfaABCsfaD::Km 
This study; (6) 
H1331 Newman ΔsbnABCDEFGHI::Tc This study; (6) 
H1665 Newman ΔsfaABCsfaD::Km This study; (6) 
H1666 Newman ΔsbnABCDEFGHI::Tc 
ΔsfaABCsfaD::Km 
This study; (6) 
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Table 2-1 continued 
H1074 Newman ΔfhuCBG::Em (63) 
H1112 Newman fhuG::Tn917 (60) 
AD25 Canadian atopic dermatitis isolate M. McGavin 
collection 
MSSA476 American osteomyelitis/sepsis methicillin-
sensitive isolate 
(36) 
MW2 American septic arthritis methicillin-resistant 
isolate 
(3) 
UAMS-1 American osteomyelitis isolate (27) 
USA300 LAC American community-acquired necrotizing 
fasciitis isolate 
(50) 
S. epidermidis 
strains 
  
846-1 Plasmid-cured type strain D. Mack 
1457-M10 Biofilm-deficient 846-1 mutant (icaA::Tn917; 
EmR) 
(20) 
Plasmids   
pBC SK(+) E. coli cloning vector; Cm
R 
Stratagene 
pUC19 E. coli cloning vector; Ap
R 
(70) 
pLI50 E. coli/S. aureus shuttle vector; Ap
R/CmR Novagen 
pDG1513 pMTL22 derivative carrying tetracycline 
resistance cassette; ApR 
(33) 
pDG780 BluescriptKS
+ derivative carrying kanamycin 
resistance cassette; ApR 
(33) 
pAUL-A E. coli/S. aureus shuttle and temperature-
sensitive suicide vector; EmR 
(10) 
pFB10 pAUL-A derivative carrying 
ΔsbnABCDEFGHI::Tc allele; TcR EmR 
(6) 
pEV83 pAUL-A derivative carrying ΔhtsABC::Tc 
allele; TcR EmR 
(6) 
pFhuC pLI50 derivative carrying fhuC; Cm
R 
(63) 
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Table 2-1 continued 
 
pEV90 pLI50 derivative carrying S. aureus 
sfaABCsfaD; CmR 
This study; 
(6) 
pEV95 pLI50 derivative carrying S. epidermidis 
sfaABCsfaD; CmR 
This study; 
(6) 
pEV96 pLI50 derivative carrying S. saprophyticus 
sfaABCsfaD; CmR 
This study; 
(6) 
pFB50 pEV90 derivative carrying 
ΔsfaABCsfaD::Km allele with loss of 
function frameshift mutation in 
Gram-positive replicase gene repB; CmR 
This study; 
(6) 
pALC2073 E. coli/S. aureus shuttle vector; Ap
R/CmR (5) 
pSirABC pBC SK(+) derivative carrying sirABC; Cm
R 
(18) 
pFB54 pALC2073 derivative carrying S. aureus 
fhuC/sirABC transcriptional fusion; CmR 
This study 
pFB57 pALC2073 derivative carrying S. aureus 
fhuC[K42N] (loss of function Walker motif 
missense mutation)/sirABC transcriptional 
fusion; CmR 
This study 
Oligonucleotides*   
hts5’F-SacI 
hts5’R-BamHI 
5’ TGAGCTCTGCGATTACATTGGAGGCTG 3’ 
5’ GGGATCCGATAACAATTATCATTGTCAAG 3’ 
Generation of S. aureus ΔhtsABC::Tc allele, 5’ arm 
 
hts3’F-BamHI 
hts3’R-XbaI 
5’ CGGATCCCTAACATATGATTAGAGTTTAAAA 3’ 
5’ GTCTAGAGGTCTCATAACCGGTCTAAAAA 3’ 
Generation of S. aureus ΔhtsABC::Tc allele, 3’ arm 
 
sbn5’F-KpnI 
sbn5’R-SmaI 
5’ TTGCGCGGTACCAGGAAGCGCTTTTGATTGAA 3’ 
5’ TTGTGTCCCGGGATGACTGACCCTTTCGCATC 3’ 
Generation of ΔsbnABCDEFGHI::Tc allele, 5’ arm 
 
sbn3’F-SmaI 
sbn3’R-XbaI 
5’ TTGCGCCCCGGGCGCAATTGGAAGCAGTTTT 3’ 
5’ TTGCGCTCTAGAGATGCCAATACGATGACAGG 3’ 
Generation of ΔsbnABCDEFGHI::Tc allele, 3’ arm 
 
sfaSA5’ 
sfaSA3’ 
5’ GTATAGATTGTATTTAATAAGTTAATGTAATCC 3’ 
5’ TGCAAACGATATGTAGTATAACTTGTCAAC 3’ 
Cloning of S. aureus sfaABCsfaD 
 
sfaSE5’-EcoRI 
sfaSE3’-SmaI 
5’ ATATGAATTCTTGAGCATGACGCTCAAGTGC 3’ 
5’ ATATCCCGGGGAGACGGTGCGTTGAGTTAAAG 
   G 3’ 
Cloning of S. epidermidis sfaABCsfaD 
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Table 2-1 continued 
 
sfaSS5’-BamHI 
 
sfaSS3’-SmaI 
5’ TATAGGATCCATCTATTTTTACTTTAATCTAGCGG  
   ACGG 3’ 
5’ TATACCCGGGCTATGTTTCATCGTTTTCCCTCCT 
   TAG 3’ 
Cloning of S. saprophyticus sfaABCsfaD 
fhuC5’-SphI 
fhuC3’-PstI 
5’ TTGATAGCATGCCATGACAAATCGAGCTATCC 3’ 
5’ TTGATACTGCAGTTAAGAATAAGCTCTGCGAC 
   A 3’ 
Cloning of S. aureus fhuC or fhuC[K42N] to make a 
transcriptional fusion with sirABC 
sfaD-RT-PCR-F 
sfaD-RT-PCR-R 
sfaA-RT-PCR-F 
sfaA-RT-PCR-R 
htsA-RT-PCR-F 
htsA-RT-PCR-R 
gyrB-RT-PCR-F 
gyrB-RT-PCR-R 
5’ CCTCTAATGCAATGCCATATTTA 3’ 
5’ ACAATGAATCACCTATCGTGACA 3’ 
5’ AGTCTATCATGCGCCAACAAC 3’ 
5’ AACCTGTCGCCATAATCAATAA 3’ 
5’ TTTAAATCCAGAGCGTATGATCA 3’ 
5’ CAGAAGAAATTAAGCCACGAGAT 3’ 
5’ ATAATTATGGTGCTGGGCAAAT 3’ 
5’ AACCAGCTAATGCTTCATCGATA 3’ 
Real time PCR primers (gyrase B used as internal 
―housekeeping gene‖ reference) 
 
*underlined sequences in oligonucleotides denote restriction sites 
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purchased from New England Biolabs and Roche Diagnostics according to 
manufacturers’ instructions.  Blunting reactions were performed using Klenow 
fragment (Roche Diagnostics) according to manufacturer’s instructions.  Linear 
DNA fragments were purified directly from restriction reactions or following 
resolution through agarose gels using the QIAQuick PCR purification kit 
(QIAgen) according to the manufacturer’s instructions.  Ligation reactions were 
performed using T4 DNA ligase (New England Biolabs).  Sequencing reactions 
were performed by the London Regional Genomics Centre. 
 
2.2.3   Cloning and mutagenesis of S. aureus 
Plasmids generated and used in this study are summarized in Table 2-1.  
Allelic replacement was used to delete the majority of operons sbnABCDEFGHI 
and htsABC, and locus sfaABCsfaD, from the chromosome of S. aureus.  The 
ΔsbnABCDEFGHI::Tc knockout allele contained arms homologous to sbnA and 
to noncoding DNA downstream of sbnI.  The arms were cloned sequentially to 
plasmid pBC SK(+), XbaI to SmaI and KpnI to SmaI.  A tetracycline resistance 
cassette was excised from plasmid pDG1513 with restriction enzymes SspI and 
Nae, blunted with Klenow fragment, and cloned between the arms at the SmaI 
site.  The knockout allele was excised and cloned to the temperature sensitive 
E. coli/S. aureus shuttle vector pAUL-A, KpnI to XbaI, creating plasmid pFB10.  
This was electroporated into S. aureus strain RN6390 after passaging through 
strain RN4220.  The RN6390 recipient was grown in TSB to mid-log phase at 
30 °C, shifted to 42 °C for 16 h, then plated to TSB agar plates containing 
kanamycin and neomycin.  Resistant clones were screened for sensitivity to 
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erythromycin, indicating a loss of pAUL-A backbone DNA following integration of 
the knockout allele to the chromosome via homologous recombination on either 
side of the tetracycline resistance cassette. 
To generate the ΔhtsABC::Tc allele, 5’ and 3’ arms targeting the noncoding 
region flanking the operon were PCR amplified and sequentially cloned to 
plasmid pUC19, SacI to BamHI then BamHI to XbaI.  A tetracycline resistance 
cassette was excised from plasmid pDG1513 with restriction enzymes BamHI 
and BglII and ligated between the flanking arms at the BamHI site.  The 
ΔhtsABC::Tc allele was excised and cloned to plasmid pAUL-A, SacI to XbaI, 
generating plasmid pEV83.  Subsequent passaging into S. aureus and 
integration into the chromosome was performed as described above for sbn 
mutagenesis. 
To generate the ΔsfaABCsfaD::Km knockout allele, the sfa cluster was 
PCR amplified, restricted at a SacI site downstream of the sfaD stop codon, and 
cloned SacI to SmaI to the E. coli/S. aureus shuttle vector pLI50, making 
plasmid pEV90.  Plasmid pEV90 was digested with SpeI and EcoRV internally to 
sfaD and sfaC, excising most of the gene cluster, which was replaced by the 
XbaI/PvuII excised kanamycin resistance cassette from plasmid pDG780.  NsiI 
restriction followed by Klenow fragment fill-in introduced a frameshift mutation 
into the repB gene of the pLI50 backbone, inactivating the Gram positive 
replicase protein, and creating plasmid pFB50.  Plasmid pFB50 was 
electroporated to S. aureus strain RN4220 carrying unmodified pLI50, enabling 
propagation of pFB50 by complementation in trans with wild type RepB.  
Plasmid pFB50 was transduced to S. aureus strain RN6390 using phage 80α as 
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described below, and recipient culture was plated to TSB agar containing 
kanamycin and neomycin.  Resistant clones were screened for sensitivity to 
chloramphenicol, indicating a loss of pLI50 backbone DNA following integration 
of the knockout allele to the chromosome via homologous recombination on 
either side of the kanamycin resistance cassette. 
Mobilization of S. aureus plasmids and mutated chromosomal alleles 
between strains was performed using transducing ϕ80α as follows.  Cultures of 
donor strains were grown overnight in TSB then diluted 1:2 into fresh TSB 
containing 2.5 mM CaCl2.  Cultures were incubated for 10 min then infected with 
>108 plaque forming units of bacteriophage.  Cultures were incubated for 15 min 
then added to 20 mL fresh TSB containing 2.5 mM CaCl2.  Cultures were 
incubated with gentle shaking through several rounds of bacterial replication 
followed by culture lysis.  Debris was pelleted by centrifugation at 3 krpm and 
supernatant was passaged through a 0.2 µM filter.  Lysate was serially diluted in 
10-fold increments in bacteriophage buffer (50 mM Tris pH 7.8, 0.1 M NaCl, 
1 mM MgSO4, 4 mM CaCl2) and 100 µL aliquots were combined with 100 µL 
aliquots of recipient strains grown to early exponential phase in TSB containing 
2.5 mM CaCl2.  Following a 20 min incubation at 37 
oC, recipient/lysate mixtures 
were spiked with 50 mM sodium citrate and plated on selective TSB agar. 
 
2.2.4   Real time PCR 
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl 
were washed twice in saline buffer and diluted 1:100 into HoS-TMS.  Cultures 
were grown at 37 °C with ample aeration to mid-logarithmic phase (OD600 ~ 1.0), 
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then partitioned into two aliquots of equal volume.  One aliquot from the pair was 
spiked with 50 µM FeCl3.  Growth was allowed to resume for 1 h, then 20 mL 
culture aliquots normalized to OD600 of 1.0 were pelleted by centrifugation at 
4 °C.  RNA was extracted using RNeasy kits (QIAgen) according to the 
manufacturer’s instructions.  RNA extraction was preceded by mechanical cell 
disruption through two 20 s treatments in 500 µL RLT buffer in a FastProtein 
Blue #6550-500 tube using a FastPrep disruptor at a setting of 5.0 (Qbiogene). 
 100 ng RNA was reverse transcribed and PCR amplified using the 
iScriptTM One-Step RT-PCR kit with SYBR Green (Bio-Rad), as directed, with 
primers listed in Table 2-1, in a Rotor-Gene 6000 Real Time Analyzer (Corbett 
Life Sciences).  Quantification relative to housekeeping gene gyrB was 
performed using the comparative CT method according to User Bulletin #2:  ABI 
Prism 7700 Sequence Detection System (2001) (Applied Biosystems).  For each 
representative RNA extraction, one-step reactions were performed in triplicate. 
 
2.2.5   Heterologous expression of SirABC in S. epidermidis 
In previous attempts to make a sirABC-expressing vector, numerous 
attempts to clone the operon into S. epidermidis-compatible shuttle vectors 
along with its native operator region, or under control of an inducible 
vector-borne promoter, proved unsuccessful.  Thus, the promoterless sirABC 
operon from the previously constructed pSirABC (18) was excised using 
restriction enzymes SacI and PstI and cloned to pALC2073, replacing the tetR/O 
region.  To enable expression of sirABC, and to provide the potentially requisite 
S. aureus FhuC ATPase for proper SirABC function (63), fhuC and its operator 
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region were PCR amplified from the S. aureus chromosome with engineered 
flanking PstI and SphI restriction sites and cloned to the pALC2073 derivative 
within the PstI located at the 5’ end of sirABC.  The resulting plasmid, pFB54, 
thus carried a transcriptional fusion of sirABC to fhuC under control of the fhuC 
operator.  Alternately, a nonfunctional fhuC allele harbouring a K42N Walker A 
domain mutation, characterized previously (63), was cloned in similar fashion to 
create a transcriptional fusion for plasmid pFB57.  After passaging through 
S. aureus RN4220, pFB54 and pFB57 were transformed to sucrose-competent 
S. epidermidis 1457-M10 via electroporation. 
 
2.2.6   Complementation of the sfa deletion mutation 
The ΔsfaABCsfaD::Km mutation in the S. aureus RN6390 chromosome 
was complemented using plasmid pEV90, described above.  Additionally, 
complementation was performed using the annotated sfaABCsfaD locus from 
S. epidermidis.  This was PCR amplified and cloned to pLI50 between restriction 
sites EcoRI and SmaI. 
 
2.2.7   Bacterial growth curves 
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl 
were washed twice in saline buffer and diluted 1:100 into HoS-TMS broth.  
Culture medium was left unamended (iron deplete) or amended with 50 µM 
FeCl3 (iron replete).  Cultures were grown at under constant medium amplitude 
shaking in a Bioscreen C machine (Oy Growth Curves Ab Ltd.), with absorbance 
measured at 600 nm. 
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2.2.8   Concentration of siderophore from culture supernatants 
S. aureus cells grown to stationary phase in TMS with 100 µM 2,2-dipyridyl 
were washed twice in saline buffer and diluted 1:100 into TMS containing 
250 nM EDDHA in acid washed glass flasks with generous head space.  
Cultures were grown to the postexponential phase (approximately 30 h).  
Culture aliquots were extracted and cells were removed by centrifugation at 
5 krpm.  Supernatants were frozen at -80 °C and liquid was removed under a 
vacuum at -80 °C.  Lyophilized extract was resuspended in 1/5 the original 
supernatant volume in methanol with gentle shaking for 30 min at room 
temperature.  Insoluble debris was removed by ultracentrifugation.  Methanol 
was removed by rotary evaporation and residue was redissolved in 1/20 the 
original supernatant volume in water.  Further purification included passage 
across an amberlite IRA-402 (Fluka) anion exchange column.  The column was 
washed extensively with water before elution with 3 M formic acid.  Siderophore 
active fractions (see next section) were subjected to a desalting step using a 
C18 cartridge (Applied Separations). 
 
2.2.9   Chrome-azurol S assay for siderophore activity 
Siderophore activity of solutions was measured using the chrome azurol S 
(CAS) assay (59).  Dilutions of sample were mixed with equal volumes of CAS 
shuttle solution and incubated in darkness at room temperature with gentle 
shaking for 45 min.  With an empty cuvette serving as the blank, siderophore 
units  were calculated as follows:  
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100 x dilution factor x (A630 of control solution – A630 of sample) 
 
A630 of control solution  
 
 
For describing siderophore activity of raw culture supernatants, 
siderophore units were normalized to a culture OD600 of 1.0. 
 
2.2.10   Mass spectrometry 
Spectrometric analyses were performed by the staff of the laboratory of 
G. A. Lajoie (Department of Biochemistry, University of Western Ontario).  
Eluent desalted across a C18 cartridge (see above) was dried and re-dissolved 
in 100 μl of water containing 100 mM EDTA and 0.1% formic acid.  Addition of 
EDTA greatly increased the detection level of metabolites, since contaminating 
metal ions have been shown to interfere with detection (46).  20 µL was injected 
into a liquid chromatography mass spectrometry/tandem mass spectrometry 
(LC-MS/MS) system comprised of a Waters CapLC with a Phenomenex Jupiter 
Proteo 90 A column (150 x 1.0 mm), 4 μm coupled to a Micromass Q-TOF micro 
mass spectrometer (Waters).  Separation was carried out at a flow rate of 
40 µl/min with a gradient starting at 0% B for 4 min, ramping to 15% B in 4 min, 
then ramping to 90% B in 4 min and holding for 4 min.  Solvent A was water and 
solvent B was 95% acetonitrile, both with 0.1% formic acid.  LC-MS was 
performed with electrospray in negative ion mode with a scan range 
200-950 m/z.  Collision-induced dissociation was performed with a mass range 
60-500 m/z using Argon as collision gas.  Variable collision energy of 20-30 V 
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was applied to obtain an informative fragmentation spectrum.  Data were 
analyzed using MassLynx 4.0 (Micromass). 
 
2.2.11   Siderophore plate bioassays 
Staphylococcal cells were successively cultured in TMS then TMS 
containing 100 µM 2’2-dipyridyl (S. aureus) or CAA-RPMI then CAA-RPMI 
containing 100 µM 2’2-dipyridyl (S. epidermidis).  Cells were pelleted and 
washed twice in saline buffer.  Cells were seeded into cooled molten agar media 
to densities of 5 x 108 CFU/mL.  Media used included TMS agar containing 
10 µM EDDHA (S. aureus) and CAA-RPMI agar containing 5 µM EDDHA 
(S. epidermidis).  Media were dispensed into Petri dishes in precise 25 mL 
aliquots.  Plates were allowed to gel and dry in the dark at room temperature for 
approximately 6 h.  Sterile 6 mm diameter paper discs (Becton, Dickinson and 
Co.) impregnated with up to 20 µL of an iron-ligand solution were placed on the 
surface of the agar.  Growth promotion was measured as the diameter of a halo 
of bacterial colonies forming around the paper disc after 36 h of growth. 
 
2.2.12   Mouse models of S. aureus infection 
Mouse sepsis experiments were performed as follows.  S. aureus cultures 
were grown overnight in TMS or TSB, pelleted by centrifugation, washed twice 
in saline buffer, and diluted 1:50 (OD600 = 1.0) into fresh TMS or TSB.  These 
cultures were grown to midexponential phase (OD600 ~ 1 to 3), pelleted by 
centrifugation, washed twice in saline buffer, and resuspended in saline buffer.  
After a 30 min equilibration incubation at room temperature, cells were diluted to 
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an optical density correlating to a predetermined CFU/mL titre.  Seven week old 
female BALB/c mice (Charles River Laboratories or Jackson Laboratories) 
housed in microisolator cages (maximum four per cage) were infected via tail 
vein injection with 100 µL bacterial suspension containing 0.1 to 5 x 107 CFU.  
Mice were euthanized if the infection rendered them immobilized, incapable of 
eating or drinking, or if they lost greater than 25% body mass.  Four days post 
infection, mice were euthanized via intraperitoneal injection of sodium 
pentobarbitol.  During dissection, organs including hearts, kidneys (as a pair), 
livers, spleens, and/or lungs (as a pair) were removed and placed in sterile 
phosphate-buffered solution containing 0.1% v/v Tween-20.  Organs were 
homogenized.  Homogenates were serially diluted and four 10 µL aliquots were 
spotted onto TSB agar plates.  After 24 h growth, CFU were counted and 
bacterial loads (log CFU/organ or organ pair) were calculated.  The Student’s 
t-test was used to calculate statistical significance for differences in data sets. 
Bacteria were cultured and prepared in a similar fashion for skin lesion 
models of infection.  Seven week old male BALB/c or nude SKH-1 mice were 
purchased from Charles River.  The backs of BALB/c mice (Charles River 
Laboratories) were shaved 24 h prior to infection.  Mice were injected 
subcutaneously on the right flank with 200 µL bacterial suspension containing 
5 x 108 CFU.  Lesions were measured at 24 h intervals until sacrifice using 
electronic calipers.  Lesion area was calculated as 0.5 x length x width x π (47).  
The Student’s unpaired t-test was used to calculate statistical significance for 
differences in data sets. 
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2.3   Results 
2.3.1   A Δsbn mutant secretes siderophore(s) 
It was previously reported that a S. aureus strain RN6390 staphylobactin 
synthetase mutant (sbnF::Km, erroneously described as sbnE::Km in the report) 
was severely impaired for growth in chelated basal medium (TMS containing 
10 µM EDDHA).  This defect was attributed to lack of siderophore production 
(17).  Attempts were made to reproduce this experiment using an 
operon-spanning Δsbn deletion mutant, also in S. aureus strain RN6390.  These 
proved unsuccessful as even the wild type parental strain was severely growth 
impaired in this medium (data not shown).  As EDDHA is a very strong iron 
chelator, the assay was repeated using a lower concentration sufficient to create 
conditions of moderate iron restriction (0.25 µM). 
In this revised growth medium, both the sbnF::Km and Δsbn mutants grew 
equally capably as their isogenic wild type parent (Figure 2-1A).  Culture 
supernatant siderophore activity was sampled at three intervals (10, 30, and 
60 h).  While the sbnF::Km mutant was moderately but significantly impaired for 
siderophore output at all three sampling times, it nevertheless secreted 
quantifiable amounts of (an) alternate iron chelator(s), while its Δsbn counterpart 
performed at a level statistically comparable to the wild type parent 
(Figure 2-1B).  From this pilot study, it was concluded that at least one alternate 
genetic locus to the sbn operon mediates S. aureus siderophore production. 
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Figure 2-1:  S. aureus sbn operon mutants produce siderophore(s).  
(A)  S. aureus RN6390 derivatives with mutations in the sbn operon (sbnF::Km 
and Δsbn) were grown in low iron medium.  (B)  Mutants and wild type alike 
secreted iron-chelating metabolite(s) into the supernatant, detected using the 
CAS assay at sampling times of 10, 30, and 60 hours.  Error bars represent 
standard deviation from the mean.  Statistical differences between mutants and 
the wild type parental strain were calculated using the Student’s unpaired t-test 
(* = P < 0.01). 
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2.3.2   sfa encodes putative NIS synthetases and is conserved among 
pathogenic staphylococci 
The sfa locus is conserved across all sequenced Staphylococcus 
genomes, as is an adjacently transcribed operon encoding a putative iron 
compound ABC transporter, htsABC (Figure 1-4A).  BLAST searches uncovered 
similarities between predicted sfa and sbn siderophore synthetases, and with 
aerobactin synthetase genes from E. coli, suggesting the sfaABCsfaD locus may 
be involved in production of a staphylococcal siderophore (Table 2-2).   
 
2.3.3   sfa is repressed by iron via Fur 
Previous work demonstrated that the sbn operon is expressed under 
conditions of iron restriction in a Fur/Fe-dependent fashion (17); it was of 
interest to determine if sfa would be regulated in such a fashion as well.  The 
intergenic region between divergently transcribed sfaA and sfaD as well as the 
operator region of htsABC contain sequence motifs resembling canonical Fur 
protein recognition sites (42) (Figure 2-2), suggesting these genes play roles in 
the iron deprivation response of staphylococci.  Real-time PCR analysis 
confirmed that, consistent with this prediction, all three transcripts are 
upregulated in an iron deprivation-dependent fashion, i.e. they are repressed by 
iron saturation of the culture medium, but continue to be readily expressed 
regardless of iron availability in a fur-inactivated mutant (Figure 2-3). 
Having established the sfa locus is a component of the Fur-mediated iron 
deprivation transcriptional response, and that it encodes putative siderophore 
synthetases, a Δsfa mutant knockout allele was constructed in the S. aureus   
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Table 2-2:  BLAST matches to putative S. aureus siderophore 
biosynthesis/transport proteins 
 
Protein/ 
locus 
(strain 
Newman 
genome) 
Match Bacterium Identity 
(%) 
Similarity 
(%) 
E 
SfaA/ 
2081 
Predicted major 
facilitator family 
transporter 
(SERP1780) 
S.epidermidis 
RP62A 
75 91 1e-
167 
 Predicted major 
facilitator family 
transporter 
(SSP0706) 
S.saprophyticus 
ATCC15305 
62 81 1e-
131 
SfaB/ 
2080 
Predicted 
siderophore 
biosynthesis 
protein 
(SERP1779) 
S.epidermidis 
RP62A 
65 79 0.0 
 Predicted 
siderophore 
biosynthesis 
protein (SSP0707) 
S.saprophyticus 
ATCC15305 
60 78 0.0 
 SbnC S. aureus 
Newman 
24 43 7e-
16 
 Aerobactin 
biosynthesis 
protein IucC 
E. coli 
APEC O1 
22 42 2e-
6 
SfaC/ 
2079 
Predicted amino 
acid racemase 
(SERP1778) 
S. epidermidis 
RP62A 
64 82 3e-
126 
 Predicted amino 
acid racemase 
(SSP0708) 
S.saprophyticus 
ATCC15305 
60 81 8e-
122 
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Table 2-2 continued 
 
SfaD/ 
2082 
Predicted 
siderophore 
biosynthesis 
protein 
(SERP1781) 
S. epidermidis 
RP62A 
60 76 0.0 
 Predicted 
siderophore 
biosynthesis 
protein (SSP0705) 
S.saprophyticus 
ATCC15305 
54 70 0.0 
 SbnE S. aureus 
Newman 
24 41 4e-
21 
 Aerobactin 
biosynthesis 
protein IucC 
E. coli 
APEC O1 
23 43 2e-
12 
HtsA/ 
2078 
Predicted iron 
compound-binding 
protein 
(SERP1777) 
S. epidermidis 
RP62A 
73 85 8e-
129 
 Predicted iron 
compound-binding 
protein (SSP0709) 
S.saprophyticus 
ATCC15305 
63 79 4e-
105 
HtsB/ 
2077 
Predicted iron 
compound 
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Figure 2-2:  Operator regions of the sfa/hts locus.   Nucleotide sequences of 
the operator regions of the htsABC operon and the sfaABCsfaD locus.  
Predicted start codons are in bold; predicted Shine-Dalgarno sequences (S.D.) 
are underlined; putative Fur box sequences are between two lines.  Nucleotide 
positions along the S. aureus strain Newman chromosome are indicated. 
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Figure 2-3:  Expression of sfa and hts genes is regulated by Fur-Fe.  
Regulation of sfaD, sfaA, and htsA by iron and Fur in S. aureus strain Newman.  
Real-time PCR of wild type and a fur inactivated mutant demonstrates 
upregulation in the absence of iron, or in the absence of Fur protein when iron is 
present.  Error bars represent standard deviation from the mean (n = 3).  Strains 
were grown in HoS-TMS medium.  + Fe denotes cultures spiked with 
100 µM FeCl3 for one hour at mid-log phase prior to cell harvesting. 
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chromosome for the purpose of characterizing its contribution to siderophore 
iron uptake.  When combined with the Δsbn mutation, this resulted in a 
S. aureus strain devoid of NIS synthetases. 
 
2.3.4   The sbn operon mediates SB biosynthesis; staphylobactin is SB 
Low iron culture supernatant concentrates of the S. aureus strain RN6390 
Δsbn Δsfa mutant and its isogenic Δsfa counterpart were examined for 
differences in mass ion composition, especially for those correlating to the 
known structures of staphylococcal siderophores (i.e. SA and SB), using 
LC-ESI-MS.  Shown in Figure 2-4 are the selected ion chromatograms and 
mass spectra for the two samples.  A peak with m/z of 447.14, corresponding to 
the published structure of SB (34), eluted from the Δsfa preparation at 5.09 min 
(Figure 2-4A), while no peak for that mass above background levels of detection 
was observed for the Δsfa Δsbn preparation (Figure 2-4B).  To further confirm 
that the peak at 447.14 m/z represented SB, LC-MS/MS with collision-induced 
dissociation (CID) was carried out, generating a fragmentation pattern consistent 
with the chemical structure of SB (data not shown). 
 
2.3.5   The sfa locus mediates SA biosynthesis 
LC-ESI-MS was also used to determine the molecular identity of the 
Sfa-synthesized metabolite.  Low iron culture supernatant concentrates of the 
S. aureus strain RN6390 Δsbn Δsfa mutant and its isogenic Δsbn counterpart 
were examined for differences in mass ion composition.  Shown in Figure 2-5 
are the selected ion chromatograms and mass spectra for the two samples.  A  
104 
 
 
 
 
 
 
 
 
 
 
Figure 2-4.   Identification of staphyloferrin B production by S. aureus 
strain RN6390.  (A)  Concentrated spent culture supernatant from the 
iron-starved Δsfa mutant was subjected to LC-ESI-MS analysis.  Shown is the 
selected ion chromatogram for the ion at m/z 447.1 from LC-ESI-MS, with the 
ESI-MS spectrum of that peak displayed in the inset.  (B)  Similar analysis to 
(A), using concentrated spent culture supernatant from the iron-starved Δsbn 
Δsfa mutant.  
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Figure 2-5.   Identification of staphyloferrin A production by S. aureus 
strain RN6390.  (A)  Concentrated spent culture supernatant from the 
iron-starved Δsbn mutant was subjected to LC-ESI-MS analysis.  Shown is the 
selected ion chromatogram for the ion at m/z 479.1 from LC-ESI-MS, with the 
ESI-MS spectrum of that peak displayed in the inset.  (B)  Similar analysis to 
(A), using concentrated spent culture supernatant from the iron-starved Δsbn 
Δsfa mutant. 
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peak with m/z of 479.11, corresponding to the published structure of SA (39), 
eluted from the Δsbn preparation at 11.27 min (Figure 2-5A), while no peak for 
that mass above background levels of detection was observed for the Δsbn Δsfa 
preparation (Figure 2-5B).  To further confirm that the peak at 479.110 m/z 
represented SA, LC-MS/MS with collision-induced dissociation (CID) was 
carried out, generating a fragmentation pattern consistent with the chemical 
structure of SA (data not shown). 
 
2.3.6   SA and SB are transported by HtsABC and SirABC, respectively and 
exclusively 
Given the chromosomal proximity of operon htsABC to the sfa locus, it was 
hypothesized that HtsABC is responsible for transport of SA, despite an earlier 
report that it contributes to staphylococcal heme acquisition (62).  To 
characterize the role of HtsABC in staphyloferrin transport, a ΔhtsABC mutant 
allele was constructed.  It has previously been demonstrated that SirABC is 
involved in transport of staphylobactin/SB using a sirA insertional inactivation 
mutant (18).  Disc diffusion agar plate assays were used to test the interaction 
between staphyloferrins and transporters, by measuring the growth promotion 
caused by siderophore concentrates obtained from isogenic RN6390 
staphyloferrin biosynthesis mutants toward a series of isogenic transporter 
mutants seeded into an otherwise prohibitively iron chelated medium.  Results 
(Figure 2-6) can be summarized as follows.  The ability to grow on SA was 
solely dependent on HtsABC; the ability to grow on SB was solely dependent on  
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Figure 2-6.   Growth on staphyloferrins A and B is dependent on ABC 
transporters HtsABC and SirABC, respectively.  S. aureus strain RN6390 
wild type (WT) and isogenic transporter mutants were seeded in agar for a disc 
diffusion assay to compare growth on concentrated culture supernatants from 
donors that produce both, one, or neither of the staphyloferrins.  Plates 
contained TMS agar chelated with 10 µM EDDHA, suppressing growth without 
addition of an exogenous iron source.  Asterisks denote statistically significant 
differences in diameter of growth around the disc relative to wild type treated 
with the same iron amendment (P < 0.001), as calculated using the Student’s 
unpaired t-test (n = 3).  The dashed grey line denotes the diameter of the disc.  
Error bars represent standard deviation from the mean. 
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SirABC; in the absence of SA and SB, S. aureus produced no detectable 
growth-promoting metabolites; and, the double transporter mutant strain was 
insensitive to application of a preparation replete for both staphyloferrins.  It was 
also observed that inactivation of hts had no effect on growth promotion by 
positive controls including hemin. 
 
2.3.7   FhuC is required for staphyloferrin transport by HtsABC and SirABC 
By definition, ABC transporters harness the energy of ATP hydrolysis to 
carry out translocation of a substrate across the cell membrane; however, 
annotation of both htsABC and sirABC operons (Figures 1-4A and 1-5A) reveals 
they are lacking candidate genes for ATP-hydrolyzing enzymes.  It has been 
shown that FhuC, the requisite ATPase for transport of staphylobactin (i.e. SB), 
is coopted from the FhuCBG ABC transporter for hydroxamate type 
siderophores of exogenous origin (63).  Agar plate bioassays were used to 
demonstrate that FhuC is also required for SA-dependent growth promotion in 
iron-restricted medium (Figure 2-7).  S. aureus strain Newman ΔfhuCBG was 
unable to grow on exogenously applied S. aureus supernatant concentrates 
containing SA, or on the hydroxamate siderophore ferrichrome.  
Complementation with a vector encoding native FhuC protein restored growth 
promotion on SA, while complementation with the entire fhuCBG operon, 
including permease genes, was required to restore growth promotion on the 
hydroxamate siderophore ferrichrome.  
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Figure 2-7.   Growth on staphyloferrins is dependent on ATPase FhuC.  
S. aureus strain RN6390 wild type (WT) and its isogenic ΔfhuCBG mutant 
complemented with vectors encoding fhuC (pFhuC) or the full fhu operon 
(pFhuCBG) were seeded in agar for a disc diffusion assay to compare growth on 
concentrated culture supernatants from donors that produce SA.  Plates 
contained TMS agar chelated with 10 µM EDDHA, suppressing growth without 
addition of an exogenous iron source.  The dashed grey line denotes the 
diameter of the paper disc spotted with concentrate.  Error bars represent 
standard deviation from the mean (n = 3). 
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2.3.8   Staphyloferrins enable growth of S. aureus in serum 
Several studies have demonstrated that microbial siderophores contribute 
to the growth of pathogens in the iron-restricted milieu of serum (Table 1-1), 
prompting the hypothesis that staphyloferrins might play a similar role for 
S. aureus.  To test this, S. aureus mutants inactivated for production of one or 
both of SA and SB were grown in a medium comprised of 60% 
complement-deactivated horse serum and 40% low-iron TMS broth (HoS-TMS).  
A previous characterization of a S. aureus RN6390 sbnF mutant 
(SB-deficient) described this strain as severely defective for growth in TMS due 
to a lack of siderophore output (17).  In this study, a strain Newman Δsbn mutant 
demonstrated markedly impaired growth compared to its wild type parent within 
the first 15 h of incubation, but subsequently recovered to reach an 
approximately equivalent 30 h cell density (Figure 2-8A).  Supplementation of 
the medium with free iron obviated this defect.  Despite an absence of SB, 
end-point supernatant siderophore activity of the Δsbn mutant was equivalent to 
that of its parent strain, as measured using the CAS assay (Figure 2-8B), 
implying SA might account for this recovery.  To ensure these results were not 
specific to strain Newman, growth experiments were repeated using RN6390 
and its isogenic staphyloferrin biosynthetic mutants, and similar growth 
dynamics were observed (Figure 2-9). 
In contrast to Δsbn mutants, Δsfa mutants were not noticeably impaired for 
growth in horse serum (Figures 2-8A and 2-9A), despite a decrease in overall 
output of siderophore into the culture supernatant (Figures 2-8B and 2-9B).  
Strains lacking both sets of staphyloferrin loci, however, were severely  
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Figure 2-8.   Staphyloferrin production promotes growth of S. aureus 
Newman in serum.  (A)  S. aureus strain Newman (WT) and isogenic SA and 
SB deficient mutants (Δsfa, Δsbn respectively) were cultured in Hos-TMS 
medium.  Production of SA alone resulted in delayed growth kinetics, toward an 
eventual culture density equivalent to wild type.  Production of SB alone was 
sufficient for wild type growth.  Lack of staphyloferrin production severely 
restricted growth.  All mutant kinetics were ameliorated to wild type with addition 
of 50 µM FeCl3 (inset).  (B)  Culture supernatant siderophore activity, measured 
using the CAS assay, was dependent on intact sfa or sbn loci, and repressed by 
addition of 50 µM FeCl3.  Error bars represent standard deviation from the mean 
(n = 3). 
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Figure 2-9.   Staphyloferrin production promotes growth of S. aureus 
RN6390 in serum.  (A)  S. aureus strain RN6390 (WT) and isogenic SA and SB 
deficient mutants (Δsfa, Δsbn respectively) were cultured in Hos-TMS medium.  
Production of SA alone resulted in delayed growth kinetics, toward an eventual 
culture density equivalent to wild type.  Production of SB alone was sufficient for 
wild type growth.  Lack of staphyloferrin production severely restricted growth.  
All mutant kinetics were ameliorated to wild type with addition of 50 µM FeCl3 
(inset).  (B)  Culture supernatant siderophore activity, measured using the CAS 
assay, was dependent on intact sfa or sbn loci, and repressed by addition of 
50 µM FeCl3.  Error bars represent standard deviation from the mean (n = 3). 
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attenuated for growth (Figures 2-8A and 2-9A).  This defect was presumably due 
to their inability to produce siderophore above background detection levels 
(Figures 2-8B and 2-9B), and growth could be corrected to wild type levels if the 
medium was saturated with free iron.  Taken together with data presented above 
describing the inability of Δsbn Δsfa supernatant concentrates to promote the 
iron-restricted growth of wild type S. aureus, these results strongly suggest that 
total siderophore production is mediated by the sbn and sfa loci.  
It was also of interest to determine if inactivation of staphyloferrin 
transporters would result in comparable growth defects to mutating biosynthetic 
loci (Figure 2-10A).  Similar to the lack of a growth defect for the Δsfa mutant, a 
Δhts knockout strain was not impaired for growth in horse serum relative to the 
wild type parent, while a sirA insertional mutant demonstrated growth kinetics 
characterized by extended lag and slower logarithmic growth, mimicking its 
Δsbn counterpart.  More importantly, a double sirA::Km Δhts mutant was equally 
attenuated for growth to its Δsbn Δsfa counterpart.  Interestingly, siderophore 
output by transporter mutants did not appear compromised, as endpoint 
supernatant activities of all cultures tested were roughly equivalent to the wild 
type parent if normalized to cell density (Figure 2-10B). 
 
2.3.9   Staphyloferrins enable growth of S. aureus on transferrin 
Numerous microbial siderophores contribute to the extraction of iron from 
the serum sequestration protein transferrin (Table 1-1), prompting the 
hypothesis that staphyloferrins might play a similar role for S. aureus.  To test 
this, S. aureus staphyloferrin mutants were grown in TMS broth that had  
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Figure 2-10.   Staphyloferrin transport promotes growth of S. aureus 
Newman in serum.  (A)  S. aureus strain Newman (WT) and isogenic SA and 
SB transporter mutants (Δhts, sirA::Km respectively) were cultured in Hos-TMS 
medium.  Transport of SA alone resulted in delayed growth kinetics, toward an 
eventual culture density equivalent to wild type.  Transport of SB alone was 
sufficient for wild type growth.  Lack of staphyloferrin transport severely 
restricted growth.  All mutant kinetics were ameliorated to wild type with addition 
of 50 µM FeCl3 (inset).  (B)  Culture supernatant siderophore activity, measured 
using the CAS assay, was not dependent on intact hts or sir operons, and was 
repressed by addition of 50 µM FeCl3.  Error bars represent standard deviation 
from the mean (n = 3). 
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 previously been deferrated by application of the chelating resin, Chelex-100 
(C-TMS), and reconstituted for iron with 10 µM human transferrin.  According to 
the manufacturer’s claims, this was approximately 60% iron saturated, thus 
serving as both a source of iron for strains with suitable extraction strategies, but 
also as a sink of iron for strains lacking these strategies. 
Despite Chelex treatment, enough contaminating iron persisted to promote 
some growth of S. aureus in the absence of a deliberately applied amendment 
(i.e. transferrin) (Figure 2-11).  Obtaining this iron did not require staphyloferrin 
production, since it was observed for the Δsbn Δsfa mutant, although either 
staphyloferrin accelerated the onset of exponential growth for single locus 
mutants.  Holotransferrin was sufficient to promote otherwise iron-restricted 
growth of S. aureus producing at least one staphyloferrin, to roughly equivalent 
levels (Figure 2-11), suggesting iron extraction from this mammalian 
sequestration factor is a redundant process mediated by both SA and SB.  The 
siderophore-deficient growth defect could be rescued with addition of sufficient 
free FeCl3 to saturate transferrin (inset).  In contrast to holotransferrin, 
apotransferrin was detrimental to growth of all strains tested, suggesting 
competition occurred for binding to free contaminating iron with staphylococcal 
siderophores. 
 
2.3.10   The sfa/hts locus is conserved in CNS 
To determine whether coagulase-negative staphylococcal (CNS) sfa loci 
are analogous to their S. aureus counterparts, attempts were made to correct 
the S. aureus Δsbn Δsfa growth defect to a Δsbn mode of growth through   
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Figure 2-11.   Staphyloferrin production promotes growth of S. aureus 
Newman on human transferrin.  S. aureus strain Newman (WT) and isogenic 
SA and SB deficient mutants (Δsfa, Δsbn respectively) were cultured in C-TMS 
medium supplemented with 10 µM human transferrin (Tf), in apo- or holo- 
(approximately 60% saturated) forms.  Production of either staphyloferrin 
permitted growth on holotransferrin approaching that of the wild type parent, 
while lack of staphyloferrin production severely restricted growth.  All mutant 
kinetics on holotransferrin were ameliorated to wild type with addition of 
50 µM FeCl3 (inset).  Error bars represent standard deviation from the mean 
(n = 3). 
  
124 
 
 
 
 
125 
 
 expression of cloned CNS sfa loci in trans.  These loci were cloned to vector 
pLI50 such that expression of sfaABC and sfaD operons remained reliant on the 
promoter-operator region between ORFs sfaA and sfaD (Figures 1-4A and 2-2).  
For S. aureus staphyloferrin mutants grown in HoS-TMS medium, 
complementation was achieved using pEV90 (sfa aureus) and pEV95 (sfa 
epidermidis), but could not be achieved using pEV96 (sfa saprophyticus) 
(Figure 2-12A).  CAS assays performed on exponential stage culture 
supernatants revealed that siderophore output was markedly high for strains 
carrying pEV90 and pEV95, regardless of the iron status of the medium 
(Figure 2-12B).  This was likely the result of Fur protein titration due to the high 
copy number of the Fur-box encoding sfa plasmids.  Curiously, this was not 
sufficient to compensate for SB and correct Δsbn growth kinetics to wild type.  
Despite failing to contribute to the iron-restricted growth of the Δsbn Δsfa 
mutant, pEV96 carriage nonetheless improved CAS activity of this strain beyond 
basal levels (relative to pLI50), and subsequent studies have demonstrated that 
S. saprophyticus produces a siderophore available to S. aureus in a 
HtsABC-dependent fashion; the reason for a lack of growth promotion through 
heterologous genetic expression of S. saprophyticus sfa genes remains 
unresolved. 
 
2.3.11   Heterologous expression of SirABC in S. epidermidis enables 
growth on SB 
To date, no sbn-like genetic loci have been annotated in any sequenced 
CNS genomes, and with the exception of S. lugdunensis, no sir-like loci have   
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Figure 2-12.   sfa is conserved in S. epidermidis.  (A)  S. aureus strain 
RN6390 growth defects in HoS-TMS arising from sfa inactivation could be 
rescued in trans by sfa genes expressed from vector pLI50.  Chromosomal 
genotypes included wild type (WT), SB-inactivated (Δsbn), and 
SA/SB-inactivated (Δsbn Δsfa).  pLI50 derivatives contained sfa loci from 
S. aureus (pEV90), S. epidermidis (pEV95), and S. saprophyticus (pEV96); the 
latter failed to rescue the Δsfa growth defect.  Presence of empty 
complementation vector (pLI50) did not contribute to iron restricted growth.  
Growth defects could also be rescued by addition of 50 µM FeCl3 (inset).  
(B)  Expression of sfa from high copy number vector pLI50 derivatives (pEV90, 
pEV95, pEV96) resulted in increased siderophore production even in the 
presence of 50 µM FeCl3; siderophore production was measured using the CAS 
assay.  Error bars represent standard deviation from the mean (n = 3). 
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been annotated.  S. aureus is exquisitely adapted to surviving in low iron niches; 
during its evolutionary history, its genome has acquired multiple determinants 
endowing transport of exogenously derived siderophores that facilitate such a 
lifestyle.  Certain CNS species also profit from exogenous siderophores; for 
instance, S. epidermidis, whose genome encodes an annotated Fhu-like ABC 
transporter, is known to use hydroxamate siderophores (19), despite not 
synthesizing these molecules (49).  It was thus of interest to determine if a 
directed genetic acquisition event could render a CNS species capable of using 
SB, which could foreshadow the emergence of more virulent strains capable of 
exploiting a wider range of clinically relevant iron ligands.  
This was achieved through heterologous expression of sirABC in 
S. epidermidis strain 1457-M10.  A biofilm deficient mutant was selected for this 
experiment because of its improved transformability relative to its biofilm 
proficient parental strain.  Previous attempts to construct sirABC-expressing 
vectors have been hindered by the apparent incompatibility of the sir-sbn 
operator region in E. coli strains used for genetic manipulations, necessitating 
the transcriptional fusion of this operon to an alternate staphylococcal 
iron-regulated promoter.  To forestall the possibility that S. epidermidis FhuC 
might be unsuitable for proper functioning of SirABC, sirABC was cloned 
downstream of S. aureus fhuC and its native operator region in shuttle vector 
pALC2073, forming plasmid pFB54.  To determine if S. epidermidis FhuC is an 
adequate surrogate for its S. aureus homologue, a transcriptional fusion to a 
nonfunctional Walker domain mutant allele of S. aureus fhuC was also made, 
generating plasmid pFB57.  Either vector rendered strain 1457-M10 responsive 
129 
 
to application of a supernatant concentrate from a SB-producing, SA-deficient 
S. aureus donor strain (Figure 2-13), demonstrating that genetic transfer events 
between S. aureus and S. epidermidis can augment the iron uptake repertoire of 
the latter’s genome.  
 
2.3.12   Inactivating siderophore biosynthesis has a minimal impact on 
virulence in a mouse sepsis model of infection 
It was previously shown that S. aureus with a chromosomal inactivation of 
one of the three SB synthetases was attenuated in a five to six day mouse 
kidney abscess model of infection (17).  In this model, S. aureus is injected to 
mice intravenously but rarely persists in the blood more than a few hours; rather, 
it localizes to soft tissues and seeds within organs (11).  Because of their 
exquisite susceptibility to bloodborne S. aureus, kidneys are the most commonly 
investigated organs for quantification of bacterial load, with the hallmark of 
severe infection being the formation of bacteria-laden renal abscesses.  In 
contrast to the previous study, numerous pilot studies with injected Newman 
Δsbn and Δsfa mutants failed to demonstrate significant reductions in kidney 
bacterial burden resulting from inactivation of staphyloferrin production (data not 
shown); thus subsequent studies were expanded to include other organs, chiefly 
livers and hearts.  Spleens and lungs were also examined in some experiments, 
but yielded data with extreme variability, and will not be discussed further.  
Additionally, different infective loads were tested.  
The results of four infection studies are presented in Figure 2-14 and 
Appendix Figure A1.  At a lower infective dose a significant attenuation of   
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Figure 2-13.   Heterologous expression of sirABC enables S. epidermidis 
to grow on SB.  S. epidermidis strain 1457-M10 expressing S. aureus 
fhuCsirABC as a transcriptional fusion from plasmid pALC2073 (pFB54) seeded 
in agar for a disc diffusion assay grew in response to addition to S. aureus 
culture concentrate containing SB.  A Walker domain null mutant allele of 
S. aureus fhuC in the fusion (pFB57) did not compromise this growth promotion.  
Plates contained RPMI agar chelated with 5 µM EDDHA, suppressing growth 
without addition of an exogenous iron source.  The dashed grey line denotes the 
diameter of the paper disc spotted with concentrate.  Error bars represent 
standard deviation from the mean (n = 3). 
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Figure 2-14.   S. aureus Newman strains mutated in sfa and sbn loci are 
minimally attenuated in a mouse systemic model of infection.  
Approximately 8 x 106 CFU (A) or 5 x 106 CFU (B) S. aureus Newman and 
isogenic staphyloferrin biosynthetic mutant derivatives were injected 
intravenously to Charles River BALB/c immunocompetent mice.  Percentage of 
mouse body mass lost over four days and CFU recovered from target organs 
are plotted.  Statistical analysis was performed using the Student’s unpaired 
t-test.  P values denote significant differences from wild type (WT).  Calculated 
infective doses, in millions of CFU injected, were as follows:  wild type, 8.000 (A) 
and 6.000 (B); Δsfa, 8.625; Δsbn, 8.625; Δsfa Δsbn, 8.750 (A) and 6.000 (B). 
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bacterial load in hearts was observed in Charles River mice (Figure 2-14B); this 
was not reproducible using mice purchased from Jackson Laboratories 
(Appendix Figure A1).  No significant differences in bacterial loads between 
strains were observed for other organs.  These results suggest siderophore 
production is not important for virulence in four-day mouse sepsis models. 
 
2.3.13   Inactivating siderophore biosynthesis has no impact on virulence 
in a mouse skin abscess model of infection 
Siderophore mutants were also examined for attenuation in a mouse skin 
abscess model.  S. aureus Newman saline cell suspensions were injected 
subcutaneously into the rear flank of Charles River nude SKH-1 or shaved 
BALB/c mice (approximately 5 x 108 CFU).  Pus-filled lesions appeared within 
24 to 36 h, and surface area was measured at 24 h intervals for up to a week.  
Lesion size generally stabilized by the second day, and data are presented for 
that day (Figure 2-15).  Lesion sizes were highly variable and no significant 
differences were noted between wild type and isogenic siderophore biosynthetic 
mutant strains. 
 
2.3.14   Inactivating siderophore transport has a significant impact on 
virulence in a mouse sepsis model of infection 
The mouse sepsis infection model was approached again to assess 
virulence phenotypes associated with isogenic S. aureus Newman siderophore 
transport mutants.  The ΔfhuCBG mutant was also tested, as a strain lacking the 
FhuC ATPase is impaired for Hts and Sir-mediated transport functions.  To  
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Figure 2-15.   S. aureus Newman strains mutated in sfa and sbn loci are 
not significantly attenuated in a mouse skin lesion model of infection.  
Approximately 5 x 108 CFU S. aureus Newman and isogenic staphyloferrin 
biosynthetic mutant derivatives were injected subcutaneously to nude SKH-1 (A) 
or shaved BALB/c (B) immunocompetent mice.  An equivalent volume of sterile 
saline suspension buffer was injected as a negative control.  Two day lesion 
areas are plotted.  Statistical analysis was performed using the Student’s 
unpaired T-test.  Calculated infective doses, in billions of CFU injected, were as 
follows:  wild type (WT), 0.519 (A) and 0.319 (B); Δsfa, 0.437 (A) and 0.325 (B); 
Δsbn, 0.458 (A) and 0.350 (B); Δsfa Δsbn, 0.460 (A) and 0.303 (B). 
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discount any Δfhu phenotypes being attributed to loss of the FhuBG permease, 
rather than the promiscuous FhuC ATPase, a fhuG transposon insertion mutant 
(fhuC+) was used as a control. 
In contrast to the sepsis trial involving biosynthetic mutants, strains wholly 
deficient for staphyloferrin transport—i.e. the Δhts sirA::Km and the Δfhu 
mutants—generated robust attenuation phenotypes in BALB/c mice.  Significant 
reductions (P < 0.05 using the Student’s t-test) were observed for weight loss, 
kidney load, and heart load for at least one of these two mutants (Figure 2-16).  
The Δfhu mutant was likely attenuated due to lack of ATPase FhuC for 
HtsABC/SirABC-mediated transport processes, rather than a lack of 
FhuD1/FhuD2FhuBG-mediated ferric hydroxamate transport, as the fhuG- 
mutant performed comparably to wild type (Figure 2-16). 
 
2.3.15   Inactivating siderophore transport enhances siderophore 
production by S. aureus 
Transcriptional regulation of sfa, hts, sbn, and sir is described as 
iron-regulated in the paradigmatic sense, i.e. through a mechanism whereby 
transcriptional derepression occurs when cellular iron levels decrease and 
Fur-Fe2+ dissociates from the operator regions of genes within its regulon 
(Figure 2-3 and (17, 18)).  By the rules of this model it would be reasonable to 
predict that a genetic mutation compromising iron uptake, including one affecting 
staphyloferrin transport, would exacerbate iron starvation, consequently 
enhancing expression of unchanged iron acquisition genes, including those 
involved in staphyloferrin production.  It has been shown that inactivation of Sir  
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Figure 2-16.   S. aureus Newman strains mutated in hts, sir, and fhu 
operons are significantly attenuated in a mouse systemic model of 
infection.  Approximately 9 x 106 CFU S. aureus Newman and isogenic 
siderophore transport mutant derivatives were injected intravenously to Charles 
River  immunocompetent mice.  Percentage of mouse body mass lost over four 
days and CFU recovered from target organs are plotted.  Statistical analysis was 
performed using the Student’s unpaired T-test.  P values denote significant 
differences from wild type (WT).  Calculated infective doses, in millions of CFU 
injected, were as follows:  WT, 9.750; Δhts, 9.750; sirA::Km, 10.625; Δhts 
sirA::Km, 8.875; Δfhu, 9.250; fhuG::Tn917, 8.750. 
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leads to upregulation of sbn (18).  In an attempt to explain why the virulence 
attenuation phenotype of staphyloferrin transport mutants was much more 
pronounced than that of corresponding biosynthetic mutants, the relative total 
siderophore output of the host of strains used in the mouse infection models was 
examined.  These were grown in TMS broth and supernatant siderophore 
activity was sampled at six hour intervals.  In this culture medium, the only 
source of iron stems from trace contamination of the other ingredients; thus it is 
readily depleted by exponentially growing cells. 
This medium sustained growth of all strains tested.  Single-locus mutants 
and the Δsfa Δsbn mutant all grew comparably to the isogenic wild type parental 
strain (Figure 2-17A), and this growth was apparently not dependent on 
siderophores, as the Δsfa Δsbn mutant did not render its supernatant 
CAS-positive above background levels of detection (Figure 2-17B).  While the 
Δhts sirA::Km and Δfhu strains (i.e. strains wholly deficient for transport of 
staphyloferrins) also experienced a normal lag phase and some exponential 
growth, they entered stationary phase at lower culture density.  Their 
siderophore output, however, continued to rise drastically well into stationary 
phase, well exceeding output of the parental strain.  This is dissimilar to 
siderophore output measured in HoS-TMS medium (Figure 2-9B), but different 
results might be attributable to differences in carbon availability between 
HoS-TMS and TMS.  This would suggest that, at least under certain 
iron-restricted growth conditions, impairing siderophore transport does not affect 
siderophore production by S. aureus and may cause the organism to 
hyperchelate its own surroundings. 
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Figure 2-17.   Inactivation of siderophore transport does not impair 
siderophore production by S. aureus.  (A)  S. aureus strain Newman (WT) 
and isogenic mutant derivatives inactivated for staphyloferrin biosynthesis (Δsfa, 
Δsbn, Δsfa Δsbn) or transport (Δhts, sirA::Km, Δhts sirA::Km, Δfhu) were grown 
in TMS medium.  (B)  Siderophore activity of culture supernatants was sampled 
at 6 h intervals using the CAS assay.  The mutant wholly impaired for 
biosynthesis (Δsfa Δsbn) failed to generate siderophore activity above baseline 
levels, while mutants wholly impaired for transport (Δhts sirA::Km and Δfhu) 
demonstrated markedly enhanced siderophore output.  Error bars denote 
standard deviation from the mean (n = 3). 
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2.3.16   S. aureus strain Newman is an efficient producer of siderophores 
From the mouse infection models, it was apparent that inactivation of sbn 
and sfa had minimal impact on the virulence of this strain compared to the wild 
type parent, suggesting minimal reliance on siderophore-mediated iron uptake in 
vivo.  It was therefore of interest to compare siderophore production of Newman 
to other clinically relevant S. aureus strains.  These were grown in HoS-TMS 
media with periodic sampling of culture supernatant siderophore activity using 
the CAS assay.  Growth dynamics for all wild type strains were comparable; 
notably, Newman achieved higher stationary phase density than all other 
isolates (Figure 2-18A).  At all intervals, Newman supernatant siderophore 
activity was lower than all other S. aureus strains tested, with the exception of 
dermatitis-associated strain AD25 (Figure 2-18B), with the most marked 
differences noted within the first 12 hours of growth.  Despite apparently 
secreting less siderophore than other strains, Newman output was sufficient to 
counter the bacteriostatic effects of serum. 
  
2.4   Discussion 
Decades-old surveys of Staphylococcus culture collections described 
members of this genus to produce at least two carboxylate siderophores:  SA 
and SB (34, 39, 43).  More recently, Dale et al. (17) provided the first insight into 
the molecular and biochemical mechanisms underlying staphylococcal 
siderophore synthesis in demonstrating that the sbn operon of S. aureus 
encodes NIS synthetases involved in the production of a secreted ferric iron 
chelator.  Lacking structural information linking the molecule to either  
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Figure 2-18.  Siderophore production by S. aureus strain Newman is 
comparatively lower than other laboratory strains and clinical isolates.   
(A)  S. aureus strain Newman, its isogenic mutant derivative inactivated for 
staphyloferrin biosynthesis (Δsfa Δsbn), and an array of laboratory and clinical 
S. aureus isolates were grown in HoS-TMS medium.  (B)  Siderophore activity of 
culture supernatants was sampled at 6 h intervals using the CAS assay.  Strain 
Newman exhibited lower amounts of siderophore production than most of the 
other strains, nevertheless achieving the highest endpoint density.  Error bars 
denote standard deviation from the mean (n = 3). 
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staphyloferrin, researchers tentatively termed the metabolite staphylobactin.  
Data presented in this study (Figure 2-4) and by collaborators (12) formally 
described the role of sbn-encoded enzymes in synthesis of SB.  In 
characterizing a synthetase mutant, Dale et al. reported that S. aureus does not 
produce another siderophore and cannot grow in conditions of severe iron  
eprivation.  Genome sequencing projects revealed that the sbn operon is unique 
to S. aureus among the staphylococci; however, a second locus encoding 
putative NIS synthetases, sfaABCsfaD, is found on the chromosome of 
S. aureus and among all other members of the genus.  This annotation 
prompted reinvestigation of the findings of Dale et al., to test the hypothesis that 
the sfa locus encodes for synthetases involved in production of a second 
siderophore.  
The current study has revealed that under conditions of iron restriction, 
SB-deficient mutants, including the strain used by Dale et al., do in fact readily 
secrete siderophore (Figure 2-1).  The discrepancy between studies might be 
attributed to methodological differences not described in the published protocols.  
Chromosomal deletion of the sfa locus abolished production of the second 
siderophore, and combining this mutation with an sbn operon deletion rendered 
S. aureus devoid of siderophore output.  Cotton et al. (14) concurrently 
demonstrated assembly of SA to be mediated in vitro by synthetases SfaD and 
SfaB, and in this study sfa mutants were generated to confirm this genetic locus 
is responsible for SA production (Figure 2-5).  It was also shown that an 
orthologous locus is responsible for production of the same metabolite for other 
pathogenic staphylococci, including S. epidermidis (Figure 2-12). 
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A central dogma in S. aureus physiology is that its preferred iron source 
during infection is heme (62).  The most abundant reservoir of iron in the 
mammalian host is within heme groups of hemoglobin (23); in S. aureus, the Isd 
complex of cell wall and membrane associated proteins extract and transport 
heme as detailed in numerous reports (for a review, see (31)).  Expression of isd 
genes is directly regulated by iron and comprises part of the Fur-mediated iron 
deprivation response (48).  However, uncompartmentalized serum hemoglobin 
(i.e. outside of erythrocytes) is relatively scarce, circulating at a concentration of 
approximately 2.5 µM (53), representing 10 µM Fe.  In contrast to isd genes, 
expression of S. aureus haemolysins is under direct control of multiple 
two-component regulatory systems, and most importantly the Agr 
quorum-sensing system, such that their production occurs after the initial stages 
of infection, once attachment has occurred (for a review, see (54)).  Enhanced 
production of lytic toxins including α- and γ-hemolysin has been documented for 
a S. aureus fur- mutant (64), but mechanistic data directly linking this phenotype 
to an absence of Fur repression is lacking, and this phenotype is probably a 
symptom of a more global disruption of regulatory processes; in another study, 
transcriptional upregulation of hemolysin genes by wild type S. aureus was not 
noted for cells in vitro under conditions of iron limitation (2).  Thus, haemolysin 
secretion is not directly dependent on the intracellular iron status of the bacterial 
cell and is likely preceded by siderophore production at the onset of invasive 
infection.  In comparison to hemoglobin, transferrin is found in serum at a 
concentration of approximately 25 µM (4); assuming 30% saturation, this 
represents a concentration of 7.5 µM Fe, rivalling the serum hemoglobin pool as 
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a reservoir for iron during initial stages of staphylococcal sepsis.  In fact, in 
sufferers of hemochromatosis, who demonstrate above average transferrin 
saturation, this protein’s reservoir may constitute a more abundant serum iron 
pool than uncompartmentalized hemoglobin; hemochromatosis is well 
documented as a predisposing factor to infection (38).   
In this study, it was shown that the ability of S. aureus to withstand the 
bacteriostatic effects of serum is alleviated through production of either 
staphyloferrin (Figure 2-9), and these siderophores are required for S. aureus 
proliferation on holotransferrin as a sole iron source (Figure 2-10).  This is in 
good agreement with the role attributed to siderophores for a range of 
pathogenic bacteria (Table 1-1).  However, inactivation of staphyloferrin 
biosynthesis had marginal effects on S. aureus virulence in a mouse bacteremia 
model of infection (Figure 2-14).  With cursory consideration, this would suggest 
against describing siderophores as important players in the S. aureus repertoire 
of virulence factors.  Other findings of this study, however, suggest further 
investigation into the contributions of siderophores toward staphylococcal 
pathogenesis is merited.  Most importantly, it was noted that inactivation of 
siderophore transport without concomitant inactivation of biosynthesis did result 
in significant and reproducible attenuation of infection in the model (Figure 2-16).  
This may have been a consequence of transporter mutants continuing to secrete 
staphyloferrins (Figures 2-10, 2-17), to the point they enhanced the 
iron-withholding capacity of their milieu.  This phenomenon hints that 
therapeutics incapacitating siderophore transport might be efficacious in 
combating S. aureus infection.  With an improved understanding of Sfa/Sbn 
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synthetase biochemistry, it might be feasible to design staphyloferrin derivatives 
that compete with the natural ligands for binding to receptor proteins SirA and 
HtsA, without benefiting the S. aureus cell through subsequent transport and 
release of iron.   
A reevaluation of the mouse as a model for studying infective processes of 
a predominantly primate and livestock-adapted pathogen is merited.  Mice 
exhibit a remarkable innate immunity toward S. aureus infection, and the 
requirement for an infective dose exceeding one million CFU, directly injected 
into the bloodstream, is hardly representative of the opportunistic infective 
process in humans, whereby many orders of magnitude fewer infective units 
enter the bloodstream through a traumatic breach in the endothelium.  To some 
degree, murine innate resistance reflects the lack of coevolution between 
pathogen and surrogate host; S. aureus virulence factors have evolved for 
enhanced specificity toward human factors, at the expense of specificity toward 
homologous factors in other genera.  Pertinently, it was recently shown that 
humanizing mice for hemoglobin vastly enhanced S. aureus virulence 
phenotypes associated with Isd-mediated heme uptake (58).  While the ability of 
a siderophore to extract iron from transferrin largely reflects the higher affinity for 
Fe3+ exhibited by the former, this phenomenon may also result from a more 
dynamic interaction.  The enteric bacterial siderophore aerobactin has an 
in vitro-calculated affinity for iron well below that of transferrin (40), yet mediates 
extraction of iron regardless (25), and is a noted virulence factor (67); this is 
necessarily the result of an uncharacterized facet of the interaction between the 
two molecules, which might further be influenced by the species from which the 
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transferrin is derived.  The difficulties in generating robust attenuation 
phenotypes for siderophore mutants in mice may reflect decreased compatibility 
of murine transferrin with staphyloferrins.  It was of interest to evaluate the 
growth of S. aureus on mouse transferrin, but purchasing sufficient quantities of 
this molecule proved prohibitively expensive. 
The adaptive significance of producing two staphyloferrins with redundant 
functions is not clear, though S. aureus is certainly not unique among bacteria in 
secreting multiple siderophores; this has been documented for pathogens 
including Pseudomonas aeruginosa, Escherichia coli, and Bacillus anthracis, to 
name a few (9, 15, 68).  In certain cases, production of a second siderophore is 
an adaptive mechanism countering the innate immune factor siderocalin (24).  
This host protein sequesters a range of iron ligands with 2,3-catecholate iron 
coordination groups, such as bacillibactin (1).  To compensate for the 
sequestration of this chelator during infection, B. anthracis also produces 
petrobactin, which coordinates iron using one carboxylate and two 
3,4-catecholate groups, and is not recognized by siderocalin; based on this 
virtue, it is has been called a ―stealth‖ siderophore (71).  Siderocalin evasion is 
not likely to have been a selective pressure influencing the acquisition of a 
second siderophore biosynthetic locus by S. aureus, as neither staphyloferrin 
incorporates catechol groups; the ability of siderocalin to sequester SA and SB, 
however, has not been examined.  Acquisition of SB biosynthesis may 
contribute to the higher virulence of S. aureus over other CNS, by giving it a 
competitive advantage in the battle for iron in mixed population niches such as 
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skin and mucosa; as demonstrated in Figure 2-13, SB iron is unavailable to 
S. epidermidis lacking heterologously expressed SirABC. 
The availability of either staphyloferrin was exclusively contingent on the 
presence of its cognate transport system; no overlapping functionality between 
Hts and Sir was observed (Figure 2-6).  The crystal structures of HtsA bound to 
Fe-SA and SirA bound to Fe-SB have been elucidated (29, 30).  Both receptors 
have conserved sequence and structure; both have extremely high affinities for 
their ferrated ligands (Kd values in the lower nanomolar range); and for both, 
ligand binding is characterized by localized conformational changes within the 
binding pockets, acting to encase the siderophore, in lieu of larger, hinge-like 
conformational change encompassing the greater protein structure, as occurs in 
the B. subtilis tris-catecholate binding protein FeuA (57).  Neither receptor has 
notable affinity for the other’s ligand.   Specificity is dictated in large part by 
basic residues within either protein’s binding pocket positioned to cater to the 
overall charge of either staphyloferrin and the geometrical distribution of 
iron-coordinating atoms across either molecule’s structure.  The HtsA binding 
pocket is characterized by six arginine residues which act to neutralize the large 
negative charge of SB (net charge of -5 when deferrated; Figure 1-4B), and are 
oriented to target closely clustered Fe3+-coordinating oxygen molecules.  The 
SirA binding pocket is also characterized by key arginine residues; in contrast to 
HtsA, these are fewer in number (three, to accommodate the -3 charge of SA; 
refer to Figure 1-5B), and located on different loops of the binding pocket to 
cater to the wider dispersion of Fe3+-coordinating atoms across the SB 
molecule.   
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This is the first study to characterize phenotypes of a siderophore-deficient 
mutant of S. aureus.  We have demonstrated that siderophores are major 
factors contributing to the noteworthy resistance S. aureus toward the 
bacteriostatic effects of transferrin.  These, however, are not the only means this 
pathogen has of extracting iron from transferrin; Chapter 3 is dedicated to the 
characterization of an alternate mechanism, whose discovery was facilitated by 
the mutant strains described in this chapter. 
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Chapter 3 
Catecholamine and catechol-mediated iron uptake in 
Staphylococcus aureus 
 
 
Significant portions of this chapter have been published in the following article: 
 
Beasley, F. C., C. Marolda, J. Cheung, S. Buac, and D. E. Heinrichs (2011).  
Staphylococcus aureus transporters Hts, Sir and Sst capture iron liberated from 
human transferrin by staphyloferrin A, staphyloferrin B and catecholamine stress 
hormones, respectively, and contribute to virulence.  Infection and Immunity, in 
press.  Mouse surgeries were performed by Martha Harding, Animal Care and 
Veterinary Services, University of Western Ontario. 
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3.1   Introduction 
Circulatory catecholamine stress hormones, including norepinephrine, 
epinephrine, dopamine, and L-3,4-dihydroxyphenylalanine (L-DOPA) 
(Figure 1-2), interfere with the extracellular iron scavenging functions of host 
immune proteins transferrin and lactoferrin.  This occurs through direct binding 
of catecholamines to transferrin/lactoferrin-complexed Fe3+, with resultant 
reduction to the Fe2+ valence, for which serum sequestration proteins have 
minimal affinity (31).  Released ferrous iron can be captured by pathogenic 
bacteria (9).  Alternatively, catecholamines compete with serum proteins for 
coordination of Fe3+ in solution using their 3,4-dihydroxybenzoyl moieties, such 
that three catecholamine molecules can complex around one iron atom in a 
geometrical arrangement evocative of the enterobactin-Fe complex (see 
2,3-dihydroxybenzoic acid, Figure 1-2).  It was shown that a siderophore 
biosynthetic mutant of E. coli was further compromised for 
catecholamine-mediated capture of transferrin iron in a contact-independent 
fashion (across a dialysis membrane) if the strain was also defective for 
enterobactin transport (entA-), implicating the enterobactin transporter in the 
additional function of capturing the Fe-catecholamine complexes (2).   
Catecholamine-dependent promotion of bacterial growth has been 
proposed as a contributory factor in the development of gut sepsis following 
trauma with associated increases in circulating stress hormone levels (10) and 
with localized destruction of norandrenergic neurons (16).  Catecholamines have 
also been shown to enhance growth of pathogenic bacteria on serum (1, 9, 19, 
31) but empirical data linking this phenomenon to virulence is lacking.  Studies 
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on the stimulatory effects of catecholamines toward the growth of staphylococci 
on transferrin or in serum have described a positive response by S. epidermidis 
(16, 22, 31) but no response or a marginally positive response by S. aureus (22, 
26, 31). 
In Chapter 2, the ability of S. aureus to obtain iron from bulk serum and 
from the serum iron sequestering protein transferrin was demonstrated.  This 
mode of growth was dependent on production of at least one of two 
staphyloferrins:  siderophore molecules that are assembled from amino acid and 
organic acid precursors.  Surveys of culture collections have thus far 
demonstrated that staphylococcal isolates do not produce two other classes of 
siderophore molecules, namely hydroxamates and catecholates (5, 7, 18).  In 
Chapter 2, the ability of S. aureus to capture xenosiderophores (siderophores 
produced by other organisms) was also introduced, in the context of FhuC, the 
ATPase required by ABC transporters HtsABC and SirABC for active uptake of 
SA and SB, respectively.  The original characterization of FhuC, however, 
pertained to its role in driving the FhuDBG ABC transporter, required for growth 
of S. aureus on hydroxamate-coordinating iron ligands, such as the fungal 
siderophore ferrichrome (32, 35).  It is also known that S. aureus uses 
catecholate siderophores, such as enterobactin, for growth under iron restriction 
(32), through an undescribed transport system. 
Bioinformatic analysis of the S. aureus genome has uncovered operon 
sstABCD (Figure 3-1), encoding a putative ABC transporter sharing sequence 
identity with bacterial transport systems for various iron ligands, including 
catecholate siderophores.  SstD is a member of the class III substrate binding  
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Figure 3-1:  The S. aureus sstABCD operon.  Schematic of the sstABCD 
operon, encoding a predicted heterodimeric permease (SstAB), a predicted 
ATPase (SstC), and a lipoprotein receptor (SstD).   Numbers refer to locus tags 
within the S. aureus strain Newman genome (e.g. NWMN_0702). 
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protein family, a family which includes the S. aureus Fe3+-staphyloferrin 
receptors HtsA and SirA, and shares significant sequence identity (E = 9e-59) 
with the Bacillus subtilis petrobactin receptor YclQ (39).  The sst operon is 
transcriptionally upregulated under conditions of iron deprivation (21), 
suggesting a role in the adaptive response to restrictive environments such as 
serum; the same study, however, did not identify any ligands for receptor 
lipoprotein SstD, and genomic inactivation of the transporter did not compromise 
virulence in a rat chamber implant model of infection.  In this study, it was shown 
that S. aureus is in fact capable of catecholamine-mediated acquisition of serum 
iron, but this phenomenon is secondary to staphyloferrin-mediated iron uptake 
in vitro and can only be observed in the absence of siderophore production 
using sfa/sbn mutants.  Mutants lacking Sst were unable to grow on 
xenosiderophores using catechol iron coordinating groups exclusively, including 
enterobactin, suggesting Sst is a broad specificity transporter of catecholate 
iron-coordination ligands.  Inactivation of sstABCD enhanced the attenuation 
phenotype of siderophore biosynthesis and transporter mutants in the mouse 
sytemic model of infection, suggesting the ability of S. aureus to acquire iron 
from host serum is the sum of multiple mechanisms and not exclusively limited 
to staphyloferrin-mediated uptake. 
 
3.2   Materials and methods 
3.2.1   Bacterial growth conditions 
Bacterial strains include those summarized in Table 2-1 and additional 
strains summarized in Table 3-1.  Growth conditions, including temperature, 
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composition of media, and selective concentrations of antibiotics used were as 
described in Section 2.2.1.  An additional growth medium used consisted of 
80% C-TMS with 20% human serum (HuS-TMS).  Human serum was collected 
from healthy volunteers without use of heparin sulfate; serum was separated 
from blood cells immediately upon collection by centrifugation at 2000 X g for 
20 min at 4 oC, and complement was deactivated through incubation at 55 oC for 
2 h. 
 
3.2.2   General molecular genetic methodologies  
DNA purification, manipulation, and recombination was performed 
essentially as described in Sections 2.2.2 and 2.2.3, with additions/modifications 
described below. 
 
3.2.3   Mutagenesis of S. aureus 
Oligonucleotides and plasmids strains used in this study are summarized 
in Tables 2-1 and 3-1.  Allelic replacement was used to delete the majority of 
operon sstABCD from the chromosome of S. aureus.  The operon and flanking 
regions were PCR amplified from strain RN6390 and cloned into plasmid 
pBAD24 using restriction enzymes SalI and XbaI. The majority of the operon 
was excised via PvuII digestion.  A Klenow-blunted BamHI restriction fragment 
containing an erythromycin resistance cassette was prepared from plasmid 
pDG646 and cloned into the PvuII restriction site. The ΔsstABCD::Em knockout 
allele was excised using restriction enzymes SalI and XbaI, and cloned to vector 
pAUL-A-Km, generating pSB10.  Subsequent passage through S. aureus   
166 
 
Table 3-1:  Bacterial strains, plasmids, and oligonucleotides used in this 
study 
 
 Description Ref. 
S. aureus strains   
H1861 RN6390 ΔsstABCD::Em This study 
H2221 Newman ΔsstABCD::Em This study 
H2224 Newman sirA::Km ΔhtsABC::Tc 
ΔsstABCD::Em 
This study 
H2228 Newman ΔsbnABCDEFGHI::Tc 
ΔsfaABCsfaD::Km ΔsstABCD::Em 
This study 
Bacillus subtilis 
strains 
  
HB5800 Bacillibactin-producing strain (27) 
Escherichia coli 
strains 
  
BL21ʎ(DE3) F- ompT hsdSB(rB
-, mB
-) dcm gal ʎ(DE3) Novagen 
AN102 Enterobactin-producing strain (6) 
Plasmids   
pBAD24 E. coli cloning vector; Ap
R 
(15) 
pDG646 E. coli vector containing the ermC gene; Ap
R (14) 
pGEX-2T-TEV E. coli vector for overexpression of 
recombinant proteins with tobacco etch virus 
protease cleavable glutathione-S-
transferase (GST) tags; ApR 
(33) 
pJB1 pGEX-2T-TEV derivative for overexpression 
of SstD with a TEV-cleavable GST; ApR 
This study 
pSB5 pLI50 derivative carrying sstABCD; Cm
R 
This study 
pSB10 pAUL-A derviative carrying ΔsstABCD::Em 
allele; EmR 
(3) 
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Table 3-1 continued 
Oligonucleotides*  
sst5’-SalI 
sst3’-XbaI-1 
5’ AAAAGTCGACGGAATCACTGAAGATGTG 3’ 
5’ GGGGTCTAGAGGTGAACATCCAAAGGAATCGTA 3’ 
Generation of ΔsstABCD::Em allele 
sst3’-XbaI-2 5’ CCCCTCTAGACAATGATTAAGACCTTTAACCAT 3’ 
Cloning of sstABCD to pLI50 for complementation (with 
sst5’-SalI) 
sstD-28/343-5’- 
   BamHI 
sstD-28/343-3’ 
5’ TTGGATCCCAATCAAAATCAGAAACTAAAGG 3’ 
 
5’ CCTTTAACCATTGTTCCCCTCTTT 3’ 
Cloning of soluble portion of sstD (codons 28-343) to 
pGEX-2T-TEV for overexpression 
* underlined sequences in oligonucleotides denote restriction sites 
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strains, recombination into the chromosome with colour-based selection, and 
transduction between strains was performed as described in Section 2.2.3. 
 
3.2.4   Complementation of the Δsst mutation 
The chromosomal ΔsstABCD::Km mutation was complemented in trans 
using plasmid pSB5, which was generated by cloning PCR-amplified, 
SalI/XbaI-digested sstABCD into plasmid pLI50. 
 
3.2.5   Bacterial growth curves and plate bioassays 
For generation of growth curves, S. aureus cells grown to stationary phase 
in TMS with 100 µM 2,2-dipyridyl were washed twice in saline buffer and diluted 
1:100 into HuS-TMS or C-TMS containing 10 µM human transferrin.  Culture 
medium was left iron depleted or enriched with 100 µM FeCl3 (iron replete).  
Other culture medium amendments included 50 to 200 µM catecholamine 
hormones (norepinephrine, epinephrine, dopamine, or L-DOPA) 
(Sigma-Aldrich).  Norepinephrine and dopamine were purchased as 
hydrochlorides and dissolved in water to generate stock solutions; dopamine 
and L-DOPA were dissolved in equimolar and twice equimolar concentrations of 
HCl, respectively. 
Disc diffusion plate availability bioassays were performed as described in 
Section 2.2.11.  Discs were spotted with 20 µL of 750 µM stocks of 
catecholamines (described above) or 2,3-dihydroxybenzoic acid 
(Sigma-Aldrich), or 250 µM stocks of the following catecholate siderophores:  
enterobactin-Fe, petrobactin-Fe, salmochelin S-4-Fe (EMC Microcollections 
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GmbH), or bacillibactin (described below).  All ligands were ferrated with 50 µM 
FeCl3 if not described as ferrated by the vendor. 
Bacillibactin was purified from B. subtilis strain HB5800 as described (11), 
with modifications.  Briefly, B. subtilis was grown in enterobacterial minimal 
culture medium (23) with modifications as described (4) for 48 h.  Cells were 
removed by centrifugation and culture supernatant was acidified to pH 3 with 
HCl then extracted three times with 200 mL volumes of ethyl acetate.  Pooled 
ethyl acetate fractions were dried over NaSO4, filtered, and dried in a rotary 
evaporator.  Residue was dissolved in 1 mL methanol and added dropwise into 
50 mL stirred ether.  Precipitate was pelleted by centrifugation, air dried, and 
resuspended in dimethyl sulfoxide.  Bacillibactin concentration was calculated by 
measuring absorbance at 318 nm as described (24). 
 
3.2.6   Generation of anti-SstD antiserum 
The soluble portion of the sstD gene (downstream of the lipoprotein 
consensus sequence) was PCR-amplified and cloned into plasmid 
pGEX-2T-TEV using restriction sites BamHI and SmaI, generating plasmid pJB1 
in E. coli strain BL21λ(DE3).  For overexpression of SstD-GST, E. coli cells were 
grown at 30 °C to mid log phase, induced with 0.4 mM isopropyl 
β-D-1-thiogalactopyranoside, and grown for another 16 h.  Cells were collected 
by centrifugation and ruptured using a French press.  Insolubles and cellular 
debris were removed following centrifugation at 5000 x g for 15 min then at 
164000 x g for 60 min.  Filtered supernatant was passaged over a 5 mL GSTrap 
FF column (GE Healthcare) and eluted in buffer containing 50 mM Tris and 
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10 mM reduced glutathione, pH 8.0.  SstD-GST was digested with recombinant 
hexahistidine tagged TEV protease (home brewed) overnight at 4 °C.  GST and 
uncleaved SstD-GST were removed with a second passage over the GSTrap FF 
column and TEV protease was removed by passaging over a 1 mL HisTrap 
column (GE Healthcare).  SstD concentration was calculated using a Bio-Rad 
protein assay as instructed (Bio-Rad). 
Polyclonal antibodies against soluble SstD were generated in New Zealand 
white rabbits by ProSci Inc. using custom antibody production protocol 1. 
 
3.2.7   Immunoblot analysis of whole cell lysates 
S. aureus strains precultured as described in Section 3.2.5 were grown in 
HuS-TMS to mid-log phase.  Cells from approximately 1.5 mL of culture were 
pelleted by centrifugation and incubated for 30 min at 37 oC in 100 µL cell wall 
digestion buffer containing 0.3 g/L raffinose, 50 µM Tris-Cl (pH 7.5), 145 mM 
NaCl, 5 mM iodoacetamide, 0.1 mM phenylmethanesulfonylfluoride, and 1 µg 
lysostaphin (Sigma-Aldrich).  Sample total protein concentrations were 
calculated using the Bio-Rad protein assay following the manufacturer’s 
instructions (Bio-Rad).  Samples were boiled for 10 min, and sample volumes 
normalized to contain 10 µg total protein were resolved through 
SDS-polyacrylamide gel electrophoresis (12% acrylamide resolving gel) then 
transferred to 45 µm nitrocellulose membrane, according to standard protocols 
(30).  Detection of SstD on nitrocellulose was performed after the following 
steps: 12 h of blocking at 4 oC in phosphate-buffered saline (PBS) containing 
20% horse serum (Sigma-Aldrich) and 10% w/v skim milk; 2 h exposure to the 
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primary antibody at room temperature in PBS containing 0.05% Tween-20 and 
2% w/v skim milk (1:7500 dilution of rabbit antiserum); 1 h exposure to 
secondary α-rabbit IgG antibody conjugated to IRDye-800 (LI-COR Biosciences) 
at room temperature in PBS/0.05% Tween/2% skim milk (1:10000 dilution of 
antibody).  Immunoblot fluorescence was imaged using a LI-COR Odyssey 
Infrared Imager (LI-COR Biosciences). 
 
3.2.8   SstD ligand binding assays 
SstD was adjusted to 1 µM in 100 mM NaCl, 10 mM Tris pH 8.0.  
Equimolar bovine serum albumin (Sigma Aldrich) was used as a protein 
negative control.  Ligand stocks were added in twofold concentration increments 
ranging between 0 and 40 µM.  Ligands included enterobactin, salmochelin, 
petrobactin, bacillibactin, 2,3-DHBA, norepinephrine, epinephrine, dopamine, 
L-DOPA and DesferalTM.  For ferration, ligands were incubated for 5 min at room 
temperature with FeCl3 at a ratio of 1:3 (Fe:catecholamines) or 1:1 
(Fe:siderophores).  Ligand affinity was measured at room temperature using 
intrinsic tryptophan fluorescence quenching in a Cary Eclipse (Agilent 
Technologies).  Excitation was performed at 280 nm and fluorescence was 
detected at 345 nm using a excitation slit width of 5 nm and emission slit width 
of 5 nm.  For ferrated catechol siderophores, fluorescence data  were corrected 
for nonspecific tryptophan quenching by ligands after analogous titration with 
1 µM N-acetyl-tryptophanamide, as described (37).  The volume of starting 
protein solutions were 500 L and data were corrected for changes in 
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fluorescence due to changes in sample volume due to ligand additions. 
Fluorescence data were fitted to nonlinear regression analysis using a one-site 
binding model and data were analyzed using Microsoft Excel. 
 
3.2.9   Mouse models of S. aureus infection 
Mouse infection experiments were performed using Charles River or 
Jackson Laboratories BALB/c mice as described in Section 2.2.12.  Additionally, 
an infection study was performed on mice carrying surgically implanted 
norepinephrine dispensers to evaluate the contribution that elevated circulatory 
catecholamine levels make on the progression of staphylococcal disease.  48 h 
prior to infection, mice purchased from Charles River were anaesthetized with 
isofluorane gas and administered with 1 mg/kg of the analgesic meloxicam 
(Boehringer Ingelheim) in 400 µL saline solution via intraperitoneal injection.  
The right flank of each mouse was shaved and disinfected with a routine three 
step scrub.  A dorsoventral incision was made near the shoulder and a region of 
skin orienting toward the hips was undermined.  Alzet 2001 osmotic pumps 
(Durect Corp., dispensing rate of 1 µL/h) loaded with 1 mg/mL epinephrine in 
0.8% buffered saline, pH 4 (Bioniche Life Sciences, Inc.), were inserted into the 
fold.  Drug dosage and osmotic pump model were selected based on a previous 
report (36).  pH-adjusted sterile saline-loaded pumps were inserted for mice in a 
drug-free control group.  Incisions were closed with sutures.  24 h prior to 
infection, mice were administered a second dose of meloxicam.  Mice were 
monitored daily for symptoms of adverse reactions to the surgical procedure, 
prior to and during the staphylococcal infection trial; none were noted. 
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3.3   Results 
3.3.1   Catecholamine stress hormones promote the growth of S. aureus in 
serum and on transferrin in the absence of siderophore production 
Catecholamines stimulate the growth of S. epidermidis on transferrin (17, 
22), although a similar effect was not noted for S. aureus (22, 26, 31).  In this 
investigation, four catecholamine hormones, including norepinephrine, 
epinephrine, dopamine, and L-DOPA, did not enhance growth of wild type 
S. aureus on human serum or human holotransferrin when added at a 
concentration of 50 µM.  They did, however, partially restore the growth of the 
siderophore-deficient strain at the same concentration (Figures 3-2A, 3-3).  
Serum growth promotion up to levels conferred by siderophore production could 
be achieved at catecholamine concentrations of 200 µM (Figure 3-2B).  
Catecholamine-stimulated growth promotion in basal culture medium was 
negligible in the absence of holo-transferrin or whole serum, ruling out the 
possibility that the commercially obtained molecules were preloaded with iron 
(data not shown). 
 
3.3.2   Uptake of catecholamine-liberated serum iron occurs through 
transporter SstABCD 
The proposed model for the 3:1 molar complexation of a catecholamine 
hormone with Fe3+ in solution resembles the mechanism by which the three 
coordinating moieties of bacterial catechol siderophores orient around a central 
Fe3+ atom (31).  Following the observation that catecholamine hormones 
stimulate growth in serum in the absence of siderophores, it was of interest to  
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Figure 3-2:  Catecholamine stress hormones enhance the growth of 
siderophore-deficient S. aureus on human serum.  Wild type S. aureus strain 
Newman (WT) and its siderophore nonproducing isogenic mutant (Δsbn Δsfa) 
were grown in HuS-TMS.  Catecholamine stress hormones 
(NE = norepinephrine; E = epinephrine; D = dopamine; LD = L-DOPA) were 
added to concentrations of 50 (A) or 200 µM (B).  FeCl3 (Fe) was added to a 
concentration of 100 µM.  Hormones only marginally improved the growth of the 
wild type strain (NE used as a representative curve).  Error bars represent 
standard deviation from the mean (n = 3). 
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Figure 3-3:  Catecholamine stress hormones enhance the growth of 
siderophore-deficient S. aureus on human transferrin.  Wild type S. aureus 
strain Newman (WT) and its siderophore nonproducing isogenic mutant (Δsbn 
Δsfa) were grown in C-TMS with 10 µM human holo-transferrin (~60% 
iron-saturated).  Catecholamine stress hormones (NE = norepinephrine; 
E = epinephrine; D = dopamine; LD = L-DOPA) were added to concentrations of 
50 µM.  FeCl3 (Fe) was added to a concentration of 100 µM.  Hormones only 
marginally improved the growth of the wild type strain (NE used as a 
representative curve).  Error bars represent standard deviation from the mean 
(n = 3). 
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determine what transport system might be involved in catecholamine iron 
uptake.  Based on the shared sequence identity between the components of 
SstABCD and other bacterial iron transporters, and a report describing its genes 
to be iron regulated (21), the sst operon was chosen for chromosomal deletion 
through allelic replacement.  With production of staphyloferrins, a ΔsstABCD 
mutation did not have adverse effects on growth in human serum compared to 
an isogenic wild type parental strain (Figure 3-4A).  The mutation, however, 
rendered a siderophore deficient mutant insensitive to the growth promoting 
effects of catecholamines, at concentrations as high as 200 µM.  Similar defects 
were observed on human transferrin as a sole iron source (data not shown).  
The mutant phenotype was fully complemented by expression of wild type 
sstABCD in trans (Figure 3-4B). 
 
3.3.3   SstD is expressed by laboratory and clinical strains of S. aureus 
Western blots against whole cell lysates using polyclonal SstD antiserum 
confirmed a lack of detectable SstD expression in the Newman ΔsstABCD 
mutant strain (Figure 3-5A).  Conserved expression of SstD through a range of 
commonly used laboratory and clinical strains, including three community-
acquired strains, was also noted (Figure 3-5C). 
 
3.3.4   SstD binds a range of catechol-coordinating Fe3+ ligands 
Fluorescence quenching assays were used to measure the affinity of 
purified SstD for catecholamines and catechol siderophores.  Titration with 
iron-free hormone or siderophore ligands showed no quenching of the   
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Figure 3-4:  SstABCD is required for catecholamine-mediated growth on 
serum.  (A)  Catecholamine stress hormone-mediated growth promotion of a 
siderophore nonproducing mutant of S. aureus strain Newman (Δsbn Δsfa) was 
negated by concomitant mutagenesis of sstABCD (Δsbn Δsfa Δsst).  Strains 
were grown in HuS-TMS.  Catecholamine stress hormones 
(NE = norepinephrine; E = epinephrine; D = dopamine; LD = L-DOPA) were 
added to concentrations of 200 µM.  FeCl3 (Fe) was added to a concentration of 
100 µM.  (B)  Expression of sstABCD from vector pSB5 restored growth with 
200 µM norepinephrine in HuS-TMS.  Error bars represent standard deviation 
from the mean (n = 3). 
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Figure 3-5:  Detection of SstD in S. aureus whole cell lysates using 
polyclonal antiserum.  (A)  Polyclonal anti-SstD rabbit antibodies were used to 
confirm mutagenesis of the sst operon in S. aureus strain Newman in a Western 
blot.  1 = 1 µg purified SstD (soluble portion); 2 = wild type Newman; 
3 = Newman Δsst mutant; 4 = SDS-PAGE low molecular weight ladder.  (B), 
(C)  A selection of S. aureus strains’ whole cell lysates normalized to total 
protein content, confirmed with a Coommassie stain of a SDS-PAGE gel (B), 
were probed with anti-SstD serum in a Western blot (C).  1, 9 = SDS-PAGE low 
molecular weight ladder; 2 = RN6390; 3 = Newman; 4 = USA300 LAC; 
5 = MW2; 6 = MSSA476; 7 = UAMS-1; 8 = AD25.  The yellow arrows denote 
which band corresponds to SstD. 
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tryptophan/tyrosine fluorescence of SstD (data not shown).  The fluorescence of 
bovine serum albumin, a protein negative control, was not quenched with any of 
the ligands tested (data not shown).  SstD fluorescence was quenched by all 
four ferrated catecholamines tested ferrated catechol siderophores.  
Dissociation constants are reported in Table 3-2. 
 
3.3.5   SstABCD contributes to virulence 
A mouse systemic model of infection was used to evaluate the relative and 
combined contributions of siderophore biosynthesis, siderophore transport, and 
catecholamine iron acquisition genes in vivo.  Mice were infected intravenously 
with approximately 5 to 10 x 106 bacteria and bacterial loads in target organs 
were enumerated 96 h postinjection.  Trials were performed using both Charles 
River and Jackson Laboratories mice.  Bacterial processes disrupted via 
mutation included catecholamine iron uptake (sst), siderophore biosynthesis 
(sbn sfa), and siderophore uptake (sirA hts).  Furthermore, the effect of 
combined mutations for catechol iron uptake with staphyloferrin biosynthesis 
(sbn sfa sst) or staphyloferrin uptake (sirA hts sst) were tested.  Disruption of 
any single process resulted in a mild but significant reduction in heart 
colonization in Charles River mice, and combined inactivation of all three 
transport systems resulted in attenuation phenotypes in kidneys, livers, and 
hearts for both Charles River and Jackson Laboratories mice (Figure 3-6, 
Appendix Figure A2). 
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Table 3-2:  Dissociation constants (Kd) for SstD-ferric-catecholamine and 
SstD-ferric-catechol complexes 
 
Ligand Kd (µM) Standard 
deviation 
Norepinephrine 1.07 0.54 
Epinephrine 1.65 0.08 
Dopamine 0.49 0.22 
L-DOPA 1.44 0.27 
Bacillibactin 1.21 0.14 
2,3-DHBA 1.62 0.27 
Enterobactin 0.29 0.06 
Petrobactin 1.62 0.25 
Salmochelin S-4 0.35 0.20 
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Figure 3-6:  Inactivation of siderophore and catecholamine transport 
attenuates S. aureus Newman in a mouse systemic model of infection.  
Approximately 5 to 10 x 106 CFU S. aureus Newman and isogenic iron transport 
mutant derivatives were injected intravenously to Charles River BALB/c 
immunocompetent mice.  Percentage of mouse body mass lost over four days 
and CFU recovered from target organs are plotted.  Statistical analysis was 
performed using the Student’s unpaired t-test.  P values denote significant 
differences from wild type (WT) (*) or from an isogenic siderophore 
biosynthesis/transport mutant parent (**).  Infective doses were as follows (in 
millions of CFU/dose):  7.00 (WT), 5.50 (Δsbn Δsfa), 5.75 (sirA::Km Δhts), 5.00 
(Δsst), 6.00 (Δsbn Δsfa Δsst), 6.50 (sirA::Km Δhts Δsst).   
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3.3.6   Augmentation of circulating epinephrine levels does not render 
mice more susceptible to S. aureus infection 
Mice implanted with steady dose epinephrine dispensers were evaluated 
for enhanced susceptibility to S. aureus infection.  In a pilot trial, it was observed 
that mice receiving surgical implants exhibited reduced external symptoms of 
infection compared to a surgery-free control group (less pronounced weight loss, 
fewer signs of septic arthritis, and generally healthy grooming and activity 
patterns), despite mice having been administered a typically infective dose of 
bacteria (~5.0 x 106 CFU).  Post mortem analysis described atypically low 
bacterial colonization in target organs for implant-carrying mice (data not 
shown).  It was thus hypothesized that the surgical procedure elicited an 
immunostimulatory change in mice prior to infection, so subsequent experiments 
were performed using a higher infective dose (~1.0 x 107 CFU). 
In the first experiment, mice carrying epinephrine-dispensing pumps proved no 
more susceptible to infection with wild type S. aureus strain Newman than mice 
implanted with saline pumps (Figure 3-7).  Both surgical groups exhibited 
decreased amounts of organ colonization than surgery-free control mice, 
although data did not achieve statistical significance; surgery-free mice, 
however, did experience significantly more weight loss, in agreement with the 
pilot study. 
In the second experiment, mice carrying epinephrine-dispensing pumps 
proved no more susceptible to infection with wild type S. aureus Newman than 
its isogenic Δsst mutant derivative (Figure 3-8).  In agreement with data 
presented in Chapter 2, mice experienced reduced rates of colonization in the  
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Figure 3-7:  Subcutaneous epinephrine pumps alter mouse immunity but 
epinephrine does not enhance virulence of S. aureus.  Charles River BALB/c 
immunocompetent mice were fitted with subcutaneously implanted osmotic 
pumps dispensing 1 µL/h 1 mg/mL epinephrine (epi) or buffered saline (saline), 
or were not surgically treated (none).  Weight loss and organ bacterial loads 
were calculated four days postinfection with S. aureus Newman (intravenous 
infective dose of 4 x 106 CFU).  Statistical analysis was performed using the 
Student’s unpaired t-test.  P values denote significant differences from 
epinephrine (*) or from saline treatment (**). 
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Figure 3-8:  Subcutaneous epinephrine pumps do not enhance virulence of 
S. aureus expressing SstABCD.  Mice were fitted with subcutaneously 
implanted osmotic pumps dispensing 1 µL/h 1 mg/mL epinephrine (epi).  Weight 
loss and organ bacterial loads were calculated four days postinfection with 
S. aureus Newman.  Intravenous infective doses were as follows (in millions of 
CFU/dose):  8.00 (WT), 8.50 (sirA::Km Δhts), 9.00 (Δsst), 9.75 (sirA::Km Δhts 
Δsst).  Statistical analysis was performed using the Student’s unpaired t-test.  
P values denote significant differences from wild type. 
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heart with S. aureus sir/hts mutants; this was not, however, enhanced by 
simultaneous inactivation of sst. 
 
3.3.7   SstABCD contributes to growth on catecholate siderophores 
It was previously reported that S. aureus strain RN6390 is capable of 
growing on ferric enterobactin, a tris-catecholate enteric siderophore, in a plate 
bioassay (32).  Having established that SstABCD plays a role in uptake of 
catecholamine-liberated serum iron, it was of interest to investigate a possible 
role for the transporter in uptake of exogenous catechol siderophores.  
Curiously, when strain Newman and its isogenic Δsst mutant derivative were 
examined for growth promotion on enterobactin, other catechol-coordinating 
siderophores, and catecholamines, following prescribed protocols (32), no 
enterobactin growth promotion was observed even for the wild type parent.  The 
study was expanded to include RN6390, its Δsst mutant, and the host of clinical 
isolates first mentioned in Chapter 2 (Tables 2-1, 3-1).  Data are presented in 
Figure 3-9.  Strains AD25 and UAMS-1 were discounted from the study as no 
amount of EDDHA chelation tested (up to 30 µM) was sufficient to eliminate 
substrate-independent background growth, making growth promotion around a 
disc unquantifiable; the mechanism for this phenomenon is unclear.  Unlike for 
strain Newman, all isolates tested formed growth halos around three of the four 
catecholamines (L-DOPA excluded), and catecholate siderophores enterobactin, 
salmochelin S-4, bacillibactin, and petrobactin; Newman was responsive only to 
petrobactin, and as evidenced by the RN6390 Δsst mutant, this siderophore is 
not exclusively reliant on SstABCD for transport.  Strain Newman was 
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Figure 3-9:  Plate bioassay growth promotion using ferrated 
catecholamines and catechol siderophores.  A host of S. aureus strains 
seeded in TMS agar chelated with 10 µM EDDHA were evaluated for growth 
halo formation around a paper disc spotted with 20 µL ferrated catecholamine 
hormones (750 µM), 2,3-dihydroxybenzoic acid (750 µM), catechol siderophores 
(250 µM), or FeCl3 (50 µM).  Growth was measured after incubation at 37 
oC for 
36 h.  Growth is represented as the diameter of the halo (in mm).  The dashed 
line represents the diameter of the paper disc.  Error bars represent standard 
deviation from the mean (n = 3). 
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subsequently demonstrated to be weakly responsive to enterobactin at 
millimolar concentrations (data not shown).  FeCl3 added at equimolar 
concentration was only weakly growth promoting, at best, for any strain 
examined. 
 
3.4   Discussion 
A key theme of the S. aureus iron uptake strategy is the blending of 
redundancy and complexity in targeting specific iron reservoirs.  In the preceding 
chapter, the ability of S. aureus to capture iron from transferrin and bulk serum 
through two redundant siderophores, was demonstrated.  Here, the molecular 
basis of an alternate mechanism for holotransferrin iron extraction has been 
elucidated.  This second mechanism capitalizes on the liberation of 
holotransferrin iron following complexation with mammalian catecholamine 
stress hormones (31).  Catecholamine iron was shown to promote the growth of 
Bacillus and E. coli on holotransferrin at concentrations comparable to those 
tested in this study (2, 20).  Similar to this study, the role was characterized in 
strains mutated to inactivate production of the catecholate siderophores 
bacillibactin (Bacillus) and enterobactin (E. coli).  Uptake was dependent on 
either organism’s catechol siderophore ABC transporter. Due to the 
overshadowing contribution of staphyloferrins, characterizing the contribution of 
catecholamines toward iron uptake from human serum or transferrin was made 
possible only after constructing and characterizing two whole-locus siderophore 
biosynthesis knockout strains (Figures 3-1, 3-3).  Catecholamine iron uptake 
was subsequently shown to be mediated by a distinct transporter, SstABCD 
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(Figures 3-2, 3-4), previously implicated in the S. aureus adaptive response to 
low iron environments (21).   
A large reservoir of plasma catecholamines is found in the venous and 
arterial circuitry between mesenteric organs, kidneys, and the liver (8).  While 
hormone concentrations tested in this study (50 to 200 µM) have been alluded 
to as physiologically or therapeutically relevant (10, 20), typical serum reference 
ranges are in the nanomolar range (28), and it is unlikely they approach 
micromolar concentrations in bulk plasma even after gastric surgery.  In fact, a 
catecholamine concentration of 100 µM has been reported as neurotoxic in vitro 
(25).  Nevertheless, in concert with siderophore activity, low concentrations of 
stress hormones may subvert the bacteriostatic effects of transferrin to promote 
sufficient proliferation in the bloodstream for evasion of phagocytic immune cells 
prior to colonization of organs.  This highlights the necessity for precaution prior 
to therapeutic administration of catecholamines.  Catecholamines might also be 
found in elevated levels in microenvironments surrounding wounds where 
nervous damage has occurred.  Other research has noted increases in 
indigenous bacterial gut flora following localized destruction of noradrenergic 
neurons (16).  In addition to providing a source of iron, these wounds provide an 
epithelial breach through which opportunistic bacteria may enter the 
bloodstream.  
Previously, SstABCD was shown to make no significant contribution to 
bacterial survival in a rat intraperitoneal cage model of infection (21).  In this 
study, sst inactivation significantly decreased colonization of the mouse heart or 
liver in two separate trials (Figure 3-6 A and B, respectively).  This finding is 
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significant as S. aureus is a leading cause of infective endocarditis.  Additionally, 
a mutant lacking both siderophore transport systems was consistently further 
attenuated in mouse kidneys, livers, and hearts by inactivation of sst 
(Figures 3-6A and B), demonstrating that highly coordinated extraction of iron 
from host sources other than hemoproteins contributes to the pathogenesis of 
S. aureus. 
Elevation of a circulating catecholamine stress hormone, specifically 
epinephrine, did not render mice more susceptible to S. aureus infection 
(Figure 3-7), nor did it result in a difference in bacterial loads in mouse organs 
between wild type Newman and its isogenic sst mutant (Figure 3-8).  These 
experiments proved to be extremely technically challenging and negative results 
could reflect inadequate protocol rather than a genuine lack of 
catecholamine-enhanced virulence.  Owing to the extremely short half life of 
stress hormones in circulation (minutes) (34, 38), the only way to ensure steady 
dispensing of epinephrine within a mouse for the duration of the experiment (two 
days pre- and four days post-infection) was to use an implanted pump roughly 
equal in weight to 10% of the mouse’s body mass.  This invasive and intensive 
surgical procedure clearly affected the innate immunity of the mouse toward 
S. aureus by mechanisms unknown.  While such a stress would intuitively 
render mice more susceptible to further medical insult, i.e. infection, the opposite 
was in fact observed; surgery enhanced the innate resistance of mice to 
S. aureus challenge, reflected in improved symptoms assessed externally and 
internally (Figures 3-6, 3-7).  Future experiments to correlate increased levels of 
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circulating catecholamines to enhanced infectivity of S. aureus should involve 
larger animals with a more manageable body to implant mass ratio. 
The opportunistic coopting of other organisms’ siderophores may provide 
S. aureus with a competitive advantage in heterogeneously colonized host 
niches such as on skin or in the nares.  Little is known about the dissemination 
of enteric catechol siderophores from the gut flora and it is possible that these 
may be found in sufficient quantities to contribute to growth of invasive 
S. aureus, confirmed here to be capable of growth on exogenous 
catecholate-type siderophores (Figure 3-9).  Strangely, in bioassay conditions, 
there appear to be strain-specific differences in the ability to grow on these 
siderophores which did not correlate to strain-to-strain expression of SstD on the 
surface of iron-starved S. aureus cells (Figure 3-5 C).  This may reflect inherent 
differences in cellular metabolic requirements between strains rather than an 
inability to transport iron ligands.  Strain Newman was not responsive to ferrated 
catecholamines or catecholate siderophores, while the other strains tested in the 
plate bioassay exhibited varying degrees of growth around the supplied iron 
ligands.  (It was subsequently determined that Newman would begin to grow on 
enterobactin spotted from a stock solution of 500 µM, while the data presented 
in Figure 3-9 represent growth on 250 µM.)  Another interesting finding was that 
in the absence of SstABCD, siderophores salmochelin S-4 (glucosylated 
tris-catecholate) and petrobactin (bis-catecholate + carboxylate) promoted the 
growth of strain RN6390, albeit to a lesser degree than for the wild type parent.    
This could explain why strain Newman did form a growth halo around 
petrobactin; uptake efficiency was enhanced by redundancy in transport 
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systems.  Salmochelin S-4 clearly enters S. aureus RN6390 through an 
alternate transporter to SstABCD as well. 
SstD demonstrated affinity for ferrated catecholamines and catecholate 
siderophores; for all ligands, Kd values were in the M range (Table 3-2).  The 
Kd values resemble those determined for the B. subtilis FeuA protein and 
ferric-norepinephrine complex (1.6 M) (20).  Interestingly, of all ligands 
examined, SstD had the highest affinity for the enteric siderophores enterobactin 
and salmochelin S-4, suggesting that under certain favourable conditions, these 
ligands might be viable iron sources for S. aureus in vivo, in spite of the 
inconsistent ability of these siderophores to stimulate growth of S. aureus strains 
in vitro.  The Kd values of SstD for its ligands, in the M range, contrasts with the 
Kd values in the nM range that were determined for HtsA and SirA for their 
cognate ligands, staphyloferrin A and staphyloferrin B (12, 13).  In line with the 
M range of affinities of E. coli FhuD for several hydroxamate ligands (29), this 
might reflect a sacrifice in ligand affinity in lieu of greater ligand diversity. 
Findings presented here demonstrate that inactivation of three 
transporters, namely Sir, Hts, and Sst, inhibits utilization of transferrin-iron.  
Combined with the lack of inhibitory feedback on siderophore production, this 
strain may enhance the bacteriostatic potential of its milieu through the secretion 
of nonviable iron chelators.  This phenomenon may underlie the reduced fitness 
of the Δsst Δhts sir- transporter mutant relative to the Δsst Δsfa Δsbn mutant in 
the murine infection model used in this study.  In combination, these lipoproteins 
may be worthy candidates for inclusion in a multivalent antistaphylococcal 
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vaccine, wherein the effectiveness of antibodies would rely upon inhibiting 
transporter function. 
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Chapter 4 
General Discussion 
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4.1   General overview 
In this report, we have described two mechanisms through which S. aureus 
extracts iron from serum using endogenously derived molecules.  These 
comprise the essentially redundant strategies of secreting a high affinity Fe3+ 
chelator, i.e. siderophore, produced by enzymes encoded from the sfa or sbn 
loci.  Using mutants inactivated at those loci, the siderophores were shown to be 
staphyloferrins A and B (SA and SB), in agreement with previous studies that 
interrogated staphylococcal culture collections for siderophore production (20, 
28, 32), and with concomitant biochemical studies characterizing the functions of 
S. aureus synthetases (9, 11).  Furthermore, it was shown that SB is the same 
metabolite as the previously reported staphylobactin molecule (12).  The 
staphyloferrins extract ferric iron from transferrin and facilitate its active uptake 
by the S. aureus cell through ABC transporters HtsABC and SirABC.  Production 
of either of these siderophores was sufficient for maximal growth in human and 
animal sera, demonstrating that S. aureus overcomes the bacteriostatic nature 
of serum through secretion of SA and SB; thus, hts/sfa and sir/sbn could 
reasonably be described as virulence loci.  In agreement with this statement, 
mutations impacting siderophore transport rendered S. aureus attenuated in a 
mouse sepsis model of infection. 
We have further identified another mechanism by which S. aureus subverts 
host molecules for extraction of iron from serum.  This mechanism exploits the 
propensity of catecholamine neurendocrine stress hormones to interfere with the 
iron scavenging capacity of transferrin.  In addition to reductively liberating 
transferrin iron, these molecules possess 3,4-dihydroxylphenyl groups with 
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proposed Fe3+-coordination capacities resembling that of the catecholate family 
of bacterial siderophores (15, 35, 45).  S. aureus was shown to acquire 
transferrin iron via these ligands through the SstABCD transporter, which was 
also required for transport of catecholate xenosiderophores.  Mutation of sst 
enhanced the attenuation phenotype of a staphyloferrin transport mutant. 
 
4.2   Significance of this study 
It has long been known that S. aureus is capable of growth in serum and 
on transferrin (29, 36, 41), and that catecholamine hormones may enhance this 
growth (39).  This study is the first to employ a molecular genetics approach 
toward describing the genes associated with these processes, and to 
comprehensively assess their impact on virulence.  Furthermore, this study 
complements biochemical characterization of the assembly of staphyloferrin 
siderophores using sfa and sbn-encoded NIS synthetases (9, 11), by 
establishing these genes encode proteins producing these metabolites in 
S. aureus itself. 
In combination with the discoveries of other members of our research 
group (5, 9, 12, 13, 17, 18, 51), the findings of this study enable the drafting of a 
model describing a multifaceted, heme-independent serum iron acquisition 
strategy executed by S. aureus, presented in Fig. 4-1.  This comprehensiveness 
suggests the lowly abundant but highly labile transferrin iron pool to be a vital 
reservoir supporting growth of invasive S. aureus.  In comparison, published 
scientific reports describe only two transport systems involved in acquisition of 
heme iron by S. aureus.  Furthermore, we have shown that one of these 
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transporters, HtsABC, is involved in the transferrin iron strategy, despite its 
earlier description as a heme transporter (48).  The controversy over its true role 
will be addressed in greater detail shortly.  The Hts debate notwithstanding, 
much has been said about the heme iron preference of S. aureus and its 
significance in virulence (30, 42, 48, 55), largely overshadowing contributions 
from other potentially significant iron reservoirs. 
Despite involving less mechanistic redundancy (based on what is 
published to date), heme iron acquisition is certainly crucial for S. aureus 
infection.  In murine sepsis models of infection, mutants deficient for production 
of either staphyloferrin and for acquisition of catecholamine-liberated transferrin 
iron were mildly attenuated relative to the wild type, but nevertheless quite 
capable of causing severe illness.  Conversely, similar observations have been 
made for mutants of heme uptake system Isd (31, 55).  There is a strong 
likelihood that alternate heme transporters are used by S. aureus; beyond 
characterizing these, it remains to be seen if combined inactivation of transferrin 
and heme iron acquisition mechanisms results in a severely attenuated mutant, 
or if alternate mechanisms permit S. aureus to continue to target these host iron 
reservoirs and to exploit alternate reservoirs. 
 
4.3   Future investigative foci 
4.3.1   What is the intracellular mechanism of Fe3+ liberation from 
siderophores? 
As implied by the black boxes present in Fig. 4-1, the intracellular fate of 
Fe-siderophores in S. aureus is unknown.  This information gap is remarkably  
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Figure 4-1:  Model of transferrin iron acquisition by S. aureus.  Secreted 
staphyloferrins (SA, left; SB, right) and host-derived catecholamine hormones 
(clockwise from top left:  norepinephrine, dopamine, L-DOPA, epinephrine) 
extract iron from transferrin and are transported through the cell membrane 
through transporters HtsABCFhuC (right), SstABCD (centre, shown transporting 
Fe-tris-norepinephrine), and SirABCFhuC (left).  The intracellular fate of ferrated 
ligands is still unknown. 
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frequent in the body of literature on microbial siderophores—much is known 
about their biosynthesis, target iron reservoirs, and transport, but very few 
studies describe their fate once returned, ferrated, to the bacterial cytosol.  Is the 
mechanism for iron liberation reductive, permitting recycling of the deferrated 
siderophore, or destructive, requiring the enzymatic degradation of the molecule 
to a catabolite without iron coordination capacity? 
It has been suggested that reductive mechanisms likely extract iron from 
SA and SB, given that both molecules incorporate amide bonds which are very 
resistant to hydrolysis (34).  From the limited body of scientific reports, reduction 
appears to be the exclusive mechanism for cytosolic extraction of iron from 
hydroxamate and α-hydroxycarboxylate siderophores (34).  Considering the 
range of hydroxamate and α-hydroxycarboxylate siderophores used by 
S. aureus, it is likely that multisubstrate reductases are responsible for 
siderophore iron extraction.  No candidate reductase genes appear to be 
encoded on the S. aureus chromosome in the vicinity of any of the siderophore 
transport operons (sir, hts, sst, fhu).  These might be identified by creating a 
transposon mutant library in a Δsfa Δsbn mutant strain and screening for 
impaired growth in low iron media supplanted with exogenously derived 
staphyloferrins.  Impaired siderophore iron extraction might have similar effects 
to impaired siderophore transport, i.e. exacerbation of the iron deprivation 
response leading to enhanced secretion of unusable siderophore; thus, a 
siderophore reductase might make an attractive therapeutic target for small 
molecule drugs. 
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Destructive mechanisms of iron liberation are typically applied to high 
affinity siderophores assembled around bonds that can be efficiently attacked by 
water.  The catecholate siderophores enterobactin and bacillibactin are 
consumed thusly, by iron-regulated esterases that partially or completely 
hydrolyze the ester bridges of the trilactone structure scaffolding the catecholate 
iron-coordinating groups (27, 33).  Destructive liberation also circumvents the 
challenge posed to a reductase by the exquisitely high affinity for Fe3+ 
demonstrated by these siderophores.  In this study, clinically relevant S. aureus 
strains were characterized growing on ferric bacillibactin and ferric enterobactin 
(Fig. 3-9), suggesting they produce the requisite esterase(s) required for 
destructive liberation of iron from these siderophores.  Bacillus BesA is a broad 
specificity esterase capable of cleaving the tri-L-serine trilactone of enterobactin 
and the tri-threonine trilactone of bacillibactin; E. coli Fes is a more specific 
esterase mediating cleavage of only enterobactin (2).  BLAST searches using 
these protein sequences failed to uncover any candidate homologues in 
S. aureus genomes.  Identifying this esterase may provide insight into factors 
contributing to intestinal carriage of S. aureus, where iron uptake using coopted 
enteric siderophores could contribute to survival.  Human intestinal carriage 
rates of may be as high as 20% (3), with obvious clinical implications; 
surprisingly, this reservoir of S. aureus has received very little scrutiny.  
Furthermore, there appeared to be great interstrain variability in responsiveness 
to application of these xenosiderophores (Fig. 3-9), which did not correlate to the 
amount of SstD expressed by these strains (Fig. 3-5); describing what 
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mechanisms dictate activity of this esterase could contribute to our 
understanding of niche adaptation by S. aureus strains.   
 
4.3.2   Resolving the hts debate 
There is currently an abundance of published evidence unambiguously 
describing a role for HtsABC in SA binding and uptake, crowned by the recently 
published crystal structure of HtsA liganded to SA (18).  Nevertheless, this 
transporter is invariably cited as a heme uptake system (16, 30, 49, 50, 54) 
based on the findings of Skaar et al. (48), who characterized alterations to the 
acquisition profiles of isotopically labelled transferrin and hemin iron resulting 
from mutagenesis of putative iron transport systems.  Mutating htsB and htsC 
biased the iron source preference of S. aureus toward transferrin.  Strangely, 
this shift was not observed for an isdDEF mutant, despite the characterized 
function of IsdE as a heme-binding lipoprotein (37, 43); furthermore, no shifts 
toward a heme preference were associated with mutation of sirABC or sstABCD.  
Skaar et al. interpreted their findings to signify HtsABC is the primary ABC 
transporter of heme in S. aureus, and must work in conjunction with 
wall-anchored IsdABC for extraction of heme from host carrier proteins.   
While we cannot empirically exclude a role for any Hts protein in heme 
transport, we feel it is extremely unlikely to contribute to this process, especially 
with regards to HtsA.  The three dimensional folding of HtsA places it among the 
periplasmic binding protein family alternately referred to as class III (5) or 
cluster 8 (24).  This family includes siderophore receptors FhuD (10) and SirA 
(17), but also heme receptor isdE (19).  These demonstrate a conserved 
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bi-lobed architecture, the lobes of which are made up of central β-strands 
surrounded by several α-helices.  The two lobes are bridged by a single long 
α-helix, which imparts relative inflexibility ensuring the protein undergoes 
minimal conformational change upon ligand binding and release (7, 26, 47).  
Beyond an overarching architectural relatedness to IsdE, the HtsA binding 
pocket is markedly different from that of its heme-binding counterpart.  The 
binding groove is shallow and dominated by a large basic patch whose overall 
positive charge is the contribution of six arginine residues, conducive to the 
binding of an anionic compound such as a staphyloferrin but unlikely to 
coordinate a planar, hydrophobic heme molecule (5).  The IsdE binding pocket 
is hydrophobic, deeper, nearly completely occludes the heme molecule, and is 
reliant on heme-iron-coordinating histidine and methionine residues (19).  
Importantly, the HtsA protein demonstrates a high affinity for Fe-SA (Kd < 15 nM) 
(18); in contrast, multisubstrate binding proteins (e.g. SstD) typically sacrifice 
affinity for variety. 
With respect to HtsABC, we are at a loss to explain the findings of Skaar 
et al. (48).  There remains the possibility that HtsBC forms a permease capable 
of interacting with multiple receptors, including HtsA for SA and an alternate 
lipoprotein.  This phenomenon has been characterized in Sinorhizobium meliloti, 
whereby operon hmuTUV encodes an ABC transporter comprised of permease 
HmuUV which works in conjunction with heme receptor HmuT as well as a 
separately transcribed hydroxamate siderophore receptor, FhuP (38).  A single 
gene ORF encoding a putative class III lipoprotein has been identified as 
iron-regulated in vitro (locus tag NWMN_0908) (4), and could be a candidate 
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heme receptor.  In this case, however, it is unlikely HtsBC is the dominant heme 
permease in S. aureus, as we have repeatedly failed to demonstrate a heme 
uptake defect associated with the ΔhtsABC mutation in wild type and isdE- 
strains.  The heme transport function of HtsABC is an established paradigm that 
merits a courteous but assertive challenge and a more thorough investigation. 
 
4.3.3   Therapeutic strategies targeting siderophore transport 
In this study, it was shown that mutagenic inactivation of staphyloferrin 
transport did not abrogate staphyloferrin production; on the contrary, SA and SB 
secretion was enhanced, and transporter mutants accentuated the iron 
withholding capacity of their milieu (Fig. 2-17), presumably further exacerbating 
derepression of sfa/sbn and the remainder of the iron starvation regulon from 
Fur.  In a collaborative study, it was shown that a S. aureus Δfur mutant 
constitutively mounts an iron deprivation response regardless of iron availability, 
and furthermore demonstrates atypically coordinated expression of virulence 
factors despite a lack of direct influence of Fur on the genes involved (54).  This 
response includes enhanced secretion of leukotoxins and hemolysins, with 
decreased expression of surface-associated immunomodulatory proteins.  This 
disregulated mutant was severely attenuated in a mouse infection model.  This 
suggests that therapeutics inhibitory to SirA and HtsA functioning might be 
especially efficacious in combating S. aureus by essentially coopting bacterial 
cells into administering chelation therapy within the infected host, enhancing an 
iron starvation response that ultimately compromises virulence.   
216 
 
In considering exploiting Sir and Hts to combat S. aureus infection, 
different strategic approaches can be considered.  These include targeting 
receptor proteins SirA and HtsA with antibodies to promote bacterial clearance 
through opsonization; using said antibodies to block receptor/siderophore 
binding; blocking transport using competitive siderophore structural analogs; and 
exploiting transporters to deliver toxic siderophore structural analogs into the 
cell. 
A vaccine-based approach to targeting staphyloferrin receptors intuitively 
seems unproductive.  Gram-positive lipoproteins are membrane-tethered and 
seemingly under the protective canopy of a robust cell wall, which would shield 
them from anti-SirA and -HtsA antibodies.  Surprisingly, lipoproteins have been 
shown to significantly enhance the antigenicity of S. aureus (8).  Recently, a 
multivalent vaccine against a host of iron-regulated staphylococcal lipoproteins, 
including SirA, HtsA, and SstD, has been licensed by pharmaceutical 
conglomerate sanofi-aventis Group (1); reports on the vaccine’s efficacy do not 
yet exist within the public domain.  An independent study has corroborated that 
SirA, SstD, and FhuD2 are immunogenic in mammals, and that SstD can be 
detected on the surface of S. aureus (52); the protective value of vaccination 
with any combination of these components has not been described and merits 
further investigation.  
With our recently improved understanding of the molecular interactions 
between HtsA/SirA and their staphyloferrin ligands (17, 18), and the 
biochemistry of staphyloferrin synthesis (9, 11), developing a drug-based 
strategy targeting siderophore uptake is also feasible.  Siderophore transporters 
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could serve as conduits for the delivery of “Trojan horse” molecules to 
S. aureus.  This principle is at play in the mechanism of albomycin killing of 
E. coli.  Albomycin is a ferrichrome structural analog with a bound thioribosyl 
pyrimidine antibiotic (56).  It is recognized by and transported through the E. coli 
Fhu transport pathway; in the cytosol, the antibiotic is cleaved off the Fe3+ carrier 
by a peptidase and exerts its killing effect (21).  Few naturally-occurring 
“sideromycins” are known, but our understanding of the structural parameters 
defining receptor/staphyloferrin interaction, and our ability to synthesize 
staphyloferrins in vitro, could facilitate the design of antibacterial staphyloferrin 
analogs permissive to high affinity transport, or alternately, capable of 
irreversibly binding to SirA and HtsA. 
 
4.3.4   Characterizing the contributions of staphyloferrins in other host 
niches 
In this study, two different mouse models were used to characterize the 
contributions of siderophore biosynthesis and transport genes toward the ability 
of S. aureus to cause acute infection:  i) the skin abscess model, and ii) the 
sepsis model, which essentially characterizes abscession or colonization of a 
limited organ set following bacteremia.  Virulence was not detectably influenced 
by these genes in the first model, and significantly but modestly influenced in the 
second.  The ecology and pathology of S. aureus, however, is more expansive 
than could be described by these two models, and siderophores may play a 
more prominent role in survival in other niches.  Beyond colonization of nares, 
the rectum, and various regions of the skin, invasive S. aureus can target 
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virtually every organ of the body.  Siderophores have been shown to contribute 
to virulence in other types of infections mediated by other pathogenic organisms, 
including pneumonia caused by Klebsiella pneumonia (25), Burkholderia 
cenocepacia (57), and Pseudomonas aeruginosa (53), and urinary tract infection 
caused by Proteus mirabilis (22).  An acute pneumonia model might be 
especially pertinent in light of a recent report concluding heme uptake 
mechanisms are dispensible to S. aureus in this type of infection (31). 
Staphylococcal species, chiefly S. saprophyticus and secondarily 
S. aureus, are leading causes of non-E. coli catheter-independent urinary tract 
infections (14, 23, 44, 58).   Production of multiple siderophores in addition to 
enterobactin (notably salmochelin and aerobactin) is an epidemiological marker 
strongly associated with uropathogenic strains of E. coli (UPEC) (59).  
Additionally, urine is the primary means of catecholamine excretion from the 
body, and may contain micromolar concentrations of these molecules.  
Siderophore iron uptake thus might play a noteworthy role in staphylococcal 
urinary tract infections, yet nothing is currently known about the contributions of 
staphyloferrins, UPEC siderophores, and catecholamines.   
Siderophores may also be important for asymptomatic colonization of the 
host.  Siderophores are invariably overlooked in reviews on S. aureus factors 
enabling carriage among humans.  Iron availability at colonized sites is low, 
however, in part due to lactoferrin, a normal component of mucous.  
Furthermore, S. aureus may have to compete for iron with other commensalist 
bacteria producing their own siderophores.  In addition to expressing 
transporters for coopting siderophores produced by other species (Fhu and Sst), 
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it is tempting to speculate that production of a second staphyloferrin, SB, may 
offer a selective advantage to S. aureus over CNS species that are otherwise 
genetically homologous in terms of siderophore transport (Fhu, Sst, Hts) and 
biosynthesis (SA).  It would be interesting to evaluate the fitness of S. aureus 
siderophore mutants in murine models for colonization (46), 
colonization/transmission (6), and colonization/competition (40). 
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Appendix 1 
Systemic infection trials with Jackson Laboratories mice 
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Figure A1.   S. aureus Newman strains mutated in sfa and sbn loci are not 
attenuated in a mouse sepsis model of infection.  Approximately 8 x 106 
CFU (A) or 2 x 106 CFU (B) S. aureus Newman and an isogenic staphyloferrin 
biosynthetic mutant derivative were injected intravenously to Jackson 
Laboratories BALB/c immunocompetent mice.  Percentage of mouse body mass 
lost over four days and CFU recovered from target organs are plotted.  
Statistical analysis was performed using the Student’s unpaired t-test.  No 
signficant treatment differences were noted.  Calculated infective doses, in 
millions of CFU injected, were as follows:  wild type (WT), 7.775 (A) and 2.100 
(B); Δsfa Δsbn, 10.050 (A) and 2.300 (B). 
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Figure A2.   Mutation of S. aureus Newman at sst enhances attenuation in 
a mouse sepsis model of infection.  Approximately 1 x 107 CFU S. aureus 
Newman and isogenic iron transport mutant derivatives were injected 
intravenously to Jackson Laboratories BALB/c immunocompetent mice.  
Percentage of mouse body mass lost over four days and CFU recovered from 
target organs are plotted.  Statistical analysis was performed using the Student’s 
unpaired t-test.  Asterisks denote significant differences (P < 0.05) from wild 
type (WT) (*) or from an isogenic sst+ parent (**).  Infective doses were as 
follows (in millions of CFU/dose):  7.75 (WT), 10.50 (Δsbn Δsfa), 8.50 (sirA::Km 
Δhts), 13.25 (Δsst), 11.00 (Δsbn Δsfa Δsst), 9.25 (sirA::Km Δhts Δsst).  
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Summary of this work: 
Infection trials were performed as described in Chapters 2 and 3.  
Virulence data presented in those chapters were generated using mice 
purchased from Charles River.  In those trials, siderophore biosynthesis mutants 
of S. aureus did not demonstrate robust attenuation phenotypes, conflicting with 
an earlier report describing a strong attenuation phenotype resulting from 
insertional inactivation of sbnF (1).   
Animal vendors post online reports of infectious agent outbreaks in their 
breeding colonies.  Upon examination of the Charles River reports, it was 
determined that the mice used for the experiments described in Chapters 2 
and 3 may have had prior exposure to S. aureus, which could have altered their 
immunity to the pathogen for subsequent infection studies.  It was therefore of 
interest to repeat the experiments using mice from breeding colonies with 
immaculate surveillance histories, as were available for purchase from Jackson 
Laboratories.   
Data generated using Jackson Laboratories mice were in good agreement 
with those generated using Charles River mice.  In summary, inactivation of 
siderophore biosynthesis (Δsfa Δsbn) did not reduce the virulence of S. aureus; 
inactivation of siderophore transport (Δhts sirA::Km) reduced virulence in livers 
and hearts; and inactivation of catechol transport (Δsst) in combination with 
inactivated siderophore transport or biosynthesis reduced virulence in kidneys, 
livers, and hearts. 
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Appendix 2 
sbnA and sbnB are required in generating L-2,3-diaminopropionic acid for 
staphyloferrin B biosynthesis 
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Summary of this work: 
In addition to encoding synthetases SbnC, SbnE, and SbnF (1), the sbn 
operon includes genes for putative accessory enzymes that might play a role in 
substrate generation.  The assembly of SB requires the input of two molecules 
of the rare, nonproteinogenic amino acid L-2,3-diaminopropionic acid (L-DAPA) 
(Figure 1-5B).   
BLAST analyses revealed SbnA shares identity with an amidotransferase 
(VioB) and SbnB shares identity with an ornithine cyclodeaminase (VioK) 
encoded by the viomycin biosynthetic cluster of Streptomyces vinaceus 
(E values of 2e-45 and 5e-37, respectively).  S. vinaceus produces viomycin from 
precursors including L-DAPA (3).  It was hypothesized that the concerted roles 
of SbnA and SbnB might be to generate L-DAPA from L-ornithine and L-serine, 
whereby ammonia released from the cyclization of L-ornithine to L-proline by 
SbnB would be used as a nucleophile by amidotransferase SbnAB to aminate 
L-serine to L-DAPA (Figure A3). 
To test the hypothesis that SbnA and SbnB are required to produce 
L-DAPA for siderophore biosynthesis, attempts were made to rescue low-iron 
growth defects of S. aureus Newman sbnA and sbnB insertional inactivation 
mutants (Table A1) using L-DAPA.  Mutations were transduced into the Δsfa 
background (Table 2-1) to eliminate the compensatory function of SA.  On 
10 µM human holotransferrin as a sole iron source, the growth defects of 
sbnA::Km and sbnB::Km mutants but not that of the ΔsbnABCDEFGHI (Δsbn) 
mutant were rescued by application of 5 mM L-DAPA (Figure A3, A and B), but 
not its isomer D-DAPA (Figure A3, B) or the other predicted product of the 
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SbnA/SbnB reation, L-proline (Figure A3, C).  Furthermore, L-DAPA restored the 
siderophore output of the sbnA/sbnB mutants, as measured using the CAS 
assay (Figure A3, E and F).  The sbnA/B mutant phenotypes were also 
complementable in trans by expressing wild type copies of the genes from 
vector pALC2073 (Figure A3, D).  A final noteworthy observation was that 
exogenous application of L-DAPA massively increased the siderophore output of 
a sbn wild type strain (Figure A3, F), suggesting that procurement of this 
molecule may be a limiting factor in SB production. 
 
Materials and methods 
The sbnA::Tc and sbnB::Tc mutant alleles and vectors for complementing 
these mutations in trans were generated using methodologies described in 
Chapters 2 and 3.  Additional details are summarized briefly below: 
To create an inactivation allele, sbnA was PCR amplified using primers 
with engineered SacI and KpnI restriction sites and cloned into vector pBC SK+ 
between those sites.  A tetracycline resistance cassette was PCR amplified from 
vector pDG1513, digested with restriction enzymes NsiI and PstI, and ligated 
into a unique NsiI restriction site in sbnA within pBC SK+; this allele was excised 
and ligated into temperature-sensitive suicide shuttle vector pAUL-A using 
restriction enzymes KpnI and SacI, then integrated via double homologous 
recombination into the S. aureus RN6390 chromosome, and transduced to other 
strains essentially as described in Chapters 2 and 3.  To generate a 
complementation vector, sbnA was PCR amplified using primers with 
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engineered XhoI and EcoRI restriction sites and cloned directly to pALC2073, 
creating plasmid pFB5. 
To create an inactivation allele, sbnB was amplified using primers with 
engineered BamHI sites but cloned as a blunt-ended PCR product to vector 
pACYC184 digested with EcoRV.  A tetracycline resistance cassette was 
excised from vector pDG1514 with restriction enzymes NsiI and PstI and ligated 
into a unique PstI restriction site in sbnB within pACYC184; this allele was 
excised and ligated into temperature-sensitive suicide shuttle vector pAUL-A 
using restriction enzyme BamHI, then integrated via double homologous 
recombination into the S. aureus RN6390 chromosome prior to transduction.  To 
generate a complementation vector, sbnB was PCR amplified using primers with 
engineered EcoRI restriction sites and cloned directly to pALC2073, creating 
plasmid pSED52.   
For growth assays, bacteria were cultured in C-TMS with human 
holotransferrin as described in Chapter 2.  Amendments to the medium included  
5 µg/mL chloramphenicol (Bioshop) (complementation assay only), 5 mM L- or 
D-2,3-diaminopropionic acid (Iris Biotech GmbH), or 5 mM L-proline 
(Sigma-Aldrich). 
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Figure A3.   Proposed reactions for SbnA/SbnB-mediated generation of 
L-diaminopropionic acid from ornithine and serine.   
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Table A3:  Bacterial strains, plasmids, and oligonucleotides used in this 
study (see also Tables 2-1 and 3-1) 
 
 Description Ref. 
S. aureus strains   
H2131 Newman sbnA::Tc ΔsfaABCsfaD::Km This study 
H1718 Newman sbnB::Tc ΔsfaABCsfaD::Km This study 
Plasmids   
pACYC184 E. coli cloning vector; Cm
R 
ATCC 
pDG1514 pMTL23 derivative carrying tetracycline 
resistance cassette; ApR 
(2) 
pFB5 pALC2037 derivative carrying sbnA; Cm
R 
This study 
pSED52 pALC2037 derivative carrying sbnB; Cm
R This study 
Oligonucleotides*  
sbnA5’-SacI 
sbnA3’-KpnI 
5’ TGAGCTCGATTCTGTAGGGCAAACACC 3’ 
5’ TTGGTACCTCTAAGTAACGATCGCCTCG 3’ 
Cloning of sbnA into pBC SK+ 
Tet5’-NsiI 
Tet3’ 
5’ TTGTATATGCATACGGATTTTATGACCGATGA 3’ 
5’ TGTGTGGAATTGTGAGCGGATAAC  3’ 
Amplification/cloning of a tetracycline resistance cassette 
from pDG1513 
sbnA5’-XhoI 
sbnA3’-EcoRI 
5’ TTTCTCGAGATTTTAAATTTGAGGAGGAA 3’ 
5’ TTTGAATTCCCACATAAACTTGTGAATGATT 3’ 
Cloning of sbnA into pALC2073 
sbnB5’-BamHI 
sbnB3’-BamHI 
5’ TTGGATCCTAGTTTATTCAGATACATGG 3’ 
5’ TTGGATCCTGTCCCAATATTTTGTTGTT 3’ 
Cloning of sbnB into pACYC184 
sbnB5’-EcoRI 
sbnB3’-EcoRI 
5’ TTGAATTCTCAAGTGATCCATGTAGATG 3’ 
5’ TTGAATTCCAATTCCGGCTATATCTTCA 3’ 
Cloning of sbnB into pALC2073 
* underlined sequences in oligonucleotides denote restriction sites 
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Figure A4.   Low iron growth defects resulting from inactivation of sbnA 
and sbnB can be rescued with L-DAPA.  S. aureus Newman mutants (all 
Δsfa) were grown in C-TMS containing 10 µM human holotransferrin 
(approximately 60% saturated).  (A; E)  Inactivation of sbnA or sbnB, or deletion 
of the entire sbn operon, resulted in a growth defect, which could be rescued by 
addition of 50 µM FeCl3 (inset); this was due to loss of siderophore output, which 
could be repressed in the wild type by addition of FeCl3 (inset).  (B; F)  For the 
sbnA/B mutants this defect could be rescued by application of L-DAPA (L) but 
not D-DAPA (D); L-DAPA restored siderophore production.  (C)  L-proline could 
not rescue growth defects.  (D)  sbnA/B mutant growth defects could be rescued 
by expression of wild type copies of those genes from a plasmid. 
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